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I N T R O D U C T I O N   
Pelvic organ prolapse (POP) is defined as the downward displacement of one of the pelvic 
organs from its normal location. POP is part of the group of pelvic floor disorders, clinical 
conditions caused by dysfunction of the pelvic floor including urinary incontinence, fecal 
incontinence, lower urinary tract symptoms, defecatory dysfunction, sexual dysfunction and 
several chronic pain syndromes. Pelvic organ support depends on a combination of 
connective-tissue attachments (endopelvic fascia), tensile strength of the tissues and 
muscular support (levator ani muscle). This support has been categorized by deLancey in 
three levels [1]: level I: support of the upper third of the vagina/uterus by the cardinal and 
uterosacral ligaments to the sacrum and lateral pelvic side wall; level II: paravaginal 
attachments of the middle half of the vagina to the arcus tendineus fascia pelvis; level III: the 
fusion of the lower third of the vagina to the perineal membrane and perineal body (figure 1). 
Disruption of one of these structures can lead to loss of support and POP. Depending on the 
location of the defect and the organs involved, different types of prolapse can occur. The 
vagina is separated into three compartments: the anterior, posterior and apical 
compartment. A prolapse of the anterior vaginal wall leads to prolapse of the bladder and/or 
urethra, and is also called a (urethro) cystocele. A prolapse of the posterior vaginal wall is 
responsible for prolapse of rectum and or small bowel referred as a rectocele and 
enterocele. Prolapse of the apical compartment is known as uterine descent (if the uterus is 
still in place) or vaginal vault prolapse after hysterectomy. POP can be present in one 
compartment but usually occur in some combination of compartments.  
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
F i g u r e  1 .  DeLancey’s biomechanical levels. Level I: proximal suspension; level II: lateral attachment; level III: distal fusion.  
(From DeLancey JO. Anatomic aspects of vaginal eversion after hysterectomy. Am J Obstet Gynecol 1992;166:1717) 
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 Point Description  
Aa Anterior vaginal wall 3cm proximal to the 
hymen 
Ba Most distal portion of the anterior vaginal 
wall 
C Most distal edge of cervix or vaginal vault 
gh Genital hiatus – measured from middle of 
external urethral meatus to posterior 
midline hymen 
pb Perineal body – measured form posterior 
margin of gh to middle of anal opening 
tvl Total vaginal length – depth of vagina when 
point D or C is reduced to normal position 
Ap Posterior vaginal wall 3 cm proximal to the 
hymen 
Bp Most distal portion of the posterior vaginal 
wall 
D Posterior fornix (N/A if post hysterectomy) 
   
  
F i g u r e  2 .  POP-Q examination. (From Bump RC et al. The standardization of terminology of female POP and pelvic floor 
dysfunction. Am J Obstet Gynecol 1996;175:10)  
 
 
 
 
 
 
 
 
 
Stage 0 No pelvic organ prolapse  
Stage I  The maximal descent is > 1 cm above the hymenal remnants (outcome measure is < -1cm) 
Stage II The most distal portion of the prolapse is ≤ 1 cm proximal to or distal to the hymenal remnants (outcome 
measures are ≥ -1 cm but ≤ + 1 cm) 
Stage III The maximal descent is > 1 cm below the hymenal remnants but protrudes no further than 2 cm less than the 
TVL (outcome measure is > +1 cm, but < +(TVL-2)cm) 
Stage IV Complete eversion of the total vagina (outcome measure is ≥ + (TVL-2)cm) 
 
F i g u r e  3 .  POP-Q stages. (From Haylen BT et al. An International Urogynecological Association (IUGA)/ International 
Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Int Urogynecol J. 2010;21:5-26) 
P R E V A L E N C E  A N D  R I S K  F A C T O R S  
POP is one of the most common gynaecological problems. The exact prevalence is difficult to 
assess, as many women with POP may not seek medical attention. In a Dutch cross-sectional 
study, up to 40% of the women over 45 years of age had a prolapse stage two or higher on 
clinical examination. The lifetime risk for prolapse surgery is estimated to be 11-20% [2-4] 
and approximately 1 out of 6 women will need repeat surgery because of recurrent prolapse 
or urinary incontinence (UI) after surgery [5,6].  In 2009 about 13.000 POP procedures were 
performed in the Netherlands [7]. Prolapse development is multifactorial. Increased age, 
vaginal childbirth and obesity are established risk factors. But also other predisposing factors 
are known including constipation, connective tissue disorders, obstetric factors (forceps 
delivery, prolonged second stage of labour, infant birth weight > 4500g), race, occupations 
requiring heavy lifting, family history of prolapse and previous hysterectomy [8]  
 
P O P  S Y M P T O M S  
Although POP is not a life-threatening condition, it significantly affects women’s quality of life 
and may influence urinary, gastrointestinal, sexual and psychological functioning. In a Dutch 
cross-sectional study, symptomatic POP was found in 11.4% of the women aged between 45 
and 85 years [9]. Women with POP can present with one symptom such as seeing or feeling a 
vaginal bulge but also with other complaints like lower urinary tract symptoms, bowel 
problems, pain and sexual dysfunction. It is known that the correlation between POP 
symptoms and the stage of prolapse is weak [10]. The hymen is an important threshold for 
symptom development and of all symptoms the only one that is consistently reported is the 
presence of a vaginal bulge seen or felt [11]. The anterior vaginal wall supports the urethra 
and bladder. Therefore women with POP may report lower urinary tract symptoms. 
Approximately 40% of the women with POP stage 2 or higher reported stress urinary 
incontinence (SUI) and of the remaining 60%, 36 to 80% has occult SUI [12,13]. Women with 
POP also have a higher risk of overactive bladder symptoms (urgency, frequency and 
urgency incontinence) compared with the general population [14]. The most common bowel 
symptom associated with prolapse is constipation [10]. Other defecatory symptoms include 
faecal urgency, faecal incontinence and evacuating problems. Although sexual activity of 
women with POP has been reported comparable to women of the same age without POP, 
POP has a negative influence on sexual function [15].  One cohort study including 1.267 
sexually active women demonstrated that women with POP had lower scores on the Pelvic 
Organ Prolapse Urinary Incontinence Sexual Questionnaire short form (PISQ-12) than woman 
without POP [16].  
 
P O P  E X A M I N A T I O N   
Since 1996, the Pelvic Organ Prolapse Quantification system (POP-Q) is used to quantify the 
degree of POP [17]. This examination defines the stage of POP by measuring anterior, 
posterior and apical segments of the vaginal wall in cm relative to the hymen during Vasalva 
manoeuvre (figure 2). This assessment provides a reliable and reproducible staging system 
with good inter-observer reliability and the possibility to measure and compare pre-and 
postoperative values [18]. By using the POP-Q examination, prolapse can be divided in five 
different stages (figure 3).  
12
CHAPTER 1
501420-L-bw-Detollenaere
 Point Description
Aa Anterior vaginal wall 3cm proximal to the 
hymen
Ba Most distal portion of the anterior vaginal 
wall
C Most distal edge of cervix or vaginal vault
gh Genital hiatus – measured from middle of 
external urethral meatus to posterior 
midline hymen
pb Perineal body – measured form posterior 
margin of gh to middle of anal opening
tvl Total vaginal length – depth of vagina when 
point D or C is reduced to normal position
Ap Posterior vaginal wall 3 cm proximal to the 
hymen
Bp Most distal portion of the posterior vaginal 
wall
D Posterior fornix (N/A if post hysterectomy)
F i g u r e  2 .  POP-Q examination. (From Bump RC et al. The standardization of terminology of female POP and pelvic floor
dysfunction. Am J Obstet Gynecol 1996;175:10)  
Stage 0 No pelvic organ prolapse  
Stage I  The maximal descent is > 1 cm above the hymenal remnants (outcome measure is < -1cm) 
Stage II The most distal portion of the prolapse is ≤ 1 cm proximal to or distal to the hymenal remnants (outcome 
measures are ≥ -1 cm but ≤ + 1 cm) 
Stage III The maximal descent is > 1 cm below the hymenal remnants but protrudes no further than 2 cm less than the 
TVL (outcome measure is > +1 cm, but < +(TVL-2)cm) 
Stage IV Complete eversion of the total vagina (outcome measure is ≥ + (TVL-2)cm) 
F i g u r e  3 .  POP-Q stages. (From Haylen BT et al. An International Urogynecological Association (IUGA)/ International 
Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Int Urogynecol J. 2010;21:5-26)
13
GENERAL INTRODUCTION AND OUTLINE OF THE THESIS
1
501420-L-bw-Detollenaere
Outcome measures 
One major problem in evaluating effects of POP surgery is the range of outcome measures, 
which are not reported in a consistent manner. The International Urogynaecological 
Association (IUGA) and International Continence society (ICS) published a terminology report 
with definitions of surgery and a structure for reporting the outcomes of surgical procedures 
[32]. A study by Barber et al. evaluating 18 different surgical success definitions among 
women who underwent abdominal sacrocolpopexy showed that the definition of success 
significantly affects treatment success rates [33]. The absence of vaginal bulge symptoms 
postoperatively has a significant relationship with patient’s assessment of overall 
improvement, while anatomic success alone has not. Patient-reported outcomes prevail over 
objective outcomes such as POP-Q scores and anatomical failure or success. Validated 
questionnaires for patient reported outcomes used in The Netherlands, as advised by the 
Dutch Urogynaecological Society (Werkgroep Bekkenbodem NVOG), are the Urogenital 
Distress Inventory (UDI), Defecatory Distress Inventory (DDI), Incontinence Impact 
Questionnaire (IIQ), EuroQol 5D (EQ-5D) with five additional questions on sexual function 
and a Patient Global Impression of Improvement scale (PGI-I) in the follow-up version [34-37, 
appendix]. UDI, DDI and IIQ and EQ-5D scores range from 0 to 100, with low scores 
indicating little bother and good quality of life and high scores bothersome complaints and 
worst quality of life.  
To assess sexual functioning the Pelvic Organ Prolapse/Urinary Incontinence Sexual 
Questionnaire (PISQ-12) is recommended. This questionnaire is a shorter version of the 
original PISQ questionnaire and is validated for assessment of sexual function in women with 
POP [38,39] and recently a validated Dutch version has become available [40].  
 
O U T L I N E  O F  T H E  T H E S I S  
This thesis studies the surgical treatment of uterine prolapse. Emphasis is placed on the 
comparison of uterus preservation versus hysterectomy. In this thesis the following objectives 
are addressed:  
• What treatment do women in The Netherlands prefer (uterus preservation or removal) 
when uterine prolapse requires surgical management?  
• How do doctors in the Netherlands treat uterine prolapse? 
• How should women with uterine prolapse be treated and is there a difference in 
outcomes between uterus preservation and hysterectomy? 
  
C h a p t e r  2  describes the results of a systematic literature review regarding outcomes after 
uterus preserving procedures and vaginal hysterectomy in treatment of uterine prolapse. In 
this review the focus was on three categories of interventions, which include the most 
common uterus preserving procedures: vaginal surgery without the use of mesh, abdominal 
surgery with use of mesh and vaginal surgery with the use of mesh.  
 
In C h a p t e r  3  trends in surgical management of POP in the Netherlands and clinical practice of 
Dutch gynaecologists are presented.  
 
S U R G I C A L  P O P  T R E A T M E N T  
Management options for women with POP include observation, the use of a pessary, pelvic 
floor muscle training and surgery. The number of surgical POP procedures is increasing [7]. 
Possible explanations are: 1. increased life expectancy of women and women still being 
active at high age; 2. enhanced emphasis on quality of life; 3. decrease of coping or 
acceptance of POP and 4. POP procedures becoming less invasive and safer.   
In general, surgical POP treatment can be divided in obliterative and reconstructive 
procedures and can be performed by either abdominal or vaginal route. The vaginal route is 
being preferred as about 80-90% of all procedures are carried out vaginally [4,19]. In 
general, obliterative procedures are reserved for sexually inactive women with extensive co-
morbidity. The choice for surgical treatment of POP depends on the severity, symptoms, the 
patient’s general condition and the preference and capabilities of the surgeon. Main goals 
for surgical POP treatment are to restore normal pelvic anatomy, to restore or maintain 
normal urinary, bowel and sexual function, to reduce the impact of symptoms and to improve 
quality of life. When choosing a surgical procedure for POP different issues must be 
considered: 1. Should the uterus be preserved or removed in case of uterine prolapse? 2. 
What is the safest and best treatment in this particular patient taking risk factors into account? 
3. Is there an indication to perform concomitant anti-incontinence surgery? 4. Is there a need 
for the use of mesh? In this thesis we will focus on the first issue: should the uterus be 
preserved or removed in case of uterine prolapse.  
 
Uterus preservation or hysterectomy 
Traditionally, vaginal hysterectomy was the standard treatment for uterine prolapse. Uterus 
preserving procedures, however, are becoming more popular worldwide [20,21]. Possible 
explanations might be that the uterus is considered as ‘a victim’ and not the cause of POP 
and the higher risk of future POP after hysterectomy. There is growing acceptance that 
restoration of level I support is important in achieving successful outcome in prolapse surgery 
[22]. Therefore, performing only a vaginal hysterectomy is considered to be an inappropriate 
treatment to prevent future prolapse and additional support of the vaginal apex after 
hysterectomy is recommended [23,24]. Different vaginal vault suspension techniques are 
available but randomised trials comparing these different techniques are sparse.  
Of the different reconstructive uterus preserving procedures the sacrospinous hysteropexy 
and Manchester-Fothergill procedure (vaginal route) and abdominal hysteropexy (abdominal 
route) are the most used techniques. Advantage of uterus preservation is that recovery time 
is shorter, procedures are often quicker to perform and procedures are less invasive with less 
blood loss  [20,25-27]. Hysterectomy may cause surgical injury to the innervation and 
vascularisation of the pelvic floor muscles and even more disrupt supportive structures of the 
pelvic floor, exposing women to an increased risk for recurrent POP and stress-incontinence 
[28-31]. This adverse effect does potentially not occur after uterus preservation and fixation. 
However, little is known on uterus preservation and randomised studies to compare these 
procedures with hysterectomy are limited.  
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considered: 1. Should the uterus be preserved or removed in case of uterine prolapse? 2. 
What is the safest and best treatment in this particular patient taking risk factors into account? 
3. Is there an indication to perform concomitant anti-incontinence surgery? 4. Is there a need 
for the use of mesh? In this thesis we will focus on the first issue: should the uterus be 
preserved or removed in case of uterine prolapse.  
 
Uterus preservation or hysterectomy 
Traditionally, vaginal hysterectomy was the standard treatment for uterine prolapse. Uterus 
preserving procedures, however, are becoming more popular worldwide [20,21]. Possible 
explanations might be that the uterus is considered as ‘a victim’ and not the cause of POP 
and the higher risk of future POP after hysterectomy. There is growing acceptance that 
restoration of level I support is important in achieving successful outcome in prolapse surgery 
[22]. Therefore, performing only a vaginal hysterectomy is considered to be an inappropriate 
treatment to prevent future prolapse and additional support of the vaginal apex after 
hysterectomy is recommended [23,24]. Different vaginal vault suspension techniques are 
available but randomised trials comparing these different techniques are sparse.  
Of the different reconstructive uterus preserving procedures the sacrospinous hysteropexy 
and Manchester-Fothergill procedure (vaginal route) and abdominal hysteropexy (abdominal 
route) are the most used techniques. Advantage of uterus preservation is that recovery time 
is shorter, procedures are often quicker to perform and procedures are less invasive with less 
blood loss  [20,25-27]. Hysterectomy may cause surgical injury to the innervation and 
vascularisation of the pelvic floor muscles and even more disrupt supportive structures of the 
pelvic floor, exposing women to an increased risk for recurrent POP and stress-incontinence 
[28-31]. This adverse effect does potentially not occur after uterus preservation and fixation. 
However, little is known on uterus preservation and randomised studies to compare these 
procedures with hysterectomy are limited.  
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E X T E N D E D  A B S T R A C T  
 
O b j e c t i v E :  To compare outcomes after uterus preserving procedures and vaginal 
hysterectomy in treatment of uterine descent. 
D e s i g n :   Systematic review. 
Me t h o d s :  We searched Pubmed, Embase, the Cochrane Library and the reference lists of 
relevant publications to select articles which compared uterus preserving procedures with a 
vaginal hysterectomy in the period 1985-2010. For this review we focused on three 
categories of interventions, which includes the most common uterus preserving procedures: 
1. vaginal surgery without the use of mesh, 2. abdominal surgery with use of mesh and 3. 
vaginal surgery with the use of mesh. For each technique, we used different terms that were 
linked to the search filters: ‘woman’ and ‘article in English. Also, a search was conducted with 
the term ‘prolapse’ combined with one of the following terms: "uterine suspension," "uterus 
sparing surgery ‘and’ uterine preservation. Based on title, abstract and following selection 
criteria one reviewer (RJD) assessed if an article was relevant. In case of doubt a second 
reviewer (HWFE) was asked and consensus was obtained by discussion. The following 
outcome measures were studied: recurrence of prolapse, subjective outcome regarding 
prolapse complaints, micturition, defecation and sexual function, general quality of life, 
duration of surgery, duration of hospital stay, amount of blood loss, complications and 
postoperative recovery. Methodological quality was assessed by two reviewers (RJD and 
HWFE) using the Delphi list. The articles were also scored based on the levels of evidence. 
R e s u l t s :  Based on the prior mentioned selection criteria we selected one systematic 
Cochrane review, one randomised trial, one prospective and four retrospective studies. From 
the Cochrane review two studies could be used for this review, so eight studies were 
available for analysis. There was no difference in subjective outcome after sacrospinous 
hysteropexy, Manchester-Fothergill procedure, abdominal hysteropexy and intravaginal 
slingplasty compared to vaginal hysterectomy. All procedures, except for sacrospinous 
hysteropexy, had similar anatomical outcome compared with vaginal hysterectomy. Hospital 
stay was shorter after uterus preserving procedures except for Manchester-Fothergill 
procedure. The quality of the different studies assessed by the mentioned strategy above 
was poor with the highest level of evidence for the different studies being level B. Small 
numbers of patients were included, long term follow up was lacking and there was evidence 
of selection bias due to the retrospective design of some studies. 
C o n c l u s i o n s :  Although some of the uterus preserving procedures are associated with shorter 
operation time, shorter duration of hospital stay and less blood loss compared to vaginal 
hysterectomy, based on the current literature there is no clear preference for either uterus 
preserving surgery or hysterectomy in surgical treatment of uterine descent. Randomized 
trials of sufficient quality are lacking. Therefore a large randomized multi center study was 
started in The Netherlands to compare sacrospinous hysteropexy with vaginal hysterectomy 
in the treatment of uterine descent stage two or higher (Nederlands Trial Register 1866). 
Anatomical outcome, subjective improvement in quality of life measured, complications 
following surgery, hospital stay, post-operative recovery and sexual functioning will be 
compared during five years of follow-up. More clinical randomized trials with long-term 
follow-up are needed to investigate the value of other uterus preserving procedures. 
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I N T R O D U C T I E  
Uterovaginale prolaps is een van de meest voorkomende benigne gynaecologische 
aandoeningen en heeft een grote invloed op de kwaliteit van leven. Ongeveer 40% van de 
vrouwen van 45 jaar en ouder heeft een prolaps net boven of voorbij de hymenale ring [1]. 
Vaginale baring, ouderdom, familiaire aanleg en obesitas zijn de belangrijkste risicofactoren 
voor het ontstaan van uterovaginale prolaps. De kans op een chirurgische behandeling 
wegens prolapsklachten is 11-20% [2,3]. In Nederland worden ongeveer 13.000 
prolapsoperaties per jaar verricht (bron:www.prismant.nl). De verwachting is dat dit aantal de 
komende jaren sterk zal toenemen doordat het aantal 65-plussers binnen nu en 2040 bijna 
zal verdubbelen (www.nationaalkompas.nl/bevolking/vergrijzing/toekomst). 
Wereldwijd is een vaginale hysterectomie altijd de standaard operatieve behandeling 
geweest van patiënten met een descensus uteri. In de literatuur is in toenemende mate 
discussie over de effectiviteit en gevolgen van een hysterectomie. Door schade aan 
bekkenbodem en zenuw- voorziening zou er een verhoogd risico bestaan op incontinentie 
en blaasdisfunctie [4,5]. Daarnaast laten studies zien dat het risico op een heroperatie in 
verband met recidiefprolaps verhoogd is na een hysterectomie wegens prolaps [6-8]. Bij een 
uterusprolaps kunnen de urethra en de blaas (het voorste compartiment) of het rectum 
(achterste compartiment) betrokken zijn. Het operatieve herstel van het voorste of achterste 
compartiment is minder succesvol als er geen adequate ondersteuning bestaat van het 
middelste compartiment, waarin zich de uterus bevindt. Dit maakt fixatie van de vaginatop na 
hysterectomie dan ook zeer belangrijk [9]. Vanuit de gedachte dat de uterus zelf niet de 
oorzaak van de prolaps is, groeit de laatste jaren de interesse voor uterussparende ingrepen. 
Ondergingen in 1999 in Nederland nog 3517 vrouwen een vaginale hysterectomie vanwege 
prolaps, in 2009 was dit aantal gedaald naar 2969 terwijl het totaal aantal prolapsoperaties 
was gestegen (bron: www.prismant.nl). Vrouwen met uterovaginale prolaps zijn vaak ouder 
dan gemiddeld en hebben door hun hogere leeftijd een verhoogd risico op perioperatieve 
complicaties [10]. Als conservatieve therapie faalt, zou het primair sparen van de uterus 
voordelen kunnen hebben ten opzichte van een hysterectomie omdat dit mogelijk met 
minder morbiditeit gepaard gaat en de patiënt sneller zou kunnen herstellen. In een 
systematisch literatuuronderzoek vergeleken wij diverse uterussparende ingrepen met de 
huidige standaardbehandeling, de vaginale hysterectomie. 
 
D A T A  E N  M E T H O D E  
Zoekstrategie: In Pubmed, Embase en de cochrane-database voor systematische reviews 
zochten we naar onderzoeken uit de periode 1985-2010 waarin uterussparende chirurgische 
ingrepen werden vergeleken met een vaginale hysterectomie. Ook bekeken we de 
literatuurlijsten van de gevonden publicaties. We spitsten deze review toe op 3 categorieën 
interventies waar de meest toegepaste uterussparende ingrepen onder vallen: (a) vaginale 
chirurgie zonder 
gebruik van kunststofmateriaal; (b) abdominale chirurgie; (c) vaginale chirurgie met gebruik 
van kunststofmateriaal. Voor elke techniek gebruikten we aparte zoektermen die gekoppeld 
waren aan de zoekfilters ‘vrouw’ en ‘artikel in het Engels’. Ook werd een zoekactie verricht 
met de zoekterm ‘prolapse’ gecombineerd met een van de volgende termen: ‘uterine 
suspension’, ‘uterus sparing surgery’ en ‘uterine preservation’. Op basis van titel, 
	  
  	  
 
A B S T R A C T  
 
D o e l :  Het vergelijken van de gepubliceerde uitkomsten van uterussparende operatieve 
technieken en vaginale hysterectomie in de behandeling van descensus uteri. 
O p z e t :  Systematische review. 
Me t h o d e :  We zochten in Pubmed, Embase, de Cochrane Library en in de 
literatuurlijsten van gevonden publicaties naar relevante artikelen waarin uterussparende 
ingrepen werden vergeleken met een vaginale hysterectomie. De volgende uitkomstmaten 
werden bestudeerd: anatomisch resultaat, subjectieve uitkomst wat betreft prolapsklachten, 
mictie, defecatie en seksueel functioneren, kwaliteit van leven, operatieduur, duur 
ziekenhuisopname, hoeveelheid bloedverlies, complicaties en postoperatief herstel. 
R e s u l t a t e n :  We vonden 1 systematische review, 1 gerandomiseerde studie en 5 
cohortstudies, waarbij uiteindelijk 8 vergelijkende studies werden geselecteerd voor analyse. 
Er was geen verschil in subjectieve uitkomst na sacrospinale fixatie, Manchester-Fothergill 
procedure, abdominale hysteropexie en intravaginale-slingplastiek in vergelijking met een 
vaginale hysterectomie. Afgezien van sacrospinale fixatie hadden alle ingrepen een 
gelijkwaardig anatomische resultaat vergeleken met vaginale hysterectomie; de 
opnameduur was korter bij de uterussparende ingrepen, behoudens de Manchester-
Fothergill procedure. De methodologische kwaliteit van de meeste studies was laag. Vaak 
werden kleine groepen patiënten geïncludeerd en was er sprake van een korte follow-
upduur. 
C o n c l u s i e :  Hoewel bij sommige uterussparende ingrepen de operatietijd en de opnameduur 
korter zijn en minder bloedverlies optreedt dan bij vaginale hysterectomie, kan op basis van 
de huidige literatuur geen duidelijke voorkeur worden uitgesproken voor het verwijderen 
dan wel sparen van de uterus als operatieve behandeling van descensus uteri, omdat 
gerandomiseerd onderzoek van voldoende kwaliteit ontbreekt. Prospectieve gecontroleerde 
en gerandomiseerde studies met langdurige follow-up zijn nodig om de waarde van 
uterussparende ingrepen vast te stellen.  
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T A B E L  1 .  Overzicht van studies waarin een uterussparende interventie werd vergeleken met vaginale hysterectomie als 
behandeling van descensus uteri. 
 
Interventie 
Eerste auteur Aantal 
patiënten 
Uitkomstmaat Resultaat uterussparende 
interventie versus VUE* 
V A G I N A L E  U T E R U S S P A R E N D E  C H I R U R G I E  Z O N D E R  
T O E P A S S I N G  V A N  K U N S T S T O F M A T E R I A A L  
Sacrospinale fixatie Dietz [15] 66 Anatomisch resultaat 27 versus 3% recidief 
   Subjectieve uitkomst Geen verschil 
   Kwaliteit van leven Geen verschil 
   Duur ziekenhuisopname 3 versus 4 dagen (mediaan) 
   Complicaties Geen verschil 
   Postoperatief herstel 43 versus 66 dagen tot 
terugkeer werk 
 Jeng [14] 158 Seksueel functioneren Geen verschil 
Manchester-Fothergill-
procedure 
de Boer [17] 156 Anatomisch resultaat Geen verschil 
   Subjectieve uitkomst Geen verschil 
   Duur operatie 78 versus 110 min 
   Duur ziekenhuisopname 6,1 versus 5,2 dagen 
   Complicaties Geen verschil 
   Bloedverlies 191 versus 251 ml 
 Thomas [18] 233 Duur operatie 110 versus 130 min 
   Duur ziekenhuisopname Geen verschil 
   Bloedverlies 200 versus 300 ml 
 Kalogirou [19] 421 Duur operatie 110 versus 130 min 
   Duur ziekenhuisopname Geen verschil 
   Bloedverlies 200 versus 180 ml 
Obliteratieve procedure Geen studie 
gevonden 
  
A B D O M I N A L E  U T E R U S S P A R E N D E  C H I R U R G I E  
M E T  T O E P A S S I N G  V A N  K U N S T S T O F M A T E R I A A L  
Abdominale hysteropexie 
per laparotomie 
Roovers [16] 82 Anatomisch resultaat Geen verschil 
   Subjectieve uitkomst Na hysteropexie gemiddeld 
hogere scores voor pijn, 
overactieve blaas en 
obstructieve mictie 
   Duur operatie Geen verschil 
   Duur ziekenhuisopname Geen verschil 
   Complicaties Geen verschil 
   Bloedverlies Geen verschil 
Laparoscopische 
abdominale hysteropexie 
Diwan [20] 50 Anatomisch resultaat Cervix na hysteropexie 
gemiddeld iets 'hoger' dan 
vaginatop na hysterectomie, 
met hymenale ring als 
referentiepunt 
   Subjectieve uitkomst Geen verschil 
   Duur ziekenhuisopname 1,1 versus 1,7 dagen 
   Complicaties Geen verschil 
   Bloedverlies 72 versus 227 ml 
V A G I N A L E  U T E R U S S P A R E N D E  C H I R U R G I E  
M E T  T O E P A S S I N G  V A N  K U N S T S T O F M A T E R I A A L  
Intravaginale 'sling'  Neuman [21] 79 Anatomisch resultaat Geen verschil 
   Subjectieve uitkomst Geen verschil 
   Duur ziekenhuisopname 1,5 versus 4,2 dagen 
   Complicaties Geen verschil 
VUE = vaginale hysterectomie.  
*Alleen bij statistisch significante resultaten worden waarden weergegeven; dit zijn gemiddelden, tenzij anders 
aangegeven.  
	  
  	  
 
samenvatting en onderstaande selectiecriteria besloot een beoordelaar (R.J.D.) of een artikel 
relevant was. Bij twijfel werd overlegd met een tweede beoordelaar (H.W.F.E.) en in overleg 
werd consensus bereikt. 
 
Selectiecriteria: Artikelen werden geselecteerd als ze rapporteerden over één of meer 
gerandomiseerde, prospectieve of retrospectieve studies waarin een uterussparende 
behandeling werd vergeleken met een vaginale hysterectomie als behandeling van 
descensus uteri. Voor elke behandeling zochten we naar wetenschappelijk bewijs met de 
hoogste bewijskracht: in de eerste plaats naar systematische reviews, daarna naar 
‘randomized controlled trials’ (RCT’s) en tenslotte naar andere onderzoeksartikelen als 
prospectieve en retrospectieve klinische studies. Hierbij werden de volgende uitkomstmaten 
bestudeerd: anatomisch resultaat beschreven met behulp van het POP-Q-
classificatiesysteem of het Baden-Walker-systeem, subjectieve uitkomst wat betreft 
prolapsklachten, mictie en defecatie en seksueel functioneren, kwaliteit van leven, 
operatieduur, duur van de ziekenhuisopname, complicaties en postoperatief herstel. Studies 
waarin zowel een uterussparende ingreep als een vaginale hysterectomie waren verricht 
maar de resultaten van de 2 groepen niet apart werden gerapporteerd, werden 
geëxcludeerd, evenals casusbeschrijvingen. 
 
Beoordeling validiteit en bewijskracht: Studies werden methodologisch beoordeeld door 2 
onderzoekers (R.J.D. en H.W.F.E.) aan de hand van de delphicriteria [11]. Deze lijst bevat 9 
items, waaronder randomisatie, blindering en ‘intention to treat’-analyse. Hoewel deze lijst 
met name geschikt is voor beoordeling van de validiteit van RCT’s werden ook niet-
gerandomiseerde studies beoordeeld aan de hand van deze criteria. Daarnaast werden 
artikelen gescoord op niveau van bewijskracht. Het hoogste niveau van bewijskracht (niveau 
A1) betreft een systematische review van tenminste 2 onafhankelijk van elkaar uitgevoerde 
onderzoeken van A2-niveau. Niveau A2 betreft gerandomiseerd dubbelblind vergelijkend 
klinisch onderzoek van goede kwaliteit en voldoende omvang. Niveau B betreft vergelijkend 
onderzoek dat niet aan alle criteria voor niveau A2 voldoet (hieronder valt ook 
patiëntcontroleonderzoek en cohortonderzoek). Daarna komen niet-vergelijkend onderzoek 
(niveau C) en mening van deskundigen (niveau D). 
 
R E S U L T A T E N  E N  B E S C H O U W I N G  
Geselecteerde artikelen: Op basis van de genoemde criteria vonden we 1 systematische 
Cochrane review, 1 gerandomiseerde studie, 1 prospectieve en 4 retrospectieve 
cohortstudies. In de Cochrane review over de chirurgische behandeling van uterovaginale 
prolaps waren 3 gerandomiseerde studies geïncludeerd waarin een uterussparende 
behandeling was vergeleken met een vaginale hysterectomie [12]. In 2 studies werden 
sacrospinale fixatie en vaginale hysterectomie met elkaar vergeleken [13,14]. Een van deze 
studies betrof een abstract van een congres en de resultaten van deze studie werden later 
gepubliceerd in een artikel [13]. In onze review namen we alleen het gepubliceerde artikel 
op [15]. De derde studie in de Cochrane review vergeleek abdominale hysteropexie met 
vaginale hysterectomie [16]. In totaal waren 8 vergelijkende studies beschikbaar voor analyse  
(tabel 1). 
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‘randomized controlled trials’ (RCT’s) en tenslotte naar andere onderzoeksartikelen als 
prospectieve en retrospectieve klinische studies. Hierbij werden de volgende uitkomstmaten 
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maar de resultaten van de 2 groepen niet apart werden gerapporteerd, werden 
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R E S U L T A T E N  E N  B E S C H O U W I N G  
Geselecteerde artikelen: Op basis van de genoemde criteria vonden we 1 systematische 
Cochrane review, 1 gerandomiseerde studie, 1 prospectieve en 4 retrospectieve 
cohortstudies. In de Cochrane review over de chirurgische behandeling van uterovaginale 
prolaps waren 3 gerandomiseerde studies geïncludeerd waarin een uterussparende 
behandeling was vergeleken met een vaginale hysterectomie [12]. In 2 studies werden 
sacrospinale fixatie en vaginale hysterectomie met elkaar vergeleken [13,14]. Een van deze 
studies betrof een abstract van een congres en de resultaten van deze studie werden later 
gepubliceerd in een artikel [13]. In onze review namen we alleen het gepubliceerde artikel 
op [15]. De derde studie in de Cochrane review vergeleek abdominale hysteropexie met 
vaginale hysterectomie [16]. In totaal waren 8 vergelijkende studies beschikbaar voor analyse  
(tabel 1). 
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F I G U U R  1  ( a )  Descensus uteri vóór een operatieve ingreep. De oorspronkelijke positie van de uterus is met een rode 
stippellijn aangegeven. ( b )  Positie van de uterus na een sacrospinale fixatie, waarbij de cervix met 2 niet-oplosbare 
hechtingen is gefixeerd aan het sacrospinale ligament. Dit resulteert in elevatie van de uterus. 
 
Manchester - f o therg i l l   
De klassieke Manchester-Fothergill procedure bestaat uit een cervixamputatie, een 
voorwandplastiek en het vasthechten van de paracervicale ligamenten (ligamentum 
cardinale) aan het anterieure gedeelte van de cervixstomp (figuur 2). Als modernere variant 
worden de sacro-uteriene ligamenten gereefd. Deze ingreep wordt vaak toegepast als er 
naast een descensus van de uterus een verlenging van de cervix (elongatio colli) bestaat. We 
vonden 3 retrospectieve studies waarin de uitkomst na een – al dan niet gemodificeerde –  
Manchester-Fothergill procedure werd vergeleken met een hysterectomie (zie tabel 1) [17-
19]. Een Nederlandse studie liet zien dat er geen verschil was in anatomische uitkomst en 
subjectieve uitkomst na 1 jaar follow-up [17]. De opnameduur was in deze studie wel 
significant korter na vaginale hysterectomie, terwijl de andere 2 studies geen verschil 
toonden. Volgens 2 studies was het bloedverlies na de Manchester-Fothergill procedure 
statistisch significant minder, terwijl de derde studie juist een groter bloedverlies vond dan 
bij de vaginale hysterectomie. Na een cervicale amputatie kan stenosering van het cervicale 
kanaal optreden. Naast het ontstaan van haematometra (ophoping van bloed in de uterus) 
kan een stenose tot gevolg hebben dat vaginaal bloedverlies als alarmsymptoom van een 
endometriumcarcinoom uitblijft waardoor een vertraging in diagnosestelling ontstaat. In 
geen van de 3 studies werd het optreden van een cervicale stenose beschreven. 
	  
  	  
 
 
Kwaliteit studies: De kwaliteit van de verschillende gerandomiseerde en niet-
gerandomiseerde studies was laag (tabel 2). De patiëntenaantallen waren klein en de 
uitkomst werd postoperatief vaak beoordeeld door de operateur, waarbij onduidelijk was of 
de effectbeoordelaar geblindeerd was voor de interventies. Ook was er sprake van 
selectiebias in de observationele studies, waarin bijvoorbeeld oudere patiënten vaker een 
uterussparende ingreep kregen of omgekeerd. Het hoogste niveau van bewijskracht voor de 
verschillende behandelingen was niveau B. 
 
T A B E L  2 .  Kwaliteit van vergelijkende onderzoeken naar uterussparende interventies als behandeling voor uterusprolaps 
 
Eerste auteur Opzet Analyse volgens 'intention to treat' 
Vergelijkbare 
groepen* 
Niveau 
bewijskracht† 
Dietz [15] RCT Ja Ja‡ B 
Jeng§ [14] RCT; randomisatie onduidelijk Onbekend Ja B 
de Boer [17] Retrospectief vergelijkend onderzoek Onbekend Nee B 
Thomas [18] Retrospectief vergelijkend onderzoek Onbekend Nee B 
Kalogirou [19] Retrospectief vergelijkend onderzoek Onbekend Nee B 
Roovers§ [16] RCT Ja Ja‡ B 
Diwan [20] Retrospectief vergelijkend onderzoek Onbekend Ja B 
Neuman [21] Prospectief vergelijkend onderzoek Onbekend Ja B 
 
*Vergelijkbaar voor wat betreft de belangrijkste prognostische variabelen aan het begin van de studie. 
†Niveau B: vergelijkend onderzoek dat niet voldoet aan alle criteria voor niveau A (gerandomiseerd, dubbelblind klinisch 
onderzoek van goede kwaliteit en voldoende omvang). In geen van de onderzoeken waren de patiënten of de 
behandelaars geblindeerd; het is onbekend of de effectbeoordelaars geblindeerd waren. 
‡Kleine groepsgrootte. 
§Deze studie was opgenomen in een cochranereview [12] 
 
VAGINALE CHIRURGIE ZONDER GEBRUIK VAN KUNSTSTOF 
F i xa t i e  s acrosp i naa l  l i g ament   
De sacrospinale-ligamentfixatie (SSF) is een techniek waarbij de cervix met 2 niet-oplosbare 
hechtingen wordt gefixeerd aan het rechter sacrospinale ligament en boven het niveau van 
de M. levator ani wordt gebracht (figuur 1). Deze ingreep vindt plaats middels vaginale 
toegang via de pararectale ruimte. Wij vonden 2 vergelijkende studies waarin deze techniek 
was toegepast. In een Nederlandse gerandomiseerde studie was het recidiefpercentage van 
descensus uteri 12 maanden na een SSF statistisch significant hoger dan het percentage 
topprolaps na vaginale hysterectomie [15]. Het aantal heroperaties en de subjectieve 
uitkomst in beide groepen verschilden echter niet; wel konden patiënten na een SSF eerder 
uit het ziekenhuis ontslagen worden en sneller hun werkzaamheden hervatten (zie tabel 1). In 
een andere gerandomiseerde studie werden het seksueel functioneren na SSF en na 
vaginale hysterectomie vergeleken [14]. Er werd geen verschil gerapporteerd in dyspareunie 
na beide ingrepen. Wel hadden vrouwen na een SSF vaker last van pijn in de bil. Dit 
fenomeen wordt veroorzaakt door tractie aan het ligamentum sacrospinale of door letsel of 
beknelling van de N. pudendus [22]. Herstel hiervan treedt doorgaans binnen enkele weken 
op. Slechts bij een enkele patiënt moeten de hechtingen worden doorgenomen vanwege 
persisterende pijnklachten of zenuwuitval. 
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Obl i t erat i e v e  ch i rurg i e   
De partiële colpocleisis volgens Le Fort en de hoge perineoplastiek volgens Labhardt 
werden eerder in het Tijdschrift beschreven [23]. Bij een partiële colpocleisis worden voor- 
en achterwand met elkaar verbonden door 2 gelijke rechthoeken in de vaginavoorwand en 
achterwand te verwijderen en de randen met elkaar te verbinden. Hierdoor wordt de vagina 
afgesloten (figuur 3). Doordat niet het gehele epitheel van de wanden wordt verwijderd, blijft 
er aan beide kanten een tunneltje open voor drainage. Er waren geen studies waarin een 
obliteratieve ingreep werd vergeleken met vaginale hysterectomie of een niet obliteratieve 
uterussparende operatie. De belangrijkste verklaring voor het ontbreken van prospectief 
gerandomiseerd onderzoek is dat de obliteratieve technieken met name worden toegepast 
bij oudere, niet-seksueel actieve vrouwen met ernstige comorbiditeit. Bij deze groep wordt 
verondersteld dat een vaginale hysterectomie met meer morbiditeit gepaard zou kunnen 
gaan, hoewel hier feitelijk geen concreet bewijs voor bestaat. 
 
ABDOMINALE INGREPEN MET GEBRUIK VAN KUNSTSTOF 
Abdom ina l e  f i xa t i e  v an  d e  u t erus  p er  l a parotom i e   
Bij sacrohysteropexie wordt via laparotomie een kunststofmatje gefixeerd aan de cervix en 
vagina en het promontorium (figuur 4). Wij vonden 1 vergelijkend onderzoek waarin deze 
techniek was toegepast (zie tabel 1) [16]. In deze gerandomiseerde studie was er 1 jaar na de 
ingreep geen verschil in anatomisch resultaat tussen patiënten die abdominale hysteropexie 
en degenen die vaginale hysterectomie hadden ondergaan (n = 82) [16]. Een jaar na de 
ingreep ervoeren vrouwen na vaginale hysterectomie minder klachten van pijn, een 
overactieve blaas of obstructieve mictie en waren er minder heroperaties nodig vanwege 
recidiefprolaps. Een aanvullende analyse in een systematische review beschreef de 
uitkomsten van deze studie na 8 jaar follow-up (n = 74) [12]. Na abdominale hysteropexie 
hadden meer vrouwen een arts geconsulteerd met klachten en hadden zij vaker klachten van 
obstipatie gerapporteerd. Toch was de conclusie dat er op lange termijn geen verschil 
tussen beide ingrepen bestond, omdat de anatomische uitkomst, mictiegerelateerde 
klachten en het aantal heroperaties vergelijkbaar waren. 
 
Abdom ina l e  f i xa t i e  v an  d e  u t erus  p er  l a paroscop i e  
In de literatuur worden diverse uterussparende laparoscopische technieken voor de 
behandeling van descensus uteri beschreven. Fixatie van de uterus aan de sacro-uteriene 
ligamenten en fixatie van de uterus aan het sacrum zijn de vaakst beschreven methoden. Wij 
vonden slechts 1 studie die de uitkomsten van laparoscopische sacro-uteriene 
ligamentsuspensie (LSULS) vergeleek met die van vaginale hysterectomie; dit was een 
retrospectief onderzoek (zie tabel 1) [20]. Er was geen verschil in het optreden van 
complicaties terwijl de opnameduur korter was na LSULS. In de LSULS groep zat de cervix 
gemiddeld iets ‘hoger’ dan de vaginatop bij vrouwen die een hysterectomie hadden 
ondergaan, met de hymenale ring als referentiepunt. 
	  
  	  
 
F I G U U R  2 .  ( a )  Descensus uteri vóór een operatieve ingreep.  De oorspronkelijke positie van de uterus is met een rode 
stippellijn aangegeven. ( b )  Positie van de uterus na een Manchester-Fothergill procedure met cervixamputatie en het 
vasthechten van de paracervicale ligamenten aan het anterieure gedeelte van de cervixstomp. De voorwandplastiek die bij 
deze procedure wordt uitgevoerd, is niet afgebeeld. 
 
 
 
 
F I G U U R  3 .  Partiële colpocleisis volgens LeFort. Hierbij wordt de vagina afgesloten door twee gelijke rechthoeken in de 
vaginavoorwand en -achterwand te verwijderen en de randen met elkaar te verbinden; door niet het gehele epitheel te 
verwijderen blijft er een tunneltje open voor drainage waarlangs eventueel pus of bloed kan passeren. 
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van de patiënt, de voorkeur van de behandelend gynaecoloog voor verschillende 
chirurgische ingrepen en zijn of haar ervaring daarmee. Klinisch gerandomiseerd onderzoek 
met voldoende patiënten en langdurige follow-up is van belang om te onderzoeken welke 
ingreep de effectiefste is. Daarnaast is voor de preoperatieve counseling van patiënten 
belangrijk dat er meer onderbouwing komt van de uitkomsten na uterussparende chirurgie 
en vaginale hysterectomie. Om die reden is in Nederland een grote multicentrische studie 
gestart, de SAVE U-trial, die sacrospinale fixatie vergelijkt met vaginale hysterectomie 
(www.trialregister.nl/trialreg/admin/rctview.asp?TC=1866). Tijdens een follow-up van 60 
maanden zal onderzocht worden of beide ingrepen gelijke resultaten behalen wat betreft 
anatomisch resultaat, kwaliteit van leven, opnameduur, complicaties, seksueel functioneren 
en postoperatief herstel. Meer klinische gerandomiseerde studies zijn nodig voor 
vergelijkend onderzoek van andere therapeutische interventies bij patiënten met descensus 
uteri. 
	  
  	  
 
 
F I G U U R  4 .  Abdominale hysteropexie. Hierbij wordt de uterus laparoscopisch of tijdens laparotomie met behulp van een 
kunststofmatje aan het sacrum gefixeerd. 
 
VAGINALE CHIRURGIE MET TOEPASSING VAN KUNSTSTOF 
In 2001 werd de intravaginale ‘sling’ (IVS) ontwikkeld. Hierbij wordt paravaginaal door de 
fossa ischioanalis een 1 cm brede polypropyleenband aangebracht die aan de cervix (of 
vaginatop) wordt gefixeerd en deze eleveert [24]. ‘Mesh kits’, kant-en-klare kunststofmatjes 
voorzien van inbrengmateriaal, die met name zijn ontwikkeld voor toepassing in het voorste 
en achterste compartiment van het bekken, bieden eveneens de mogelijkheid om de cervix 
aan de mesh te fixeren; ook daarbij wordt een elevatie van de uterus bereikt. In 1 
prospectieve niet-gerandomiseerde studie werd IVS met behoud van de uterus vergeleken 
met IVS gecombineerd met vaginale hysterectomie (zie tabel 1) [21]. De conclusie was dat 
het anatomische resultaat, de subjectieve uitkomst en het aantal complicaties niet 
verschilden tussen beide ingrepen na gemiddeld 29,8 maanden follow-up. De gemiddelde 
opnameduur was significant korter na de IVS-procedure met behoud van de uterus (1,5 
versus 4,2 dagen). Het matje kwam bloot te liggen in de vaginawand (‘mesh exposure’) bij 
13,6% van de vrouwen die een hysterectomie hadden ondergaan en bij 11,4% van de 
vrouwen bij wie de uterus was behouden. Hoewel toepassing van kunststofmatjes mogelijk 
vaker gepaard gaat met dyspareunie dan wanneer géén kunststofmatje wordt gebruikt, had 
geen van de patiënten in deze 2 groepen postoperatief klachten van deze aard. 
 
C O N C L U S I E  
Op basis van de huidige literatuur kan geen duidelijke voorkeur worden uitgesproken voor 
het verwijderen dan wel het in situ laten van de uterus bij patiënten met descensus uteri. 
Hoewel waarschijnlijk 1 op de 5 vrouwen een operatieve behandeling ondergaat vanwege 
uterovaginale prolaps, is er geen duidelijke consensus over de therapie van voorkeur door 
gebrek aan kwalitatief goed onderzoek. De gepubliceerde studies zijn heterogeen en 
hebben vaak een relatief korte followupduur. Op dit moment hangt de keuze voor een 
bepaalde ingreep af van factoren als leeftijd, comorbiditeit, activiteitenniveau, de voorkeur 
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I N T R O D U C T I O N  
Pelvic organ prolapse (POP) is a common health problem that adversely affects the quality of 
life. The prevalence of POP is about 40% in women over 45 years of age and the lifetime risk 
of undergoing pelvic floor surgery is 11–20% [1-3]. POP is defined as the descent of one or 
more of the pelvic organs. Although POP can be restricted to one compartment (anterior 
vaginal wall, posterior vaginal wall and uterus or apex of the vagina) it usually occurs in some 
combination and often the uterus is involved in the prolapse. There are many surgical 
techniques available to treat uterine descent, but well-executed, randomized controlled trials 
to evaluate these therapies are limited [4]. Therefore, the choice of therapy mostly depends 
on the former training and personal experience of the surgeon. Today, vaginal hysterectomy 
is still the most frequently used operation for uterine descent worldwide, and was recently 
once more documented for the UK and in an Australian and New Zealand study [5,6]. 
However, discussion is ongoing whether or not vaginal hysterectomy is the rational first 
choice in the treatment of uterine descent, and interest in uterus preservation seems to be 
gaining [7,8]. From prospective and retrospective studies it has become clear that some 
uterus preserving techniques result in a shorter hospital stay, less morbidity, and earlier 
resumption of daily activities than a vaginal hysterectomy [7,9,10]. It has also been suggested 
that hysterectomy may cause nerve supply damage and disrupt supportive structures of the 
pelvic floor, introducing a risk of bladder dysfunction, new-onset stress incontinence, and 
recurrence of prolapse [11-13]. Although long-term follow-up is lacking, these new insights 
may have contributed to changed practice towards more uterus preserving techniques 
among (uro)gynecologists in the surgical management of uterine descent. This study was 
performed to examine decision-making and variation in surgical treatment of uterine descent 
among members of the Dutch Urogynecological Society. Furthermore, we have analyzed 
data of the Dutch National Medical Register (LMR) of the last decade to study potential 
changes in policy with regard to the preservation of the uterus in the surgical repair of POP. 
 
M A T E R I A L  A N D  M E T H O D S  
Questionnaire 
In March 2011, all members of the Dutch Urogynecological Society were invited by e-mail to 
participate in a web-based survey. Twenty-five percent (n=256) of the practicing 
gynecologists in the Netherlands are members of the Dutch Urogynecological Society and 
they represent the majority of gynecologists performing POP surgery. After 3 weeks all the 
members received a reminder by e-mail and after 6 weeks the identical questionnaire was 
sent by post to the nonresponders. The questionnaire included questions on current 
employment and practice patterns with regard to the evaluation and treatment of uterine 
descent. There were questions on the diagnosis of cervical elongation and whether or not 
this influenced the selection of the surgical procedure. In addition, the use of transvaginal 
ultrasound and cervical smear before uterus preserving surgery was examined. Finally, we 
asked for the surgical procedures used in low-grade (POP-Q stage one or two) and high-
grade (POP-Q stage three or four) uterine descent. With the use of case scenarios, the 
treatment of choice for these different stages was assessed (appendix). The survey was self 
developed and before the start of the survey we performed a pilot study among 13 
gynecologists. The questionnaire was revised and minimal modifications were made based 
 
A B S T R A C T  
 
I n t r o d u c t i o n  a n d  h y p o t h e s i s :  To evaluate current practice in the surgical treatment of uterine 
descent among members of the Dutch Urogynecological Society and to analyze possible 
trends in the surgical treatment of pelvic organ prolapse in the Netherlands during the last 
decade. 
Me t h o d s :  A questionnaire, including case scenarios, was sent to the members of the Dutch 
Urogynecological Society. Using a nationwide registry from the Netherlands, we assessed the 
number and type of surgical procedures performed for pelvic organ prolapse between 1997 
and 2009. 
R e s u l t s :  The response rate was 73%, with 161 questionnaires completed. Vaginal 
hysterectomy, sacrospinous hysteropexy, and the Manchester-Fothergill procedure were the 
most frequently performed surgical interventions for uterine descent. In the case of lower 
stage uterine descent, uterus preservation was preferred, but in the case of higher stage 
there was wide variation. Two thirds of the respondents stated that in recent years they 
tended to save the uterus more often. The registered number of hospital admissions for 
uterine descent increased by 30% between 1997 and 2009 and the number of surgical 
procedures almost doubled. The number of vaginal hysterectomies performed because of 
uterine descent increased by only 15% in this period. 
C o n c l u s i o n s :  In the Netherlands, surgical policy in the case of uterine descent is very variable, 
with no clear preference for either hysterectomy or uterus preservation. There was a high 
increase in hospital admissions and pelvic organ prolapse procedures in the last decade. The 
number of vaginal hysterectomies performed because of uterine descent did not follow this 
change, which reflects a trend toward preserving the uterus. 
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I N T R O D U C T I O N  
Pelvic organ prolapse (POP) is a common health problem that adversely affects the quality of 
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of undergoing pelvic floor surgery is 11–20% [1-3]. POP is defined as the descent of one or 
more of the pelvic organs. Although POP can be restricted to one compartment (anterior 
vaginal wall, posterior vaginal wall and uterus or apex of the vagina) it usually occurs in some 
combination and often the uterus is involved in the prolapse. There are many surgical 
techniques available to treat uterine descent, but well-executed, randomized controlled trials 
to evaluate these therapies are limited [4]. Therefore, the choice of therapy mostly depends 
on the former training and personal experience of the surgeon. Today, vaginal hysterectomy 
is still the most frequently used operation for uterine descent worldwide, and was recently 
once more documented for the UK and in an Australian and New Zealand study [5,6]. 
However, discussion is ongoing whether or not vaginal hysterectomy is the rational first 
choice in the treatment of uterine descent, and interest in uterus preservation seems to be 
gaining [7,8]. From prospective and retrospective studies it has become clear that some 
uterus preserving techniques result in a shorter hospital stay, less morbidity, and earlier 
resumption of daily activities than a vaginal hysterectomy [7,9,10]. It has also been suggested 
that hysterectomy may cause nerve supply damage and disrupt supportive structures of the 
pelvic floor, introducing a risk of bladder dysfunction, new-onset stress incontinence, and 
recurrence of prolapse [11-13]. Although long-term follow-up is lacking, these new insights 
may have contributed to changed practice towards more uterus preserving techniques 
among (uro)gynecologists in the surgical management of uterine descent. This study was 
performed to examine decision-making and variation in surgical treatment of uterine descent 
among members of the Dutch Urogynecological Society. Furthermore, we have analyzed 
data of the Dutch National Medical Register (LMR) of the last decade to study potential 
changes in policy with regard to the preservation of the uterus in the surgical repair of POP. 
 
M A T E R I A L  A N D  M E T H O D S  
Questionnaire 
In March 2011, all members of the Dutch Urogynecological Society were invited by e-mail to 
participate in a web-based survey. Twenty-five percent (n=256) of the practicing 
gynecologists in the Netherlands are members of the Dutch Urogynecological Society and 
they represent the majority of gynecologists performing POP surgery. After 3 weeks all the 
members received a reminder by e-mail and after 6 weeks the identical questionnaire was 
sent by post to the nonresponders. The questionnaire included questions on current 
employment and practice patterns with regard to the evaluation and treatment of uterine 
descent. There were questions on the diagnosis of cervical elongation and whether or not 
this influenced the selection of the surgical procedure. In addition, the use of transvaginal 
ultrasound and cervical smear before uterus preserving surgery was examined. Finally, we 
asked for the surgical procedures used in low-grade (POP-Q stage one or two) and high-
grade (POP-Q stage three or four) uterine descent. With the use of case scenarios, the 
treatment of choice for these different stages was assessed (appendix). The survey was self 
developed and before the start of the survey we performed a pilot study among 13 
gynecologists. The questionnaire was revised and minimal modifications were made based 
 
A B S T R A C T  
 
I n t r o d u c t i o n  a n d  h y p o t h e s i s :  To evaluate current practice in the surgical treatment of uterine 
descent among members of the Dutch Urogynecological Society and to analyze possible 
trends in the surgical treatment of pelvic organ prolapse in the Netherlands during the last 
decade. 
Me t h o d s :  A questionnaire, including case scenarios, was sent to the members of the Dutch 
Urogynecological Society. Using a nationwide registry from the Netherlands, we assessed the 
number and type of surgical procedures performed for pelvic organ prolapse between 1997 
and 2009. 
R e s u l t s :  The response rate was 73%, with 161 questionnaires completed. Vaginal 
hysterectomy, sacrospinous hysteropexy, and the Manchester-Fothergill procedure were the 
most frequently performed surgical interventions for uterine descent. In the case of lower 
stage uterine descent, uterus preservation was preferred, but in the case of higher stage 
there was wide variation. Two thirds of the respondents stated that in recent years they 
tended to save the uterus more often. The registered number of hospital admissions for 
uterine descent increased by 30% between 1997 and 2009 and the number of surgical 
procedures almost doubled. The number of vaginal hysterectomies performed because of 
uterine descent increased by only 15% in this period. 
C o n c l u s i o n s :  In the Netherlands, surgical policy in the case of uterine descent is very variable, 
with no clear preference for either hysterectomy or uterus preservation. There was a high 
increase in hospital admissions and pelvic organ prolapse procedures in the last decade. The 
number of vaginal hysterectomies performed because of uterine descent did not follow this 
change, which reflects a trend toward preserving the uterus. 
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was working as a subspecialist or has special interest in urogynecology. 
 
T A B L E  1 .  Surgical procedures performed because of uterovaginal prolapse according to the Dutch classification of 
procedures and corresponding ICD-9 CM codes 
 
 
Procedure with Dutch CVV code  ICD-9 CM code 
V A G I N A L  H Y S T E R E C T O M Y  ( W I T H  O R  W I T H O U T  R E P A I R  O F  C Y S T O C E L E  O R  R E C T O C E L E )   
5–684 Vaginal hysterectomy 68.5 Vaginal hysterectomy 
5–686 Radical vaginal hysterectomy 68.7 Radical vaginal hysterectomy 
A B D O M I N A L  H Y S T E R E C T O M Y  ( W I T H  O R  W I T H O U T  R E P A I R  O F  C Y S T O C E L E  A N D / O R  R E C T O C E L E )   
5–682 Subtotal abdominal hysterectomy  68.3 Subtotal abdominal hysterectomy 
5–683 Total abdominal hysterectomy  68.4 Total abdominal hysterectomy 
5–685 Radical abdominal hysterectomy  68.6 Radical abdominal hysterectomy 
5–688 Total laparoscopic hysterectomy 68.41 Laparoscopic total abdominal hysterectomy 
R E P A I R  O F  C Y S T O C E L E  A N D / O R  R E C T O C E L E  W I T H O U T  H Y S T E R E C T O M Y   
5–704 Repair of cystocele and rectocele (excluding 5–704.3)  70.5 Repair of cystocele and rectocele 
C E R V I C A L  A M P U T A T I O N  W I T H / W I T H O U T  R E P A I R  O F  C Y S T O C E L E  A N D / O R  R E C T O C E L E   
5–673 Cervical amputation 67.4 Amputation of cervix 
5–704.3 Cervical amputation with repair of cystocele and/or   
rectocele  
67.4 Amputation of cervix 
O T H E R  P E L V I C  O R G A N  P R O L A P S E  P R O C E D U R E S  W I T H O U T  H Y S T E R E C T O M Y   
5–693 Repair of uterine supporting structures  69.2 Repair of uterine supporting structures 
5–699 Other operations on the uterus and supporting structures 69.98 Other operations supporting structures uterus 
5–703 Obliteration of vagina 70.4 Obliteration of vagina 
5–705 Vaginal construction and reconstruction  70.6 Vaginal construction and reconstruction 
5–706 Other repair of vagina  70.7 Other repair of vagina 
5–707 Reconstruction and repair cul-de-sac and pelvic cavity  70.9 Other operations on vagina and cul-de-sac 
R E C T O P E X Y   
5–486 Repair of rectum  48.7 Repair of rectum 
R E P A I R  O F  V U L V A  A N D  P E R I N E U M   
5–716 Repair of vulva and perineum  71.7 Repair of vulva and perineum 
5–718 Other repair of vulva and perineum  71.8 Other operations on vulva 
5–719 Other operations on female genital organs 71.9 Other operations on female genital organs 
 
T A B L E  2 .  Characteristics of the respondents 
 
Characteristic n (%) 
Gender:  
   Male 85 (53) 
   Female  76 (47) 
Years since completing residency:  
   < 5  36 (22) 
   5–10  36 (22) 
   10–15  32 (20) 
   15–20  19 (12) 
   > 20  38 (24) 
Practice type:  
   Academic hospital  14 (9) 
   Non-academic teaching hospital 93 (58) 
   Nonteaching hospital  54 (34) 
 
on the comments from the pilot participants. All questionnaires were treated anonymously. 
No financial compensation was given.  
 
National registry 
To evaluate trends in the surgical management of uterine descent the numbers of 
procedures performed for pelvic organ prolapse between 1997 and 2009 were obtained 
from the Dutch National Medical Register (LMR), which is managed by Kiwa Prismant 
(www.prismant.nl). The LMR registers hospital discharge diagnoses from all hospital 
admissions in the Netherlands. In addition to discharge diagnosis, procedures performed 
during the hospital stay are recorded. Between 1986 and 2005, all Dutch hospitals 
participated in the LMR. After 2005 all hospitals continued reporting discharge diagnoses to 
the LMR, but a representativity formula was used to correct for missing data from hospitals 
that have stopped the registration of procedures because of the introduction of a new 
financial declaration system. Representativity is calculated by dividing the total number of 
admissions to all hospitals in the Netherlands in a specific year by the number of admissions 
to the participating hospitals in the LMR in the same year. The representativity in 2006 was 
67.89%, in 2007 63.39%, in 2008 64.82%, and in 2009 67.12%. With the use of these 
percentages we were able to correct for the non-participating hospitals and missing data. 
Diagnoses in the LMR are based on the International Classification of Diseases, 9th Revision, 
clinical modification codes (ICD-9-CM). For this analysis POP procedures that were linked to 
the primary diagnosis genital prolapse (ICD-9-CM code 618) were used. Two groups were 
defined to analyze possible trends in surgical management. Group A uterovaginal prolapse 
includes all ICD-9 CM 618 diagnosis codes (618.0 to 618.9). Group B uterine descent is a 
subgroup of group A and includes ICD-9 CM diagnosis codes: 618.1 uterine prolapse 
without mention of vaginal wall prolapse; 618.2 uterovaginal prolapse, incomplete; 618.3 
uterovaginal prolapse, complete; 618.4 uterovaginal prolapse, unspecified. The POP 
procedures in the LMR are coded according to the Dutch classification of procedures (CVV, 
Classificatie van Verrichtingen), which has been developed according to the WHO’s 
International Classification of Procedures in Medicine. Based on the classification, POP 
procedures were grouped into seven categories (Table 1). The corresponding ICD-9-CM 
codes are 48.7, 68.3–68.7, 69.2–69.29, 69.98, 70.4–70.93, and 71.7–71.9. The group “other 
pelvic organ prolapse procedures without hysterectomy” contains all other POP procedures, 
including uterus preserving procedures and the use of mesh. Owing to the coding system it 
was not possible to differentiate between specific techniques in this group. 
 
Statistical analysis 
Statistical analysis was performed with the Statistical Package for the Social Sciences (SPSS) 
18.0 for Windows. Categorical variables were compared using the Chi-squared test. A p 
value <0.05 was considered statistically significant. 
 
R E S U L T S  
The questionnaire was sent to the 256 members of the Dutch Urogynecological Society, 28 of 
whom did not belong to the target group (resident or retired) and 6 questionnaires could not 
be delivered. With 161 respondents the response rate was 73%. In Table 2, the 
characteristics of the respondents are shown. Of the respondents, 94% answered that he/she 
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was working as a subspecialist or has special interest in urogynecology. 
 
T A B L E  1 .  Surgical procedures performed because of uterovaginal prolapse according to the Dutch classification of 
procedures and corresponding ICD-9 CM codes 
 
 
Procedure with Dutch CVV code  ICD-9 CM code 
V A G I N A L  H Y S T E R E C T O M Y  ( W I T H  O R  W I T H O U T  R E P A I R  O F  C Y S T O C E L E  O R  R E C T O C E L E )   
5–684 Vaginal hysterectomy 68.5 Vaginal hysterectomy 
5–686 Radical vaginal hysterectomy 68.7 Radical vaginal hysterectomy 
A B D O M I N A L  H Y S T E R E C T O M Y  ( W I T H  O R  W I T H O U T  R E P A I R  O F  C Y S T O C E L E  A N D / O R  R E C T O C E L E )   
5–682 Subtotal abdominal hysterectomy  68.3 Subtotal abdominal hysterectomy 
5–683 Total abdominal hysterectomy  68.4 Total abdominal hysterectomy 
5–685 Radical abdominal hysterectomy  68.6 Radical abdominal hysterectomy 
5–688 Total laparoscopic hysterectomy 68.41 Laparoscopic total abdominal hysterectomy 
R E P A I R  O F  C Y S T O C E L E  A N D / O R  R E C T O C E L E  W I T H O U T  H Y S T E R E C T O M Y   
5–704 Repair of cystocele and rectocele (excluding 5–704.3)  70.5 Repair of cystocele and rectocele 
C E R V I C A L  A M P U T A T I O N  W I T H / W I T H O U T  R E P A I R  O F  C Y S T O C E L E  A N D / O R  R E C T O C E L E   
5–673 Cervical amputation 67.4 Amputation of cervix 
5–704.3 Cervical amputation with repair of cystocele and/or   
rectocele  
67.4 Amputation of cervix 
O T H E R  P E L V I C  O R G A N  P R O L A P S E  P R O C E D U R E S  W I T H O U T  H Y S T E R E C T O M Y   
5–693 Repair of uterine supporting structures  69.2 Repair of uterine supporting structures 
5–699 Other operations on the uterus and supporting structures 69.98 Other operations supporting structures uterus 
5–703 Obliteration of vagina 70.4 Obliteration of vagina 
5–705 Vaginal construction and reconstruction  70.6 Vaginal construction and reconstruction 
5–706 Other repair of vagina  70.7 Other repair of vagina 
5–707 Reconstruction and repair cul-de-sac and pelvic cavity  70.9 Other operations on vagina and cul-de-sac 
R E C T O P E X Y   
5–486 Repair of rectum  48.7 Repair of rectum 
R E P A I R  O F  V U L V A  A N D  P E R I N E U M   
5–716 Repair of vulva and perineum  71.7 Repair of vulva and perineum 
5–718 Other repair of vulva and perineum  71.8 Other operations on vulva 
5–719 Other operations on female genital organs 71.9 Other operations on female genital organs 
 
T A B L E  2 .  Characteristics of the respondents 
 
Characteristic n (%) 
Gender:  
   Male 85 (53) 
   Female  76 (47) 
Years since completing residency:  
   < 5  36 (22) 
   5–10  36 (22) 
   10–15  32 (20) 
   15–20  19 (12) 
   > 20  38 (24) 
Practice type:  
   Academic hospital  14 (9) 
   Non-academic teaching hospital 93 (58) 
   Nonteaching hospital  54 (34) 
 
on the comments from the pilot participants. All questionnaires were treated anonymously. 
No financial compensation was given.  
 
National registry 
To evaluate trends in the surgical management of uterine descent the numbers of 
procedures performed for pelvic organ prolapse between 1997 and 2009 were obtained 
from the Dutch National Medical Register (LMR), which is managed by Kiwa Prismant 
(www.prismant.nl). The LMR registers hospital discharge diagnoses from all hospital 
admissions in the Netherlands. In addition to discharge diagnosis, procedures performed 
during the hospital stay are recorded. Between 1986 and 2005, all Dutch hospitals 
participated in the LMR. After 2005 all hospitals continued reporting discharge diagnoses to 
the LMR, but a representativity formula was used to correct for missing data from hospitals 
that have stopped the registration of procedures because of the introduction of a new 
financial declaration system. Representativity is calculated by dividing the total number of 
admissions to all hospitals in the Netherlands in a specific year by the number of admissions 
to the participating hospitals in the LMR in the same year. The representativity in 2006 was 
67.89%, in 2007 63.39%, in 2008 64.82%, and in 2009 67.12%. With the use of these 
percentages we were able to correct for the non-participating hospitals and missing data. 
Diagnoses in the LMR are based on the International Classification of Diseases, 9th Revision, 
clinical modification codes (ICD-9-CM). For this analysis POP procedures that were linked to 
the primary diagnosis genital prolapse (ICD-9-CM code 618) were used. Two groups were 
defined to analyze possible trends in surgical management. Group A uterovaginal prolapse 
includes all ICD-9 CM 618 diagnosis codes (618.0 to 618.9). Group B uterine descent is a 
subgroup of group A and includes ICD-9 CM diagnosis codes: 618.1 uterine prolapse 
without mention of vaginal wall prolapse; 618.2 uterovaginal prolapse, incomplete; 618.3 
uterovaginal prolapse, complete; 618.4 uterovaginal prolapse, unspecified. The POP 
procedures in the LMR are coded according to the Dutch classification of procedures (CVV, 
Classificatie van Verrichtingen), which has been developed according to the WHO’s 
International Classification of Procedures in Medicine. Based on the classification, POP 
procedures were grouped into seven categories (Table 1). The corresponding ICD-9-CM 
codes are 48.7, 68.3–68.7, 69.2–69.29, 69.98, 70.4–70.93, and 71.7–71.9. The group “other 
pelvic organ prolapse procedures without hysterectomy” contains all other POP procedures, 
including uterus preserving procedures and the use of mesh. Owing to the coding system it 
was not possible to differentiate between specific techniques in this group. 
 
Statistical analysis 
Statistical analysis was performed with the Statistical Package for the Social Sciences (SPSS) 
18.0 for Windows. Categorical variables were compared using the Chi-squared test. A p 
value <0.05 was considered statistically significant. 
 
R E S U L T S  
The questionnaire was sent to the 256 members of the Dutch Urogynecological Society, 28 of 
whom did not belong to the target group (resident or retired) and 6 questionnaires could not 
be delivered. With 161 respondents the response rate was 73%. In Table 2, the 
characteristics of the respondents are shown. Of the respondents, 94% answered that he/she 
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T A B L E  3 .  Choice of treatment in two different case scenarios (Appendix)  
 
Procedure of choice 
1a. 40-year-old, 
uterine descent 
stage 2, n (%) 
1b. 40-year-old, 
uterine descent 
stage 3, n (%) 
2a. 65-year-old, 
uterine descent 
stage 2, n (%) 
2b. 65-year-old, 
uterine descent 
stage 3, n (%) 
2c. 80-year-
old 
Vaginal hysterectomy 43 (27) 59 (37) 49 (30) 65 (40) 39 (24) 
Sacrospinous hysteropexy 50 (31) 46 (29) 54 (34) 52 (32) 56 (35) 
Manchester-Fothergill 49 (30) 25 (15) 40 (25) 23 (14) 33 (20) 
Abdominal hysteropexy 2 (1) 8 (5) 2 (1) 3 (2) 1 (1) 
Laparoscopic hysteropexy 6 (4) 10 (6) 3 (2) 7 (4) 3 (2) 
Posterior intravaginal sling 0 (0) 0 (0) 1 (1) 0 (0) 1 (1) 
Colpocleisis 0 (0) 0 (0) 0 (0) 0 (0) 19 (12) 
Other 11 (7) 13 (8) 12 (7) 11 (8) 9 (6) 
 
T A B L E  4 .  Hospital admissions and pelvic organ prolapse (POP) procedures performed in the Netherlands because of 
uterovaginal prolapse and its subgroup defined as uterine descenta in 1997 and 2009 
 
Uterovaginal  
prolapse 
Uterine  
descent  Characteristic 
1997 2009 1997 2009 
H O S P I T A L  A D M I S S I O N S   7794 12910 4121 5373 
T O T A L  P O P  P R O C E D U R E S   8181 17376 4366 8462 
 Vaginal hysterectomy with/without repair of cystocele and/or rectocele 3799 4438 3164 3649 
 Abdominal hysterectomy with/without repair of cystocele and/or rectocele 346 165 250 115 
 Repair of cystocele and/or rectocele without hysterectomy 2543 7417 422 2022 
 Cervical amputation with or without repair of cystocele and/or rectocele 301 834 127 557 
 Other pelvic organ prolapse procedures without hysterectomy 1050 4206 379 2023 
 Rectopexy 62 161 6 25 
 Repair of vulva and/or perineum 50 155 18 72 
 
D I S C U S S I O N  
This is a report on current practice in surgical management of uterine descent in the 
Netherlands. In addition, trends in surgical treatment of uterovaginal prolapse in the last 
decade are described. This survey demonstrated that that there is no standardized method 
of surgical treatment of uterine descent in the Netherlands. Opinions about the first choice of 
surgery in cases of uterine descent are conflicting. The reason for the diversity of practice is 
probably the lack of scientific evidence that is needed to make evidence-based protocols. 
The total number of hospital admissions due to uterovaginal prolapse increased from 7,784 
to 12,910 (rise of 65%) and the number of hospital admissions due to uterine descent 
increased from 4,121 to 5,373 (a rise of 30%). Registered POP procedures due to 
uterovaginal prolapse increased from 8,151 in 1997 to 17,376 in 2009 (a rise of 113%), and 
because 1 patient can be subjected to multiple surgical POP procedures, this number 
exceeds the number of hospital admissions each year. Two-thirds of the members of the 
Dutch Urogynecologic Society stated that they more often tend to preserve the uterus in POP 
surgery in recent years. In combination with a moderate increase (15%) in the number of 
vaginal hysterectomies performed for uterine descent that does not keep up with the 
absolute rise in POP procedures, these data suggest the growing popularity of uterus 
preserving surgery in the Netherlands. In 1997, vaginal hysterectomy for uterine descent was 
responsible for 72% of the surgical procedures performed. In 2009, this percentage had 
dropped to 43%. 
 
Pre-operative care and diagnosis 
Of the respondents, 144 (89%) were performing transvaginal ultrasound routinely before 
uterus preserving surgery. A cervical smear before POP surgery was a standard procedure 
among 48 (30%) of the respondents, for 39 (24%) most of the time, for 72 (45%) only when 
indicated and 2 (1%) never performed a cervical smear pre-operatively. Of the respondents, 
154 (96%) evaluated cervical elongation by speculum, vaginal palpation, transvaginal 
ultrasound or a combination of these examinations. The POP-Q score was also mentioned as 
a tool to investigate cervical elongation, with point C being significantly more positive than 
point D. 
 
Surgical treatment of uterine descent 
Procedures used to treat uterine descent among respondents were: vaginal hysterectomy 
(n=140, 87%), sacrospinous hysteropexy (n=112, 70%), the Manchester–Fothergill procedure 
(n=101, 63%), colpocleisis (n=79, 49%), abdominal hysteropexy (n=40, 25%), laparoscopic 
hysteropexy (n=23, 14%), posterior intravaginal sling (n=18, 11%), and other procedures 
(n=16, 11%). The last group contained procedures such as certain types of mesh (Prolift® or 
Elevate®), laparoscopic supravaginal hysterectomy with sacrocervicopexy, and abdominal 
hysterectomy with sacropexy. Support of the vaginal vault after hysterectomy was reached by 
plication of the uterosacral ligaments into the vaginal vault (n=71, 44%) andMcCall 
culdoplasty, in which continuous sutures are used to approximate the uterosacral ligaments 
and obliterate the peritoneum of the posterior cul-de-sac to prevent enterocele formation 
(n=39, 24%) whereas 9 of the respondents (6%) did not support the vaginal vault at all. 
Cervical elongation influenced the choice of therapy in 127 respondents (79%) with the 
Manchester–Fothergill being the most favorite therapy (n=85, 53%) followed by vaginal 
hysterectomy (n=26, 16%) and sacrospinous hysteropexy (n=6, 4%). In the case of a lower 
stage uterine descent (stage one and two) 21 respondents (13%) preferred a hysterectomy, 
109 (68%) a uterus preserving procedure, and 31 (19%) did not have a preference. In the 
case of higher stage uterine descent (stages three and four) 64 respondents (40%) preferred 
a hysterectomy, 64 (40%) a uterus preserving procedure, and 33 (20%) did not have a 
preference. Two-thirds of the respondents (67%) answered that in recent years they used 
uterus preserving techniques more often. There was no statistical difference among male and 
female gynecologists, practice type, and years since residency between gynecologists who 
tend to preserve and those who tend to remove the uterus (p>0.05), in both lower and 
higher stage uterine descent. 
 
Case scenarios 
The outcome of the case scenarios is presented in Table 3.  
 
National registry 
In Table 4, the number of hospital admissions and registered POP procedures performed in 
the Netherlands in 1997 and 2009 is shown. Figure 1 shows the numbers of POP procedures 
performed because of uterovaginal prolapse from 1997 to 2009. 
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T A B L E  3 .  Choice of treatment in two different case scenarios (Appendix)  
 
Procedure of choice 
1a. 40-year-old, 
uterine descent 
stage 2, n (%) 
1b. 40-year-old, 
uterine descent 
stage 3, n (%) 
2a. 65-year-old, 
uterine descent 
stage 2, n (%) 
2b. 65-year-old, 
uterine descent 
stage 3, n (%) 
2c. 80-year-
old 
Vaginal hysterectomy 43 (27) 59 (37) 49 (30) 65 (40) 39 (24) 
Sacrospinous hysteropexy 50 (31) 46 (29) 54 (34) 52 (32) 56 (35) 
Manchester-Fothergill 49 (30) 25 (15) 40 (25) 23 (14) 33 (20) 
Abdominal hysteropexy 2 (1) 8 (5) 2 (1) 3 (2) 1 (1) 
Laparoscopic hysteropexy 6 (4) 10 (6) 3 (2) 7 (4) 3 (2) 
Posterior intravaginal sling 0 (0) 0 (0) 1 (1) 0 (0) 1 (1) 
Colpocleisis 0 (0) 0 (0) 0 (0) 0 (0) 19 (12) 
Other 11 (7) 13 (8) 12 (7) 11 (8) 9 (6) 
 
T A B L E  4 .  Hospital admissions and pelvic organ prolapse (POP) procedures performed in the Netherlands because of 
uterovaginal prolapse and its subgroup defined as uterine descenta in 1997 and 2009 
 
Uterovaginal  
prolapse 
Uterine  
descent  Characteristic 
1997 2009 1997 2009 
H O S P I T A L  A D M I S S I O N S   7794 12910 4121 5373 
T O T A L  P O P  P R O C E D U R E S   8181 17376 4366 8462 
 Vaginal hysterectomy with/without repair of cystocele and/or rectocele 3799 4438 3164 3649 
 Abdominal hysterectomy with/without repair of cystocele and/or rectocele 346 165 250 115 
 Repair of cystocele and/or rectocele without hysterectomy 2543 7417 422 2022 
 Cervical amputation with or without repair of cystocele and/or rectocele 301 834 127 557 
 Other pelvic organ prolapse procedures without hysterectomy 1050 4206 379 2023 
 Rectopexy 62 161 6 25 
 Repair of vulva and/or perineum 50 155 18 72 
 
D I S C U S S I O N  
This is a report on current practice in surgical management of uterine descent in the 
Netherlands. In addition, trends in surgical treatment of uterovaginal prolapse in the last 
decade are described. This survey demonstrated that that there is no standardized method 
of surgical treatment of uterine descent in the Netherlands. Opinions about the first choice of 
surgery in cases of uterine descent are conflicting. The reason for the diversity of practice is 
probably the lack of scientific evidence that is needed to make evidence-based protocols. 
The total number of hospital admissions due to uterovaginal prolapse increased from 7,784 
to 12,910 (rise of 65%) and the number of hospital admissions due to uterine descent 
increased from 4,121 to 5,373 (a rise of 30%). Registered POP procedures due to 
uterovaginal prolapse increased from 8,151 in 1997 to 17,376 in 2009 (a rise of 113%), and 
because 1 patient can be subjected to multiple surgical POP procedures, this number 
exceeds the number of hospital admissions each year. Two-thirds of the members of the 
Dutch Urogynecologic Society stated that they more often tend to preserve the uterus in POP 
surgery in recent years. In combination with a moderate increase (15%) in the number of 
vaginal hysterectomies performed for uterine descent that does not keep up with the 
absolute rise in POP procedures, these data suggest the growing popularity of uterus 
preserving surgery in the Netherlands. In 1997, vaginal hysterectomy for uterine descent was 
responsible for 72% of the surgical procedures performed. In 2009, this percentage had 
dropped to 43%. 
 
Pre-operative care and diagnosis 
Of the respondents, 144 (89%) were performing transvaginal ultrasound routinely before 
uterus preserving surgery. A cervical smear before POP surgery was a standard procedure 
among 48 (30%) of the respondents, for 39 (24%) most of the time, for 72 (45%) only when 
indicated and 2 (1%) never performed a cervical smear pre-operatively. Of the respondents, 
154 (96%) evaluated cervical elongation by speculum, vaginal palpation, transvaginal 
ultrasound or a combination of these examinations. The POP-Q score was also mentioned as 
a tool to investigate cervical elongation, with point C being significantly more positive than 
point D. 
 
Surgical treatment of uterine descent 
Procedures used to treat uterine descent among respondents were: vaginal hysterectomy 
(n=140, 87%), sacrospinous hysteropexy (n=112, 70%), the Manchester–Fothergill procedure 
(n=101, 63%), colpocleisis (n=79, 49%), abdominal hysteropexy (n=40, 25%), laparoscopic 
hysteropexy (n=23, 14%), posterior intravaginal sling (n=18, 11%), and other procedures 
(n=16, 11%). The last group contained procedures such as certain types of mesh (Prolift® or 
Elevate®), laparoscopic supravaginal hysterectomy with sacrocervicopexy, and abdominal 
hysterectomy with sacropexy. Support of the vaginal vault after hysterectomy was reached by 
plication of the uterosacral ligaments into the vaginal vault (n=71, 44%) andMcCall 
culdoplasty, in which continuous sutures are used to approximate the uterosacral ligaments 
and obliterate the peritoneum of the posterior cul-de-sac to prevent enterocele formation 
(n=39, 24%) whereas 9 of the respondents (6%) did not support the vaginal vault at all. 
Cervical elongation influenced the choice of therapy in 127 respondents (79%) with the 
Manchester–Fothergill being the most favorite therapy (n=85, 53%) followed by vaginal 
hysterectomy (n=26, 16%) and sacrospinous hysteropexy (n=6, 4%). In the case of a lower 
stage uterine descent (stage one and two) 21 respondents (13%) preferred a hysterectomy, 
109 (68%) a uterus preserving procedure, and 31 (19%) did not have a preference. In the 
case of higher stage uterine descent (stages three and four) 64 respondents (40%) preferred 
a hysterectomy, 64 (40%) a uterus preserving procedure, and 33 (20%) did not have a 
preference. Two-thirds of the respondents (67%) answered that in recent years they used 
uterus preserving techniques more often. There was no statistical difference among male and 
female gynecologists, practice type, and years since residency between gynecologists who 
tend to preserve and those who tend to remove the uterus (p>0.05), in both lower and 
higher stage uterine descent. 
 
Case scenarios 
The outcome of the case scenarios is presented in Table 3.  
 
National registry 
In Table 4, the number of hospital admissions and registered POP procedures performed in 
the Netherlands in 1997 and 2009 is shown. Figure 1 shows the numbers of POP procedures 
performed because of uterovaginal prolapse from 1997 to 2009. 
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with uterus preserving surgery in a randomized fashion [9,14,20]. The numbers of patients in 
these studies were small and one study only evaluated sexual functioning after vaginal 
hysterectomy or sacrospinous fixation [20]. Owing to an aging population, the increase in 
operative procedures for pelvic organ prolapse that we have noticed over the last decade 
will continue. This emphasizes the need for randomized controlled trials of sufficient size, 
quality, and long-term follow-up to evaluate anatomical and functional outcome after vaginal 
hysterectomy and uterus preserving surgery. In November 2009 we started a multicenter, 
non-inferiority trial (Dutch Trial Register number 1866) to determine whether the efficacy of 
sacrospinous fixation is similar to that of vaginal hysterectomy in women with symptomatic 
uterine prolapse/ pelvic organ prolapse quantification (POP-Q) stage 2 or higher. During a 
follow-up of 60 months, 208 patients will be surgically treated and followed [21]. More 
randomized studies in which uterus preserving procedures are compared with hysterectomy 
will be necessary for good decision making and counseling. A guideline describing the 
preoperative work-up before prolapse surgery is also necessary. Evaluation of the uterus 
(with ultrasound) was not always done before uterus preserving surgery. Conserving a 
prolapsed uterus without adequate pre-operative examination runs the risk of missing a 
malignancy and therefore preoperative ultrasound in these cases is rightfully recommended 
[22]. One of the strengths of our survey among Dutch urogynecologists is the high response 
rate and the use of an accurate database from a national registry. Accuracy analysis 
performed in 2002 by Prismant showed that 84% of the registered diagnoses were correct in 
a random sample, and they also found that 92% of the registered procedures were coded 
correctly. The Dutch Society of Medical Administrators (NVMA) is responsible for the training 
of people who are handling these data and the NVMA is a member of the International 
Federation of Health Record Organizations (IFHRO). On the other hand, our study also has 
some limitations. The case scenarios are fairly simple and lack important additional 
information on, for example, the menstrual cycle, which can be crucial in decision-making. 
Another drawback is that since 2005 some hospitals did not longer provide data on the 
procedures performed to the LMR. We were, however, able to correct for the missing data 
and present representative numbers. Due to the design of the registration we can 
unfortunately not differentiate among the various procedures in the group “other prolapse 
procedure without hysterectomy.” The question may arise whether the significant increase in 
prolapse surgery could (partly) be caused by 
an increase in mesh surgery. However, the use of mesh in the Netherlands is in contrast with 
some other countries not widespread and almost exclusively used in cases of recurrent POP. 
The latter indication has been placed on record in a national guideline. The use of mesh in 
primary surgery has been limited to only a few clinical trials in recent years. With unchanging 
recurrence rates over the past few decades, it is unlikely that the enormous increase in POP 
surgery is caused by recurrence surgery. Therefore, we believe that the rise in this category 
cannot be accounted for by the increased use of mesh.  
In conclusion, we found that there is a large variation in treatment of uterine descent in the 
Netherlands, with no clear preference for either uterus removal or uterus preservation. There 
was a major increase in POP procedures between 1997 and 2009, but only a moderate 
increase in the number of vaginal hysterectomies performed due to uterine descent. Uterus 
preserving procedures are gaining in popularity among Dutch urogynecologists. 
 
 
F i g u r e  1 .  Registered pelvic organ prolapse (POP) procedures performed because of uterovaginal prolapse from 1997 to 
2009 
 
This is in contrast with the results of two recently published studies considering the treatment 
of uterovaginal prolapse. In a study from Australia and New Zealand, the first choice of 
treatment in a 65-year old woman with uterine descent stage 2 was a vaginal hysterectomy in 
79% out of 196 respondents [6]. In a comparable study from the UK, vaginal hysterectomy 
was chosen by 82% among 190 respondents [5].  For comparison, in our study we used the 
same case scenario and vaginal hysterectomy was only preferred by 30% of the respondents. 
Sacrospinous hysteropexy was selected by 34% of our respondents and was therefore a 
popular therapy as well. We have considered possible explanations for this geographical 
difference. Gynecologists in the Netherlands might be more familiar with uterus preserving 
procedures like sacrospinous hysteropexy and the Manchester–Fothergill procedure than 
gynecologists in other countries. The recent number of published studies from the 
Netherlands comparing vaginal hysterectomy with uterus preserving surgery might be a 
reflection of this interest [9, 14-19]. Another explanation might be that women ask for uterus 
preserving surgery more often, because they assume it has a more positive effect on sexual 
function and body image than uterus removal. Studies on patient preferences in the 
treatment of uterine descent, however, have been lacking until now. The idea that the 
descending uterus is not in itself the cause of the prolapse is apparently gaining in popularity 
in the Netherlands. At this time, only 3 studies have been published comparing hysterectomy 
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A P P E N D I X  
 
Case scenarios 
Case 1 A 40-year-old healthy woman visits her gynecologist because of pelvic organ 
prolapse. She has no past medical history. She reports stress urinary incontinence once a 
week. Attempts to reduce her complaints with PFMT and a pessary did not work 
out. Clinical examination shows a stage 3 anterior vaginal wall prolapse, a stage 2 uterine 
descent, and a stage 1 posterior vaginal wall prolapse. POPQ: Aa +1 cm, Ba +2 cm, C 0 cm, 
GH 4 cm, PL 3 cm, TVL 8 cm, Ap −2 cm, Bp −2 cm, D −4 cm. When the prolapse is redressed 
there is no urinary incontinence. Because of her condition the patient wants a surgical 
correction.  
1.Which operative procedure do you prefer in treatment of the middle compartment of this 
patient? 
A. Vaginal hysterectomy 
B. Sacrospinous hysteropexy 
C. Manchester–Fothergill repair 
D. Hysteropexy by laparotomy 
E. Laparoscopic hysteropexy 
F. Posterior intravaginal sling 
G. Colpocleisis 
H. Other, which procedure? 
2. Would your procedure change if it was a stage 3 uterine descent? 
3. Could you further explain your answers? 
 
Case 2 A 65-year-old woman visits her gynecologist because of pelvic organ prolapse. She 
has mild hypertension. She reports urge urinary incontinence once a month. Clinical 
examination shows a stage 3 vaginal wall prolapse, a stage 2 uterine descent, and a stage 1 
posterior vaginal wall prolapse. POPQ: Aa +1 cm, Ba +2 cm, C 0 cm, GH 4 cm, PL 3 cm, TVL 8 
cm, Ap −2 cm, Bp −2 cm, D −4 cm. When the prolapse is redressed there is no urinary 
incontinence. Because of her condition the patient wants a surgical correction. 
1. Which operative procedure do you prefer in treatment of the middle compartment of this 
patient? 
A. Vaginal hysterectomy 
B. Sacrospinous hysteropexy 
C. Manchester–Fothergill repair 
D. Hysteropexy by laparotomy 
E. Laparoscopic hysteropexy 
F. Posterior intravaginal sling 
G. Colpocleisis 
H. Other, which procedure? 
2. Would your procedure change if it was a stage 3 uterine descent? 
3. Would your procedure change if it was an 80-yearold woman? 
4. Could you further explain your answers? 
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I N T R O D U C T I O N  
The choice for surgical treatment for pelvic organ prolapse (POP) in women mainly depends 
on the prolapse severity, symptoms, the general health of the woman, and the preference 
and capabilities of the surgeon [1]. Although there are many surgical techniques available, 
well-executed, randomized controlled trials to evaluate these different techniques are 
limited. Like POP, various treatment modalities for urinary incontinence (UI) have been 
described. In clinical practice, it is a convention that non-surgical therapies, e.g., 
physiotherapy, mechanical devices, drugs, or neuromodulation, are applied first, because 
they usually carry a smaller risk of harm [2]. Therefore, surgery for treating UI is usually 
considered an option after failure of conservative therapy.  
The availability of many treatment modalities can lead to variation in care between physicians 
and hospitals, the so-called practice pattern variation (PPV). PPV is defined as the difference 
in care that cannot be explained by the underlying medical condition [3]. It can be caused by 
noncompliance to evidence-based practice standards, lack of evidence for optimal 
treatment, or by a difference in skills and resources. If patient characteristics, surgical 
capabilities, and indication for surgical interventions are equally spread among hospitals, 
there should be minimal PPV. PPV is considered to be a great problem in controlling medical 
costs [4]. In the literature, PPV has been reported in several medical conditions. Decades ago, 
regional PPV was already observed. In 1936, it was reported that tonsillectomy rates in Britain 
varied substantially between the different school districts [5]. In South Florida, USA, rates for 
surgery to treat degenerative diseases of hip, knee, and spine are highly variable among 
different hospital referral regions [6]. Furthermore, rates of coronary bypass surgery, 
prostatectomy, and many other major procedures varied at least four- to fivefold across 
different hospital referral regions [7]. In addition, PPV has been reported in gynecology. 
Recently, geographical variation in hysterectomy rates and surgical routes for hysterectomy 
(vaginal/abdominal) for benign diseases was reported in The Netherlands [8]. Little is known 
about PPV in POP and UI. However, variable surgical policy for treating uterine descent and 
the wide range in types of surgery might contribute to PPV [9,10].  
The Netherlands is a small, developed country. With almost 17 million inhabitants, the 
country is densely populated. In 2010, the country contained a total of 92 hospitals and 
private clinics, with 958 practicing gynecologists. Due to its small size and good registration, 
The Netherlands is a very eligible country in which to explore practice patterns. Because of its 
size and the limited number of gynecologists (who are all member of the Dutch gynecologic 
society and are well organized in different working parties), PPV should be theoretically low. 
The aim of this study was to identify and describe PPV among Dutch gynecologists regarding 
POP and UI treatment.  
 
M A T E R I A L  A N D  M E T H O D S  
In The Netherlands, health insurance is mandatory. All procedures performed by hospitals 
are invoiced from the health insurance companies using declaration codes. Each medical 
condition has a specific declaration code; POP and UI have a common code (G25). 
Furthermore, the type of treatment (conservative/surgical) must be stated in this declaration 
code. For various medical conditions, the companies Vektis and Kiwa Carity collect these 
declaration codes. In addition, Vektis analyzes these codes and calculates PPV. To assess PPV 
 
A B S T R A C T  
 
I n t r o d u c t i o n :  Practice pattern variation (PPV) is the difference in care that cannot be 
explained by the underlying medical condition. The aim of this study was to describe PPV 
among Dutch gynecologists regarding treatment of pelvic organ prolapse (POP) and urinary 
incontinence (UI).  
Me t h o d s :  PPV was calculated from data of healthcare declaration codes of 2010. Data were 
provided by Vektis and Kiwa Carity. PPV for POP and UI in general was calculated per 
hospital and per region. Furthermore, PPV for transvaginal mesh and surgical treatment of 
uterine descent was assessed. 
R e s u l t s :  PPV of surgical treatment for POP and UI in general was assessed for 91 hospitals. 
PPV for surgical treatment of uterine descent and transvaginal mesh placement was 
calculated for 88 hospitals. A high PPV per hospital and per region was found. In some 
hospitals, a hysterectomy was performed in all cases of uterovaginal prolapse, while in other 
hospitals, uterus preserving techniques were mostly performed. A high PPV of transvaginal 
mesh placement was observed. 
C o n c l u s i o n s :  In the small country of The Netherlands, we found a high PPV in surgical 
management of POP and UI with respect to the choice for surgical treatment and the type of 
surgery. This finding might be due to the absence of clearly defined guidelines. Studies with 
respect to conservative versus surgical treatment and the type of surgery are of need to 
establish evidence-based guidelines. 
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society and are well organized in different working parties), PPV should be theoretically low. 
The aim of this study was to identify and describe PPV among Dutch gynecologists regarding 
POP and UI treatment.  
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are invoiced from the health insurance companies using declaration codes. Each medical 
condition has a specific declaration code; POP and UI have a common code (G25). 
Furthermore, the type of treatment (conservative/surgical) must be stated in this declaration 
code. For various medical conditions, the companies Vektis and Kiwa Carity collect these 
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incontinence (UI).  
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PPV for surgical treatment of uterine descent and transvaginal mesh placement was 
calculated for 88 hospitals. A high PPV per hospital and per region was found. In some 
hospitals, a hysterectomy was performed in all cases of uterovaginal prolapse, while in other 
hospitals, uterus preserving techniques were mostly performed. A high PPV of transvaginal 
mesh placement was observed. 
C o n c l u s i o n s :  In the small country of The Netherlands, we found a high PPV in surgical 
management of POP and UI with respect to the choice for surgical treatment and the type of 
surgery. This finding might be due to the absence of clearly defined guidelines. Studies with 
respect to conservative versus surgical treatment and the type of surgery are of need to 
establish evidence-based guidelines. 
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Kiwa Carity 
Kiwa Carity (www.kiwacarity.nl) analyzes declaration codes to determine the quality and costs 
of healthcare, commissioned by the Dutch government and the healthcare branch. Since this 
company analyzes at the procedure level, it is possible to distinguish between different types 
of surgery for a specific condition. However, Kiwa Carity does not have access to data with 
respect to the total number of women with healthcare insurance and their demographic 
characteristics. Therefore, Kiwa Carity is not able to correct for age and social economic 
status. Data are based on the declaration of information system (DIS), where all declaration 
codes and medical procedures of the hospitals are recorded. Based on these data, we 
calculated the PPV of transvaginal mesh by dividing the total number of transvaginal mesh 
placements in 2010 per hospital by the total number of POP procedures. Furthermore, the 
ratio of uterus preserving surgery versus vaginal hysterectomy for treating uterine descent 
was calculated. For both data sets, it was not possible to register more than one procedure 
per patient per year. In case of another surgical procedure for POP and/or UI in the same 
year, the same declaration code was used. 
 
Statistical analysis 
Statistical analysis was performed with the Statistical Package for the Social Science 22.0 for 
Windows (IBM SPSS Statistics). Differences between hospital types were compared using 
one-way analysis of variance (ANOVA) for parametric variables, and Kruskal–Wallis test for 
nonparametric variables. An additional post hoc Bonferroni test was performed to assess the 
significance of each variable. A p value <0.05 was considered to be statistically significant. 
 
R E S U L T S  
PPV in general was assessed for 91 hospitals and for 88 hospitals with respect to treating 
uterine descent and the use of transvaginal mesh specifically. In 2010, more than 40,000 
women were referred to a hospital because of POP and/or UI, and just over 15,000 surgical 
procedures were performed (Table 1). The number of patients per hospital varies depending 
on the size of the hospital service area. Differences in surgical rate between the different 
hospital types were not statistically significant (p=0.11).  
 
T A B L E  1 .  Total number of patients and procedures per practice type 
 
 
Type of hospital 
Number of initial G25* 
patients (range) 
Number of pelvic organ prolapse 
and urinary incontinence procedures 
(range) 
Mean surgical 
rate (%) 
University (n=8) 2190 (112–540) 737 (36–185) 34 
Nonuniversity teaching (n=28) 18419 (361–1222) 5888 (100 – 437) 32 
Nonteaching (n=55) 22248 (127 – 1151) 8443 (27–486) 38 
T O T A L   4 2 . 8 5 7  1 5 . 0 6 8   
 
*G25: declaration code for POP and UI 
 
Figure 2 demonstrates the total number of patients who underwent POP and UI surgery per 
100,000 women per hospital in 2010. This represents the PPV per hospital service area and 
varies between 75 and 412 procedures per 100,000 women (median 171). University 
hospitals seem to have a very high or very low surgical rate compared with other hospital 
types, and nonteaching hospitals have a higher surgical rate than teaching hospitals.  
 
for POP and UI, we used data and calculations obtained from these organizations. The year 
2010 was chosen because more recent data from both data sets (Kiwa Carity and Vektis) 
were not available when this study started.  
 
Vektis  
Vektis (www.vektis.nl) collects data from all healthcare insurance companies in The 
Netherlands. This independent organization analyses these data with respect to costs and 
quality of healthcare and calculates practice variation using the declaration codes. Data we 
obtained were corrected for age and social economic status. Information about social 
economic status was received from the Dutch Institute for Social Research, a government 
agency. Vektis did not distinguish between the different POP and UI procedures because 
they have a common code. Therefore, all surgical procedures for POP and UI were 
combined. Data analysis was performed in two ways: per region and per hospital service 
area. The Netherlands is divided into 39 regions. A region is defined as a geographical 
district with the same zip/postal code. These data reflect the treatment of patients living in 
that region, regardless of where the care was actually delivered. A hospital service area is 
determined by assigning all patients to a hospital according to the decision tree shown in 
Fig. 1. These data are hospital specific and reflect patients treated per hospital regardless of 
the region in which the patient lives.  
F i g u r e  1 .  Creating a hospital service area; assigning patients to a hospital 
 
Practice variation was defined as the number of patients who underwent POP or UI surgery 
per 100,000 women. Based on 2010 data, the practice variation was calculated both per 
region and per hospital. Furthermore, hospital and regional practice variations were pooled, 
and the ratio between conservative versus surgical treatment of POP and UI was assessed. 
Hospitals were divided into the categories of university, teaching, and nonteaching hospitals. 
All declaration codes with respect to POP and UI (G25) were used. One private clinic was 
excluded because < 20 surgical procedures were performed.  
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hospital types were not statistically significant (p=0.11).  
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*G25: declaration code for POP and UI 
 
Figure 2 demonstrates the total number of patients who underwent POP and UI surgery per 
100,000 women per hospital in 2010. This represents the PPV per hospital service area and 
varies between 75 and 412 procedures per 100,000 women (median 171). University 
hospitals seem to have a very high or very low surgical rate compared with other hospital 
types, and nonteaching hospitals have a higher surgical rate than teaching hospitals.  
 
for POP and UI, we used data and calculations obtained from these organizations. The year 
2010 was chosen because more recent data from both data sets (Kiwa Carity and Vektis) 
were not available when this study started.  
 
Vektis  
Vektis (www.vektis.nl) collects data from all healthcare insurance companies in The 
Netherlands. This independent organization analyses these data with respect to costs and 
quality of healthcare and calculates practice variation using the declaration codes. Data we 
obtained were corrected for age and social economic status. Information about social 
economic status was received from the Dutch Institute for Social Research, a government 
agency. Vektis did not distinguish between the different POP and UI procedures because 
they have a common code. Therefore, all surgical procedures for POP and UI were 
combined. Data analysis was performed in two ways: per region and per hospital service 
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district with the same zip/postal code. These data reflect the treatment of patients living in 
that region, regardless of where the care was actually delivered. A hospital service area is 
determined by assigning all patients to a hospital according to the decision tree shown in 
Fig. 1. These data are hospital specific and reflect patients treated per hospital regardless of 
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F i g u r e  2 . Practice variation per hospital: total number of patients who underwent pelvic organ prolapse (POP) or urinary 
incontinence (UI) surgery per 100,000 women per hospital service area
F i g u r e  3 .  Practice variation per region: total number of patients who underwent pelvic organ prolapse (POP) or urinary
incontinence (UI) surgery per 100,000 women per region. The minimum number of procedures per region was 55 per 
100,000 women and the maximum number 363 per 100,000 women.  
Hospitals
Total number of patients that 
underwent  POP/UI surgery 
per 100.000 women
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Figure 3 shows the total number of patients who underwent POP and UI surgery per 100,000 
women per region. This represents the practice variation per region and varies between 55 
and 363 surgical procedures per 100,000 women (median 179). The figure implies a mixed 
pattern: the northeastern and western regions seem to have a higher surgical rates 
compared with central, southern, and eastern Netherlands.
F i g u r e  4 .  Practice variation for pelvic organ prolapse (POP) and urinary incontinence (UI) surgery per hospital combined 
with practice variation per region. This figure indicates whether the hospital contributes to a high or low surgical rate in that 
region. A mostly dark-colored bar at the right side might contribute to the high surgical rate in a region, since all patients 
who underwent POP or UI surgery in that hospital come from a region with a high surgical rate. On the other hand, a mostly 
light-colored bar at the left side might contribute to a low surgical rate in that region
Figure 4 combines practice variation per hospital (see Fig. 2) with practice variation per 
region (see Fig. 3). It demonstrates surgical rate per hospital (displayed by the total length of 
the bar) and distinguishes the type of regions patients come from (displayed by the different 
colors of the bar). This figure indicates whether or not the hospital contributes to a high or 
low surgical rate in its region. If all patients who underwent POP or UI surgery in that hospital 
came from a region with a high surgical rate, it is likely that this hospital contributes to the 
high surgical rate in that region. In other words, when looking at a mostly dark-colored bar 
on the right side of the figure, it is plausible that this hospital might contribute to a high 
surgical rate in that particular region, while a mostly light-colored bar at the left side might 
contribute to a low surgical rate in the region.
Figure 5 shows the ratio between conservative and surgical treatment for POP and UI per 
hospital. Again, hospitals are listed in the same order as in Figs. 2 and 4. Unlike the previous 
figures, in which POP and UI procedures were plotted against 100,000 women (the total 
population), this figure focuses on women with declaration code G25 who were referred to 
the hospital. It also shows that hospitals with a high surgical rate (right side of the figure) not 
only have a high surgical rate compared with the total population, but patients in that 
hospital will less often receive conservative treatment as well. 
Hospitals
Total number of patients that 
underwent  POP/UI surgery 
per 100.000 women
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F i g u r e  5 .  Conservative versus surgical treatment for pelvic organ prolapse (POP) and urinary incontinence (UI) per hospital 
(hospitals are listed in the same order as in F i g u r e s  2  and 4 ) 
Figure 6 demonstrates the percentage of vaginal hysterectomy and uterus preserving 
surgery for treating uterine descent. Uterus preserving surgery is defined as vaginal 
sacrospinous hysteropexy and Manchester–Fothergill procedures. There is a high practice 
variation in treating uterine descent. In some hospitals, a hysterectomy was performed in all 
cases of uterovaginal prolapse, while in others, patients were mainly treated with uterus 
preserving surgery. This variation was observed in all types of hospitals. Nonteaching 
hospitals performed significantly more hysterectomies in relation to uterus preserving 
techniques compared with teaching (p=0.002) and university (p=0.014) hospitals. 
When looking at the practice variation with respect to transvaginal mesh placement, a high 
variation was observed (Fig. 7). In some hospitals, a transvaginal mesh was placed in 1:100 
POP patients, while in other hospitals, it was placed in 44:100 POP patients. In 21 hospitals, it 
was not used at all. Hospitals with the highest number of transvaginal mesh placements per 
100 POP patients were nonteaching hospitals. The differences in transvaginal mesh 
placement between hospital types were not statistically significant (p=0.91).
58
CHAPTER 4
501420-L-bw-Detollenaere
 
 
 
 
F i g u r e  6 .  Practice variation in treating uterine descent: percentage of vaginal hysterectomy (VH) and uterus preserving 
surgery (sacrospinous hysteropexy and Manchester–Fothergill procedure) for uterovaginal prolapse per hospital 
 
 
 
F i g u r e  7 .  Practice variation of transvaginal mesh placement per hospital: number of mesh placements per 100 patients 
referred to that hospital for pelvic organ prolapse (POP) 
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guidelines state that vaginal mesh placement is allowed only when a minimum of 20 
procedures a year are performed.  
In the literature, several factors contributing to PPV in general have been described. First, 
variations in patient characteristics and demand for surgery might contribute to PPV. Some 
regions might have a higher rate of surgical procedures because of greater demand for 
surgery. This correlation is more obvious in clinical disorders for which surgery is strongly 
recommended or needed, e.g., hip fracture. In the USA, regional rates of hip-fracture surgery 
in elderly people are almost linearly correlated with the regional incidence of hip fracture [7]. 
Second, the preference of the patient can contribute to PPV. For some clinical conditions, the 
decision to intervene should depend as much on patient preferences as on scientific 
evidence. The value of a surgical intervention depends on the tradeoff between risks and 
benefits of that intervention. In case of a large imbalance, the decision to intervene is distinct, 
and there might be some PPV. However, PPV becomes more pronounced when the tradeoff 
is a close call, and the patient’s preference can become decisive [7]. Shared decision making 
is a collaborative process that allows patients and physicians to make healthcare decisions 
together, taking into account the best scientific evidence available as well as patient 
preference. Third, scientific uncertainty contributes to PPV [6]. In the absence of a 
professional consensus and guideline-based on outcomes, individual or small groups of 
clinicians can hold on to their own clinical rules of defining which patient needs surgery. This 
might result in the surgical signature of a region: rates for specific surgical procedures that 
are peculiar to a region sometimes differ substantially between surrounding regions [4, 6]. 
Finally, surgical innovations and new technologies, such as vaginal mesh, can pronounce PPV 
by increasing the number of therapeutic alternatives available to clinicians. This variation can 
arise because of differences in clinicians’ opinions as to whether the new intervention should 
replace the existing procedures and change the indications for surgery [7].  
PPV is considered to be a great problem in controlling medical costs. In case of 
overtreatment, medical costs will be very high compared with undertreatment. Such variation 
is unfair, because people who live in a region with a low surgical rate (or are referred to a 
hospital with a low surgical rate) subsidize the care of those in high-cost regions [3]. In the 
USA, the difference in lifetime Medicare (federal social health insurance) spending for a 
typical 65-year-old in Miami, FL, and in Minneapolis, MN, is > $50,000 [4]. A strength of this 
study is the completeness of the data sets. In The Netherlands, hospitals are required to use 
declaration codes to receive funding from healthcare insurance companies. Without a 
declaration code, it is not possible for insurance companies to invoice the procedure. Since 
the declaration code is compulsory, we obtained complete data sets. Another strength of this 
study is the correction for age and social economic status in case of PPV in general, making 
data more valid. Vektis determined whether age and social economic status were relevant in 
the total number of patients with UI and POP. For instance, if in a specific region live more 
older people compared with another region, differences in surgical rate are more likely 
explained by the differences in population statistics than by PPV. In their analysis, age and 
social economic status influenced the surgical rate, and therefore, data were corrected by 
Vektis for age and social economic status. 
The study reported here has some limitations: Since UI and POP have the same declaration 
code, it is not possible to differentiate between these two conditions with respect to PPV in 
 
D I S C U S S I O N  
We assessed PPV for POP and UI surgery in The Netherlands. Our results demonstrate a high 
PPV with respect to treating POP and UI. These findings are inconsistent with our hypothesis 
that due to good cooperation and registration and the small size of The Netherlands, PPV 
should be low. We found a high PPV between regions. Because of the small size of the 
country, most regions include both rural and urban areas, and the different types of hospitals 
are equally spread throughout the country. Therefore, we believe that the regional 
differences cannot be explained by differences in population or hospital distribution. The 
surgical rate per region appears to be dominated by the treatment policy of specific hospitals 
in that specific region. Hospitals with a low surgical rate are actually responsible for the low 
surgical rate in their region. In addition, hospitals with a high surgical rate are responsible for 
the high surgical rate in their region. These hospitals seem to be mainly nonteaching 
hospitals (Figs. 2 and 4). In other words, the surgical rate per region appears to be caused by 
specific hospitals rather than being a mean of several hospitals.  
The high PPV might imply over- and undertreatment. In case of overtreatment, the patient is 
exposed to the unnecessary risks of surgery. In case of undertreatment, the patient might not 
receive adequate treatment for the specific medical condition. However, since a gold 
standard for treating POP is still a matter of debate, it is difficult to conclude whether or not 
we observed over- or undertreatment.  
The ratio between conservative and surgical POP and UI treatment varies per hospital. With 
regard to UI, guidelines state that nonsurgical therapies are tried first [2,11,12]. In case of 
failure, surgical therapy is considered. A lack of adherence to the current guidelines for UI 
might contribute to the PPV. Contrary to UI, there is no consensus or guideline for treating 
POP conservatively or surgically. As a result, treatment depends mostly on the opinion of the 
gynecologist. Therefore, one can assume that the observed variation is mainly caused by 
variation in treating POP but not UI. However, because data were pooled, we were unable to 
differentiate between disorders. 
Our results demonstrate a high PPV in the surgical treatment of uterine descent. Nonteaching 
hospitals perform significantly more hysterectomies in relation to uterus preserving 
techniques compared with teaching and university hospitals. Worldwide, vaginal 
hysterectomy is the most frequently used treatment for patients with symptomatic 
uterovaginal prolapse [13,14]. However, uterus preserving procedures are gaining interest, 
and many techniques have been described. Because well-executed randomized trials are 
limited, there is no consensus for either uterus preserving surgery or vaginal hysterectomy. 
Therefore, our results seem to be a reflection of the ongoing discussion about the value of 
uterus preserving techniques in case of uterine descent. 
There is a high PPV with respect to transvaginal mesh placement. In recent years, transvaginal 
mesh has become matter of debate. In October 2008, the U.S. Food and Drug Administration 
(FDA) issued a public health notification informing clinicians and patients of adverse events 
related to urogynecologic use of surgical mesh [15]. After this publication, the use of 
transvaginal mesh in the USA decreased from 32.1 % in 2006 to 27.5 % in 2010 [16]. In The 
Netherlands, the debate over safety and efficacy of vaginal mesh is ongoing. An important 
issue in this debate is the number of meshes placed per gynecologist. The high PPV and 
therefore limited experience of some gynecologists is one reason that recently formulated 
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guidelines state that vaginal mesh placement is allowed only when a minimum of 20 
procedures a year are performed.  
In the literature, several factors contributing to PPV in general have been described. First, 
variations in patient characteristics and demand for surgery might contribute to PPV. Some 
regions might have a higher rate of surgical procedures because of greater demand for 
surgery. This correlation is more obvious in clinical disorders for which surgery is strongly 
recommended or needed, e.g., hip fracture. In the USA, regional rates of hip-fracture surgery 
in elderly people are almost linearly correlated with the regional incidence of hip fracture [7]. 
Second, the preference of the patient can contribute to PPV. For some clinical conditions, the 
decision to intervene should depend as much on patient preferences as on scientific 
evidence. The value of a surgical intervention depends on the tradeoff between risks and 
benefits of that intervention. In case of a large imbalance, the decision to intervene is distinct, 
and there might be some PPV. However, PPV becomes more pronounced when the tradeoff 
is a close call, and the patient’s preference can become decisive [7]. Shared decision making 
is a collaborative process that allows patients and physicians to make healthcare decisions 
together, taking into account the best scientific evidence available as well as patient 
preference. Third, scientific uncertainty contributes to PPV [6]. In the absence of a 
professional consensus and guideline-based on outcomes, individual or small groups of 
clinicians can hold on to their own clinical rules of defining which patient needs surgery. This 
might result in the surgical signature of a region: rates for specific surgical procedures that 
are peculiar to a region sometimes differ substantially between surrounding regions [4, 6]. 
Finally, surgical innovations and new technologies, such as vaginal mesh, can pronounce PPV 
by increasing the number of therapeutic alternatives available to clinicians. This variation can 
arise because of differences in clinicians’ opinions as to whether the new intervention should 
replace the existing procedures and change the indications for surgery [7].  
PPV is considered to be a great problem in controlling medical costs. In case of 
overtreatment, medical costs will be very high compared with undertreatment. Such variation 
is unfair, because people who live in a region with a low surgical rate (or are referred to a 
hospital with a low surgical rate) subsidize the care of those in high-cost regions [3]. In the 
USA, the difference in lifetime Medicare (federal social health insurance) spending for a 
typical 65-year-old in Miami, FL, and in Minneapolis, MN, is > $50,000 [4]. A strength of this 
study is the completeness of the data sets. In The Netherlands, hospitals are required to use 
declaration codes to receive funding from healthcare insurance companies. Without a 
declaration code, it is not possible for insurance companies to invoice the procedure. Since 
the declaration code is compulsory, we obtained complete data sets. Another strength of this 
study is the correction for age and social economic status in case of PPV in general, making 
data more valid. Vektis determined whether age and social economic status were relevant in 
the total number of patients with UI and POP. For instance, if in a specific region live more 
older people compared with another region, differences in surgical rate are more likely 
explained by the differences in population statistics than by PPV. In their analysis, age and 
social economic status influenced the surgical rate, and therefore, data were corrected by 
Vektis for age and social economic status. 
The study reported here has some limitations: Since UI and POP have the same declaration 
code, it is not possible to differentiate between these two conditions with respect to PPV in 
 
D I S C U S S I O N  
We assessed PPV for POP and UI surgery in The Netherlands. Our results demonstrate a high 
PPV with respect to treating POP and UI. These findings are inconsistent with our hypothesis 
that due to good cooperation and registration and the small size of The Netherlands, PPV 
should be low. We found a high PPV between regions. Because of the small size of the 
country, most regions include both rural and urban areas, and the different types of hospitals 
are equally spread throughout the country. Therefore, we believe that the regional 
differences cannot be explained by differences in population or hospital distribution. The 
surgical rate per region appears to be dominated by the treatment policy of specific hospitals 
in that specific region. Hospitals with a low surgical rate are actually responsible for the low 
surgical rate in their region. In addition, hospitals with a high surgical rate are responsible for 
the high surgical rate in their region. These hospitals seem to be mainly nonteaching 
hospitals (Figs. 2 and 4). In other words, the surgical rate per region appears to be caused by 
specific hospitals rather than being a mean of several hospitals.  
The high PPV might imply over- and undertreatment. In case of overtreatment, the patient is 
exposed to the unnecessary risks of surgery. In case of undertreatment, the patient might not 
receive adequate treatment for the specific medical condition. However, since a gold 
standard for treating POP is still a matter of debate, it is difficult to conclude whether or not 
we observed over- or undertreatment.  
The ratio between conservative and surgical POP and UI treatment varies per hospital. With 
regard to UI, guidelines state that nonsurgical therapies are tried first [2,11,12]. In case of 
failure, surgical therapy is considered. A lack of adherence to the current guidelines for UI 
might contribute to the PPV. Contrary to UI, there is no consensus or guideline for treating 
POP conservatively or surgically. As a result, treatment depends mostly on the opinion of the 
gynecologist. Therefore, one can assume that the observed variation is mainly caused by 
variation in treating POP but not UI. However, because data were pooled, we were unable to 
differentiate between disorders. 
Our results demonstrate a high PPV in the surgical treatment of uterine descent. Nonteaching 
hospitals perform significantly more hysterectomies in relation to uterus preserving 
techniques compared with teaching and university hospitals. Worldwide, vaginal 
hysterectomy is the most frequently used treatment for patients with symptomatic 
uterovaginal prolapse [13,14]. However, uterus preserving procedures are gaining interest, 
and many techniques have been described. Because well-executed randomized trials are 
limited, there is no consensus for either uterus preserving surgery or vaginal hysterectomy. 
Therefore, our results seem to be a reflection of the ongoing discussion about the value of 
uterus preserving techniques in case of uterine descent. 
There is a high PPV with respect to transvaginal mesh placement. In recent years, transvaginal 
mesh has become matter of debate. In October 2008, the U.S. Food and Drug Administration 
(FDA) issued a public health notification informing clinicians and patients of adverse events 
related to urogynecologic use of surgical mesh [15]. After this publication, the use of 
transvaginal mesh in the USA decreased from 32.1 % in 2006 to 27.5 % in 2010 [16]. In The 
Netherlands, the debate over safety and efficacy of vaginal mesh is ongoing. An important 
issue in this debate is the number of meshes placed per gynecologist. The high PPV and 
therefore limited experience of some gynecologists is one reason that recently formulated 
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general. It is unknown whether the practice variation is caused by UI, POP, or both. Since 
clearly defined guidelines for UI are available in The Netherlands, and clear consensus on 
treating POP is lacking, we assume that the PPV is mostly caused by POP. In addition, a 
clearly defined diagnosis of POP (e.g., the compartment involved) cannot be obtained from 
the Vektis data set. However, since most types of prolapse can be treated surgically or 
conservatively, we believe that the PPV we found is applicable to treating POP in general. 
Furthermore, data derived from Vektis are based on 91 hospitals, and Kiwa Carity provided 
data obtained from only 88 hospitals. This difference is explained by the fact that Kiwa Carity 
did not include data from private clinics (n=1), and two hospitals did not consent to Kiwa 
Carity using their data. With respect to the practice variation of uterine descent (Fig. 6), data 
of one university hospital is missing.  
Ideally, PPV is very low, and the surgical rate for POP and UI does not differ between 
hospitals. However, in the small country of The Netherlands, we observed a high PPV in the 
surgical management of POP and UI. Furthermore, we observed a high variation in treating 
uterine descent and the placement of transvaginal mesh for POP. A patient’s odds of 
undergoing surgery for POP and UI seems to depend more on where the patient lives and to 
which hospital she is referred than on clinical circumstances. The choice of treatment seems 
to depend mainly on the preference of the gynecologists. The absence of clearly defined 
guidelines regarding indications for conservative and surgical treatment of POP and the use 
of different types of surgical technique might contribute to the high PPV. With respect to UI, 
there might be a lack of adherence to the current guidelines for UI, which contributes to the 
PPV as well. To reduce PPV and prevent over- and undertreatment, studies with respect to 
conservative versus surgical treatment, and randomized controlled trials between different 
types of surgery, are necessary to establish such evidence-based guidelines. 
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general. It is unknown whether the practice variation is caused by UI, POP, or both. Since 
clearly defined guidelines for UI are available in The Netherlands, and clear consensus on 
treating POP is lacking, we assume that the PPV is mostly caused by POP. In addition, a 
clearly defined diagnosis of POP (e.g., the compartment involved) cannot be obtained from 
the Vektis data set. However, since most types of prolapse can be treated surgically or 
conservatively, we believe that the PPV we found is applicable to treating POP in general. 
Furthermore, data derived from Vektis are based on 91 hospitals, and Kiwa Carity provided 
data obtained from only 88 hospitals. This difference is explained by the fact that Kiwa Carity 
did not include data from private clinics (n=1), and two hospitals did not consent to Kiwa 
Carity using their data. With respect to the practice variation of uterine descent (Fig. 6), data 
of one university hospital is missing.  
Ideally, PPV is very low, and the surgical rate for POP and UI does not differ between 
hospitals. However, in the small country of The Netherlands, we observed a high PPV in the 
surgical management of POP and UI. Furthermore, we observed a high variation in treating 
uterine descent and the placement of transvaginal mesh for POP. A patient’s odds of 
undergoing surgery for POP and UI seems to depend more on where the patient lives and to 
which hospital she is referred than on clinical circumstances. The choice of treatment seems 
to depend mainly on the preference of the gynecologists. The absence of clearly defined 
guidelines regarding indications for conservative and surgical treatment of POP and the use 
of different types of surgical technique might contribute to the high PPV. With respect to UI, 
there might be a lack of adherence to the current guidelines for UI, which contributes to the 
PPV as well. To reduce PPV and prevent over- and undertreatment, studies with respect to 
conservative versus surgical treatment, and randomized controlled trials between different 
types of surgery, are necessary to establish such evidence-based guidelines. 
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I N T R O D U C T I O N  
Different surgical techniques are available to treat pelvic organ prolapse (POP). Whether or 
not the uterus should be preserved in case of uterine prolapse is still a matter of debate. 
Well-executed randomized controlled trials to evaluate these therapies are limited and based 
on current literature no clear superiority in favor uterus preserving surgery or hysterectomy is 
known [1-3].  
In the Netherlands, a trend towards uterus preserving surgery was found during the last 
decade [4].  A similar change was observed in Taiwan and the USA during this period [5,6]. A 
possible explanation for this phenomenon could be that gynecologists have become more 
familiar with the different operative uterus sparing techniques. Also women’s beliefs and 
opinions about the treatment of uterine prolapse may have changed. In literature it is often 
stated that more women want to preserve the uterus in case of surgical management of 
uterine prolapse [7]. However, little is known on women’s attitudes, preferences and beliefs 
with respect to uterus preservation or hysterectomy in surgical management.  
The aim of this study was to explore attitude towards hysterectomy and uterus preservation in 
Dutch women referred with POP complaints. Patient’s perceptions and beliefs on the impact 
of uterus preservation and hysterectomy on body image and sexual function were also 
studied. Furthermore we studied the importance of treatment success, risk of urinary 
incontinence after surgery, complication risk, recovery time, length of hospital stay, costs and 
the risk of developing endometrial cancer when choosing one of the treatments.  
 
M A T E R I A L  A N D  M E T H O D S  
Women’s attitudes towards hysterectomy or preservation were assessed by a structured 
preference questionnaire in a cross-sectional study during one year. The study took place in a 
large teaching hospital (Isala, Zwolle) and a university hospital (Radboud University Nijmegen 
Medical Centre) in The Netherlands from December 2013 to November 2014. Both hospitals 
obtained approval for this study from the central medical ethical committee of the Isala 
(March 8, 2012, under number 12.0326) All women aged 18 years or older, referred with 
POP complaints by their general practitioner (GP), without previous prolapse surgery or 
hysterectomy, could participate in the study. Eligible patients were identified and selected 
based on the referral letters by the investigators (MvIJ, MG and KK). Prior to the scheduled 
gynecological consultation, eligible patients received written and oral study information and 
were asked to participate. Written informed consent was obtained from all participants. 
Demographic data were collected and prior to the consultation all patients were requested 
to complete two questionnaires: 1) a self-developed questionnaire and 2) a standardized 
validated quality of life and disease-specific questionnaire as recommend by the Dutch 
Urogynecological Society including the Urogenital Distress Inventory (UDI) [8-10].  
Primary objective of the study was to assess women’s attitudes towards uterus preservation 
versus vaginal hysterectomy in surgical treatment of uterine prolapse. Secondary objectives 
was to study women’s perception and opinions on: 1. the impact of uterus preserving surgery 
and vaginal hysterectomy on body image and sexuality, 2. the importance of treatment 
success, risk of urinary incontinence after surgery, complication risk, recovery time, length of 
hospital stay, costs and sexual functioning after surgery in choosing a surgical POP 
procedure and 3. the influence of future risk to develop endometrial cancer on the preferred 
 
A B S T R A C T  
 
A im s :  To investigate Dutch women’s attitudes and preferences towards hysterectomy or 
uterus preservation in surgical treatment of pelvic organ prolapse.  
Me t h o d s :  Women’s attitude was assessed by a structured questionnaire in one university 
hospital and one non-university teaching hospital in the Netherlands. Between December 
2013 and November 2014, 102 women referred with prolapse complaints, without previous 
prolapse surgery, responded to the questionnaire received by mail prior to gynecological 
consultation. Main outcome was the preference for uterus preserving surgery versus 
hysterectomy. Furthermore we studied the impact of uterus preservation and hysterectomy 
on body image and sexual function and the importance of treatment success, risk of urinary 
incontinence after surgery, complication risk, recovery time, length of hospital stay, costs and 
the risk of developing endometrial cancer.   
R e s u l t s :  Assuming that functional and anatomical outcomes after hysterectomy and uterus 
preserving surgery were equal, more women expressed preference for uterus preservation 
(43%, 44 out of 102 women) compared to hysterectomy (27%, 27 out of 102 women). The 
majority of women expected a similar improvement in sexuality and body image after the two 
treatment modalities. Treatment success, risk for urinary incontinence after surgery and 
complication risk were the most important factors. Taken the future risk of endometrial 
cancer into account 18% of the women preferred hysterectomy because of this risk.   
C o n c l u s i o n s :  This study demonstrated that women referred with prolapse complaints have a 
preference for uterus preservation in case outcomes after both interventions are expected to 
be equal. The majority of women expected that body image and sexual function would 
equally improve after both interventions.  
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I N T R O D U C T I O N  
Different surgical techniques are available to treat pelvic organ prolapse (POP). Whether or 
not the uterus should be preserved in case of uterine prolapse is still a matter of debate. 
Well-executed randomized controlled trials to evaluate these therapies are limited and based 
on current literature no clear superiority in favor uterus preserving surgery or hysterectomy is 
known [1-3].  
In the Netherlands, a trend towards uterus preserving surgery was found during the last 
decade [4].  A similar change was observed in Taiwan and the USA during this period [5,6]. A 
possible explanation for this phenomenon could be that gynecologists have become more 
familiar with the different operative uterus sparing techniques. Also women’s beliefs and 
opinions about the treatment of uterine prolapse may have changed. In literature it is often 
stated that more women want to preserve the uterus in case of surgical management of 
uterine prolapse [7]. However, little is known on women’s attitudes, preferences and beliefs 
with respect to uterus preservation or hysterectomy in surgical management.  
The aim of this study was to explore attitude towards hysterectomy and uterus preservation in 
Dutch women referred with POP complaints. Patient’s perceptions and beliefs on the impact 
of uterus preservation and hysterectomy on body image and sexual function were also 
studied. Furthermore we studied the importance of treatment success, risk of urinary 
incontinence after surgery, complication risk, recovery time, length of hospital stay, costs and 
the risk of developing endometrial cancer when choosing one of the treatments.  
 
M A T E R I A L  A N D  M E T H O D S  
Women’s attitudes towards hysterectomy or preservation were assessed by a structured 
preference questionnaire in a cross-sectional study during one year. The study took place in a 
large teaching hospital (Isala, Zwolle) and a university hospital (Radboud University Nijmegen 
Medical Centre) in The Netherlands from December 2013 to November 2014. Both hospitals 
obtained approval for this study from the central medical ethical committee of the Isala 
(March 8, 2012, under number 12.0326) All women aged 18 years or older, referred with 
POP complaints by their general practitioner (GP), without previous prolapse surgery or 
hysterectomy, could participate in the study. Eligible patients were identified and selected 
based on the referral letters by the investigators (MvIJ, MG and KK). Prior to the scheduled 
gynecological consultation, eligible patients received written and oral study information and 
were asked to participate. Written informed consent was obtained from all participants. 
Demographic data were collected and prior to the consultation all patients were requested 
to complete two questionnaires: 1) a self-developed questionnaire and 2) a standardized 
validated quality of life and disease-specific questionnaire as recommend by the Dutch 
Urogynecological Society including the Urogenital Distress Inventory (UDI) [8-10].  
Primary objective of the study was to assess women’s attitudes towards uterus preservation 
versus vaginal hysterectomy in surgical treatment of uterine prolapse. Secondary objectives 
was to study women’s perception and opinions on: 1. the impact of uterus preserving surgery 
and vaginal hysterectomy on body image and sexuality, 2. the importance of treatment 
success, risk of urinary incontinence after surgery, complication risk, recovery time, length of 
hospital stay, costs and sexual functioning after surgery in choosing a surgical POP 
procedure and 3. the influence of future risk to develop endometrial cancer on the preferred 
 
A B S T R A C T  
 
A im s :  To investigate Dutch women’s attitudes and preferences towards hysterectomy or 
uterus preservation in surgical treatment of pelvic organ prolapse.  
Me t h o d s :  Women’s attitude was assessed by a structured questionnaire in one university 
hospital and one non-university teaching hospital in the Netherlands. Between December 
2013 and November 2014, 102 women referred with prolapse complaints, without previous 
prolapse surgery, responded to the questionnaire received by mail prior to gynecological 
consultation. Main outcome was the preference for uterus preserving surgery versus 
hysterectomy. Furthermore we studied the impact of uterus preservation and hysterectomy 
on body image and sexual function and the importance of treatment success, risk of urinary 
incontinence after surgery, complication risk, recovery time, length of hospital stay, costs and 
the risk of developing endometrial cancer.   
R e s u l t s :  Assuming that functional and anatomical outcomes after hysterectomy and uterus 
preserving surgery were equal, more women expressed preference for uterus preservation 
(43%, 44 out of 102 women) compared to hysterectomy (27%, 27 out of 102 women). The 
majority of women expected a similar improvement in sexuality and body image after the two 
treatment modalities. Treatment success, risk for urinary incontinence after surgery and 
complication risk were the most important factors. Taken the future risk of endometrial 
cancer into account 18% of the women preferred hysterectomy because of this risk.   
C o n c l u s i o n s :  This study demonstrated that women referred with prolapse complaints have a 
preference for uterus preservation in case outcomes after both interventions are expected to 
be equal. The majority of women expected that body image and sexual function would 
equally improve after both interventions.  
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R E S U L T S  
During one year, a total of 200 women were asked to participate of which 102 women (52%) 
actually responded and filled out the questionnaire.  In 30 women (29%) UDI scores were 
missing. Table 1 shows the baseline characteristics. Of the participating women, 36 (35%) 
were aged 18 to 50 years and 66 (65%) over 50 years of age. Furthermore, 32 (33%) 
appeared to have a uterine prolapse POP-Q stage two or higher assessed by POP-Q 
examination. Anterior vaginal wall prolapse stage two or higher was found in 68% of the 
women and 24% had posterior vaginal wall prolapse stage two or higher. 
 
T a b l e  1 .  Baseline and anatomical characteristics  
Characteristics n= 102 
Age, years  56.2 (12.7) 
Parity  2.6 (1.2) 
Body mass index, kg/m2  27.0 (4.1) 
Postmenopausal  65 (63.7%) 
Highest educational level:  
    Primary  / secondary school 19 (26.8%) 
    High school 38 (53.5%) 
    Bachelor, master or academic degree 14 (19.7%) 
VAS general health (0-100)  70.9 (15.6) 
UDI subscale prolapse* 35.0 (31.2) 
Overall POP-Q stage prolapse ** 2 (0.8) 
 
Data are presented as mean (SD) or number (percentage) as appropriate. Percentages were calculated using non-missing 
data. UDI: Urogenital Distress inventory; VAS: visual analogue scale score;  
* UDI: 0=no symptoms or not bothersome and 100=most bothersome symptoms. 
** Evaluated by Pelvic Organ Prolapse Quantification (POP-Q) examination;  
 
Outcomes on preference for hysterectomy or uterus preservation assuming equivalence are 
shown in table 2. In case of equal outcome 43% (44 out of 102) preferred uterus preservation, 
27% (27 out of 102) preferred hysterectomy and 30% (31 out of 102) had no preference. In 
table 3 we show the results of counselling. Statistically significant more women preferred 
uterus preservation (65%) compared to hysterectomy (13%, p=0.001). Of the women who 
preferred uterus preservation 96% opted for the same treatment after counselling. However, 
of the women who preferred hysterectomy, 50% changed their mind after counselling and 
preferred uterus preservation instead. Among the women who had no preference, 45% 
preferred uterus preservation after written counseling.  
 
T a b l e  2 .  Preference for hysterectomy or uterus preserving surgery assuming equal outcome  
 
 Number of women (%)  
Uterus preservation 44 (43%) 
Hysterectomy  27 (27%) 
No preference 31 (30%) 
 
 
treatment. In the self-developed questionnaire the aims of the study were explained and 
information on POP and surgical treatment was given. First, women were questioned 
whether they preferred uterus preserving surgery or vaginal hysterectomy assuming 
equivalence. Furthermore we counselled women based on what was known from literature at 
that time based on the latest reviews regarding this subject: 1. Complication risk during and 
short after surgery (bleeding, infection, damage to the bladder or bowel and problems with 
micturition) appears to be equal after both interventions [11]; 2. Some women need repeat 
surgery because of recurrent prolapse. It is not clear whether this is more frequent after 
uterus preservation or hysterectomy [1,2, 11]; 3. It is possible that surgery relieves symptoms 
but also other complaints can occur. A small number of women will suffer from urinary 
incontinence after surgery for POP. Removal of the uterus is possibly more often associated 
with urinary incontinence in comparison to uterus preservation, but this need further 
investigation [12]; 4. Some uterus preserving procedures are associated with a shorter 
hospital stay (about a day shorter) and a faster recovery after surgery [11,13,14]. Women 
were asked whether this information affected their preferred surgical approach. 
Subsequently, there were specific questions about the influence of the type of surgical 
approach on the expected change in improvement of body image and sexual functioning 
after surgery. Furthermore, women rated on a 5-point Likert scale (1 = not important, 5 = very 
important) the importance of the following factors when choosing surgery: 1. treatment 
success, 2. risk of urinary incontinence after surgery, 3. post-operative recovery, 4. cost, 5. 
length of hospital stay, 6. complications, and 7. sexual functioning after surgery. Patients were 
explained that with uterus preservation there is a small risk of getting endometrial cancer. 
Information was given that in The Netherlands every year approximately 1900 women 
develop endometrial cancer and this type of cancer is usually discovered at an early stage 
due to blood loss. The 5-year overall survival of this early stage disease is 95%.  Women were 
asked whether the risk of endometrial cancer influenced their preferred treatment. . The 
preference questionnaire was piloted among 15 women referred with POP complaints. These 
women completed the questionnaire under supervision of one of the study investigators 
(RJD) and several modifications were made to increase the readability and to clarify some 
questions. The results of this pilot study were not used in the final analysis. The POP-Q score 
and UDI questionnaire scores were collected from the medical record to describe baseline 
characteristics of the study group.  
All statistical analyses were performed in SPSS for Windows version 22.0.0.1 (SPSSInc., 
Chicago, IL, USA). Patient characteristics were summarized using descriptive statistics for 
continuous variables presented with medians, means, range and standard deviations as 
appropriate. Categorical data were compared using a Chi-square test. 
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were asked whether this information affected their preferred surgical approach. 
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questions. The results of this pilot study were not used in the final analysis. The POP-Q score 
and UDI questionnaire scores were collected from the medical record to describe baseline 
characteristics of the study group.  
All statistical analyses were performed in SPSS for Windows version 22.0.0.1 (SPSSInc., 
Chicago, IL, USA). Patient characteristics were summarized using descriptive statistics for 
continuous variables presented with medians, means, range and standard deviations as 
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D i s c u s s i o n  
This study analysed women’s attitudes towards hysterectomy and uterus preserving surgery 
in treatment of POP. In case of equal outcomes after these procedures, more women 
preferred uterus preservation (43%) compared to hysterectomy (27%). After counselling 
based on what was known from literature at that moment, the percentage of women 
preferring uterus preservation increased to 65%.  
Korbly et al. performed a preference assessment in women with POP symptoms at their 
primary urogynecological examination in the USA [15]. They reported that a higher 
proportion of women with prolapse symptoms preferred uterine preservation, instead of 
hysterectomy. Assuming outcomes were equal between hysterectomy and uterine 
preservation, 36% of the women preferred uterine preservation; 20% of the women preferred 
hysterectomy, and 44% of the women had no clear preference. Overall, this is in line with our 
findings.  Geographic region, education level, and belief that the uterus is important ‘for a 
sense of self’ were predictors of preference for uterine preservation.  Frick et al. also reported 
on patients’ attitudes toward the uterus and its role in surgery among 213 women seeking 
care for POP symptoms [16]. The authors found that women had relatively neutral attitudes 
on the uterus being beneficial to sexuality or femininity. The majority of respondents 
disagreed that the uterus was important for body image and sexuality. This is line with our 
results; since approximately 80% of the women reported that the effect of uterus 
preservation and hysterectomy would be the same on sexuality and body image.  A study 
among predominately Hispanic women concluded that 32% would choose to preserve their 
uterus at the time of prolapse repair [17]. 
In our study women completed the questionnaire before gynecological consultation and 
examination and therefore could not be influenced by the preference of the gynecologist, or 
information on their actual prolapse. On the other hand, the fact that women did not really 
know whether or not they had an uterine prolapse or indication for surgery may have 
introduced bias into the study as their prolapse complaints could also be caused by anterior 
and/or posterior vaginal wall prolapse. Only one third of the respondents had an uterine 
prolapse POP-Q stage two or higher assessed by POP-Q examination. It is known that pelvic 
floor symptoms and prolapse complaints have a weak correlation with prolapse in a specific 
compartment or prolapse severity [18]. Therefore, we believe this population was 
representative for this study. Another limitation was the relatively low response rate, with only 
half of the patients giving approval. The most important reason to decline participating was 
the bother to fill out the questionnaire.  One could argue that the counselling statements 
encouraged women to choose for uterus preservation. The study would have been more 
complete if we had also used counter-factual statements providing advantages for 
hysterectomy over uterine preservation. The lack of providing such statements might be 
regarded as a limitation. The statements used for counseling were based on the best 
available evidence at the moment of project development.  
We have used a written questionnaire, which was send to women prior to gynecological 
consultation. Advantage of this type of survey is that it allows women to fill it out at their own 
conveniences. Furthermore it is relatively inexpensive and little time consuming to health 
care providers, which makes it possible to send it to a large number of women with the 
possibility to analyze the results more objectively than other types of preference survey. 
 
T a b l e  3 .  Preference for hysterectomy or uterus preserving surgery assuming equal outcome and crossover of the 
preference after counselling.  
 
 Q1. Preference in case of equal outcome   
 Uterus preservation Hysterectomy* No preference Total 
Q2. Preference after counseling**     
Uterus preservation 42 (96%) 10 (36%) 14 (45%) 66 (65%) 
Hysterectomy  0 (0%) 13 (50%) 0 (0%) 13 (13%) 
No preference 2 (4%) 3 (12%) 17 (55%) 22 (22%) 
 
Data are presented as number (percentage).  
* Preference after counseling in one patient was missing with preference for hysterectomy in case of equal outcome 
**  I. Similar complication risk, II. difference in anatomical outcome between both procedures unclear, III. Removal of the 
uterus is possibly more often associated with occurrence of urinary incontinence, IV. uterus preserving procedures are 
associated with shorter hospital stay and faster post-operative recovery.1,2, 10-13 
 
Several reasons were given to sustain the choice of treatment. Most common reasons to 
choose for hysterectomy were: to avoid problems in the future (43%), menstrual disorders 
(17%) and the uterus has become unnecessary (13%). Most frequently mentioned reasons for 
uterus preservation were: less invasive procedure (22%), want to stay as complete as possible 
(22%), not unnecessarily remove an healthy organ (22%). Only one woman had preference 
for uterus preservation because of future childbearing.  
 
T a b l e  4 .  Improvement in body image and sexuality 
 
 No of women (%) 
Body image  
   Equally improvement in body image 79 (77%) 
   Uterus preservation more improves body image  18 (18%) 
   Hysterectomy more improves body image 4 (4%) 
   Missing 1 (1%) 
Sexuality  
   Equally improvement sexuality 81 (79%) 
   Uterus preservation more improves sexuality 13 (13%) 
   Hysterectomy more improves sexuality 4 (4%) 
   Missing 4 (4%) 
 
In table 4 we show outcomes on the improvement of body image and sexuality. The majority 
of women (77%) expected that the improvement in body image would be the same after 
both interventions. Regarding sexuality, also 79% expected that both interventions would 
equally improve sexuality.  
On a 5-point Likert scale, treatment success (4.5 ± 0.7), risk of urinary incontinence after 
surgery  (4.5 ± 0.8), complication risk (4.4 ± 0.7) and postoperative recovery (4.0 ± 1.0) were 
the most important factors for the preference of a surgical intervention. In addition, sexual 
functioning after surgery was also regarded to be important (3.8 ± 1.1). Length of hospital 
stay (2.9 ± 1.1) and costs (3.0 ± 1.1) were found to be less important.  
With respect to the future risk of endometrial cancer, 18% answered they preferred 
hysterectomy because of this risk, 52% would not necessarily choose hysterectomy and 30% 
did not know. Excluding women without a specific preference and taking age into account, 
more women aged < 50 years (47.8%) preferred hysterectomy because of the future risk of 
endometrial cancer compared to women aged >50 years  (14.6%, p=0.003).  
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care for POP symptoms [16]. The authors found that women had relatively neutral attitudes 
on the uterus being beneficial to sexuality or femininity. The majority of respondents 
disagreed that the uterus was important for body image and sexuality. This is line with our 
results; since approximately 80% of the women reported that the effect of uterus 
preservation and hysterectomy would be the same on sexuality and body image.  A study 
among predominately Hispanic women concluded that 32% would choose to preserve their 
uterus at the time of prolapse repair [17]. 
In our study women completed the questionnaire before gynecological consultation and 
examination and therefore could not be influenced by the preference of the gynecologist, or 
information on their actual prolapse. On the other hand, the fact that women did not really 
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representative for this study. Another limitation was the relatively low response rate, with only 
half of the patients giving approval. The most important reason to decline participating was 
the bother to fill out the questionnaire.  One could argue that the counselling statements 
encouraged women to choose for uterus preservation. The study would have been more 
complete if we had also used counter-factual statements providing advantages for 
hysterectomy over uterine preservation. The lack of providing such statements might be 
regarded as a limitation. The statements used for counseling were based on the best 
available evidence at the moment of project development.  
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Several reasons were given to sustain the choice of treatment. Most common reasons to 
choose for hysterectomy were: to avoid problems in the future (43%), menstrual disorders 
(17%) and the uterus has become unnecessary (13%). Most frequently mentioned reasons for 
uterus preservation were: less invasive procedure (22%), want to stay as complete as possible 
(22%), not unnecessarily remove an healthy organ (22%). Only one woman had preference 
for uterus preservation because of future childbearing.  
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Body image  
   Equally improvement in body image 79 (77%) 
   Uterus preservation more improves body image  18 (18%) 
   Hysterectomy more improves body image 4 (4%) 
   Missing 1 (1%) 
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   Equally improvement sexuality 81 (79%) 
   Uterus preservation more improves sexuality 13 (13%) 
   Hysterectomy more improves sexuality 4 (4%) 
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In table 4 we show outcomes on the improvement of body image and sexuality. The majority 
of women (77%) expected that the improvement in body image would be the same after 
both interventions. Regarding sexuality, also 79% expected that both interventions would 
equally improve sexuality.  
On a 5-point Likert scale, treatment success (4.5 ± 0.7), risk of urinary incontinence after 
surgery  (4.5 ± 0.8), complication risk (4.4 ± 0.7) and postoperative recovery (4.0 ± 1.0) were 
the most important factors for the preference of a surgical intervention. In addition, sexual 
functioning after surgery was also regarded to be important (3.8 ± 1.1). Length of hospital 
stay (2.9 ± 1.1) and costs (3.0 ± 1.1) were found to be less important.  
With respect to the future risk of endometrial cancer, 18% answered they preferred 
hysterectomy because of this risk, 52% would not necessarily choose hysterectomy and 30% 
did not know. Excluding women without a specific preference and taking age into account, 
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Disadvantages of written questionnaires are low response rates and a level of subjectivity in 
the answers since people may read differently into each question and therefore reply based 
on their own interpretation. We tried to avoid this issue by piloting the questionnaire among 
women before the trial started.  
In a previous study we found a trend toward more uterus preservation among gynecologists 
in the Netherlands with large variation in treatment of uterine prolapse [4]. Better 
understanding of women’s thoughts and preference on surgical treatment of uterine 
prolapse makes that more specific information can be given prior to surgery. This is valuable 
in the shared-decision making process prior to surgery. Women appreciated treatment 
success, risk on urinary incontinence, complication risk and recovery time as important 
factors in the choice of a surgical procedure. In addition it seems that counselling had a 
significant effect on the preferred treatment. Caregivers must be aware of these points and 
evidence based information should be given prior to surgery. However, data from 
randomised trials on these outcomes are sparse. Recently, we published the results from the 
SAVE U trial, comparing uterus preserving sacrospinous hysteropexy with vaginal 
hysterectomy with suspension of the uterosacral ligaments [3]. This RCT demonstrated that 
both anatomical and functional outcome were equal for these operative techniques. 
Although vaginal hysterectomy is still the most performed operation in case of uterine 
prolapse [4,19,20] these results provide us an alternative comparable treatment.  
Unfortunately, even today there are gynecologists who argue that the uterus is an atrophic, 
non-functional organ and that uterus preservation on cultural or ideological grounds should 
be rejected. However, better understanding of women’s preferences on uterus preservation 
makes it possible to come to a process of shared-decision making with respect for women’s 
attitudes in case of POP surgery. 
 
C o n c l u s i o n s  
This study demonstrated that women referred with prolapse complaints have a preference 
for uterus preservation in case the outcomes after both interventions are equal. The majority 
of women expected that body image and sexual function would equally improve after both 
interventions.  
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I N T R O D U C T I O N  
Pelvic organ prolapse (POP) is a common health problem affecting up to 40% of parous 
women over 50 years old [1]. The life-time risk for women to undergo surgery for the 
management of POP is about 11% and 30% of these women will need additional surgery 
because of prolapse recurrence [2]. The risk of POP increases with the number of vaginal 
births and is higher in older and obese women. POP has significant negative effects on a 
woman's quality of life, ranging from physical discomfort, psychological and sexual 
complaints to occupational and social limitations.  
POP is defined as the descent of one or more of the pelvic organs. Anterior vaginal wall 
prolapse concerns the bladder and/or urethra (cystocele, urethrocele). Apical prolapse 
entails either the uterus or post-hysterectomy vaginal cuff. Posterior vaginal wall prolapse 
concerns the rectum but can also include the small or large bowel (rectocele, enterocele). 
Women can present with prolapse of one or more compartments. We will focus on the 
treatment of uterine prolapse in this study. 
In the Netherlands vaginal hysterectomy is currently the leading treatment method for 
patients with symptomatic uterine prolapse. Although the literature is inconclusive, it has 
been suggested that hysterectomy may cause nerve supply damage and disrupt supportive 
structures of the pelvic floor. Therefore women may be at increased risk for bladder 
dysfunction and new-onset stress incontinence after vaginal hysterectomy [3-5]. The 
incidence of post-hysterectomy vaginal vault prolapse varies between 0,2 and 12% [6-8]. 
Hysterectomy for pelvic organ prolapse appears to be a particular risk factor. The risk of 
prolapse repair after hysterectomy was 4.7 times higher in women whose initial hysterectomy 
was indicated for pelvic organ prolapse and 8 times higher if preoperative prolapse grade 2 
or more was present [9]. 
In several retrospective and prospective studies it has been shown that sacrospinous fixation 
in case of uterine or vaginal vault prolapse is a safe and effective treatment [10-14]. Two 
sutures suspend the cervix or vaginal vault to the sacrospinous ligament bringing the apex 
above the levator plate. The procedure is associated with a few serious complications. 
Buttock pain on the side where the sacrospinous sutures have been passed occurs in 
approximately 10-15% of the women but typically resolves in days to months. 
Two retrospective and one prospective study comparing vaginal hysterectomy to 
sacrospinous fixation demonstrated no significant difference in anatomical outcome, while 
hospital stay was shorter, less pain was experienced and recovery was quicker in the latest 
group [15-17]. However to date only one randomised study comparing both procedures is 
available. This multi-center trial compared vaginal hysterectomy to sacrospinous fixation in a 
group of 66 women with uterine descent and found a higher rate of recurrences after one 
year in patients with sacrospinous fixation (27% versus 3% recurrence in patients with vaginal 
hysterectomy) [18]. This conflicting evidence could be attributed to inadequate statistical 
power owing to small sample size and short duration of follow up. Possible other 
explanations for the difference in recurrences rates between the different studies are 
heterogeneity of data collection and selection bias, for instance excluding women with a 
stage 4 uterine descent. Also due to the multi-center design of the study more 
gynaecologists performed the procedures, possibly by using different techniques, and 
therefore introducing the risk of a difference in quality. Benefits from sacrospinous fixation 
	  
A B S T R A C T  
 
B a c k g r o u n d :  Pelvic organ prolapse is a common health problem, affecting up to 40% of 
parous women over 50 years old, with significant negative influence on quality of life. Vaginal 
hysterectomy is currently the leading treatment method for patients with symptomatic uterine 
prolapse. Several studies have shown that sacrospinous fixation in case of uterine prolapse is 
a safe and effective alternative to vaginal hysterectomy. However, no large randomized trials 
with long-term follow-up have been performed to compare efficacy and quality of life 
between both techniques. The SAVE U trial is designed to compare sacrospinous fixation 
with vaginal hysterectomy in the treatment of uterine prolapse stage 2 or higher in terms of 
prolapse recurrence, quality of life, complications, hospital stay, post-operative recovery and 
sexual functioning.  
Me t h o d s :  The SAVE U trial is a randomized controlled multi-center non-inferiority trial. The 
study compares sacrospinous fixation with vaginal hysterectomy in women with uterine 
prolapse stage 2 or higher. The primary outcome measure is recurrence of uterine prolapse 
defined as: uterine descent stage 2 or more assessed by pelvic organ prolapse quantification 
examination and prolapse complaints and/or redo surgery at 12 months follow-up. 
Secondary outcomes are subjective improvement in quality of life measured by generic 
(Short Form 36 and Euroqol 5D) and disease-specific (Urogenital Distress Inventory, 
Defecatory Distress Inventory and Incontinence Impact Questionnaire) quality of life 
instruments, complications following surgery, hospital stay, post-operative recovery and 
sexual functioning (Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire). 
Analysis will be performed according to the intention to treat principle. Based on comparable 
recurrence rates of 3% and considering an upper-limit of 7% to be non-inferior (beta 0.2 and 
one sided alpha 0.025), 104 patients are needed per group. 
D i s c u s s i o n :  The SAVE U trial is a randomized multicenter trial that will provide evidence 
whether the efficacy of sacrospinous fixation is similar to vaginal hysterectomy in women with 
uterine prolapse stage 2 or higher. 
T r i a l  r e g i s t r a t i o n :  Netherlands Trial Register (NTR): NTR1866 
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information is provided. An interval of one to two weeks between the primary visit and the 
next appointment allows sufficient time for women to think about participation. Written 
informed consent is obtained before randomisation. 
 
F I G U R E  1 .  Study design 
 
Primary and secondary endpoints 
The primary endpoint of this study is surgical failure, defined as recurrence of prolapse POP-
Q stage 2 of the middle compartment and prolapse complaints and/or redo surgery. This 
item will be evaluated by performing a POP-Q examination at 12 months follow-up. 
Secondary endpoints of this study include: subjective outcome and improvement in general 
and disease-specific quality of life, complications, hospital stay, post-operative recovery and 
sexual functioning after sacrospinous fixation or vaginal hysterectomy. 
 
Participating hospitals 
Four Dutch (non-academic) hospitals will enrol patients. 
 
Randomisation 
After patients have consented for participation in the study, they are randomized centrally 
through a website using computer-generated randomisation tables. The subjects are 
assigned in a 1:1 ratio to either sacrospinous fixation or vaginal hysterectomy. Randomisation 
will be stratified according to centre and severity of prolapse (POP-Q stage 2, 3 or 4). The 
details of the series are unknown to investigators or to the participating gynaecologists and 
all participants will receive unique study numbers. 
	  
described in previous studies were also demonstrated in the randomised trial. Median 
hospital stay was shorter after sacrospinous fixation (3 versus 4 days) and patients had earlier 
resumption of daily activities and work (43 days versus 66 days).  
In conclusion, studies that compare vaginal hysterectomy to sacrospinous fixation lack long-
term follow-up and have insufficient power because of the small numbers and heterogeneity 
of included patients. Therefore we will conduct a multi-centre, non-inferiority trial to 
determine whether the efficacy of sacrospinous fixation is similar to vaginal hysterectomy in 
women with symptomatic uterine prolapse pelvic organ prolapse quantification (POP-Q) 
stage 2 or higher. 
 
M E T H O D S / D E S I G N  
Study objectives 
The objective of this study is to compare sacrospinous fixation with vaginal hysterectomy in 
the treatment of uterine prolapse POP-Q stage 2 or higher in terms of recurrence of 
prolapse, quality of life, complications, post-operative recovery, hospital stay and sexual 
functioning. 
 
Hypothesis 
Our hypothesis for this study is that there is no difference in recurrence rate between 
sacrospinous fixation and vaginal hysterectomy in symptomatic women with uterine decent 
POP-Q stage 2 or higher. However, sacrospinous fixation may be associated with shorter 
hospital stay, more quick recovery and less postoperative pain. 
 
Study design 
The SAVE U trial is a prospective randomized non-blinded clinical trial conducted with the 
aim to determine non-inferiority of the primary endpoint between sacrospinous fixation and 
vaginal hysterectomy. The study will be an open label study, as it is impossible to blind the 
health care workers and patients involved for the surgical procedure to which the woman is 
allocated. Follow-up after one year, however, will be done by an independent physician. 
After inclusion, patients will be randomized centrally in 1:1 ratio stratified per centre and 
severity of prolapse. Patients are followed-up at 6 weeks, 6 months, 12 months and annually 
thereafter till 60 months follow-up. The design is presented in figure 1.  
 
Study population and recruitment 
All women seeking treatment for symptomatic pelvic organ prolapse with uterine descent 
POP-Q stage 2 or higher, will be considered for inclusion in the SAVE U trial. Patients with co-
existing anterior/posterior defects or concomitant incontinence surgery can be included. 
Women with previous pelvic floor or prolapse surgery, known malignancy or abnormal 
cervical smears, a wish to preserve fertility, language barriers, presence of 
immunological/haematological disorders interfering with recovery after surgery, abnormal 
ultrasound findings of uterus or ovaries or abnormal uterine bleeding and who are unwilling 
to return for follow-up are excluded from the study. Assessment for eligibility is performed by 
gynaecologist and/or residents of the participating hospital. Patients eligible for participation 
are counselled about the long duration of follow up that is involved in the study. Also the 
risks associated with uterus preservation is clearly outlined. Subsequently, written patient 
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Vaginal hysterectomy 
The patient is placed in lithotomy position and a tenaculum forceps is used to grasp the 
cervix. The vaginal wall around the cervix is circumcised. The bladder will be dissected and 
the anterior peritoneum opened. The posterior peritoneum will be opened and the Douglas 
cul-de-sac is entered. The uterosacral ligaments will be identified, transected and ligated. In 
several steps the uterus will be removed using clamps and sutures. Following removal of the 
uterus, the adnexa are inspected and the surgical pedicles are inspected for bleeding. The 
peritoneum is closed in a purse-string manner using a delayed-absorbable suture (Vicryl 1.0). 
The ligature of the uterosacral ligaments is sutured to the vaginal cuff to aid in long-term 
vaginal support. The vaginal wall incision is closed left to right with interrupted sutures. 
During the same procedure additional anterior and/or posterior colporrhaphy or 
incontinence surgery can be performed. 
 
S T A T I S T I C A L  A N A L Y S I S  
Sample size and power considerations 
The sample size for this trial has been estimated using the hypothesis that both interventions 
are equivalent regarding anatomical outcome. The aim is to show that in the sacrospinous 
fixation arm, anatomical result is comparable to the vaginal hysterectomy group. Two groups 
of 94 patients will be included to yield a 80% power for a non-inferiority margin of 7%, 
assuming a relapse rate of 3% [18]. Considering a 10% loss in follow-up 104 women per arm 
are needed and thus a total of 208 women. 
 
Data analysis 
Patient characteristics will be summarized using descriptive statistics for continuous variables 
presented with medians, means and standard deviations as appropriate. Categorical data will 
be presented as rates and percentages. Anatomical outcome and recurrence rate assessed 
by a POP-Q-examination in both study groups will be considered as primary outcome. 
Surgical failure (recurrence) is defined as the presence of prolapse stage 2 or more in the 
middle compartment with prolapse complaints and/or redo surgery at one-year follow-up. 
Non-inferiority of sacrospinous fixation to vaginal hysterectomy will be concluded if the lower 
limit of the 95% confidence interval lies above the non-inferiority margin of -7% (this is 
equivalent to performing a one-sided hypothesis test at the 0.025 level of significance, based 
on the null hypothesis that sacrospinous fixation is inferior to vaginal hysterectomy). If the 
95% confidence interval for the difference in recurrence rates not only lies above the non-
inferiority margin, but also above zero then it will be concluded that there is evidence of 
superiority of sacrospinous fixation over vaginal hysterectomy in terms of statistical 
significance at the 2-sided 5% level (p < 0.05). 
 
Ethics 
The study is conducted in accordance with the principles of the Declaration of Helsinki and 
'good clinical practice' guidelines. The SAVE U trial has been approved by the Medical 
Ethical Committee of the Isala Klinieken Zwolle (MEC 09/625) and the local Ethical 
Committees of the participating centers. Prior to randomization informed consent will be 
obtained. 
	  
Data collection 
All patients will undergo routine gynaecological examination which is part of standard 
procedure before surgery. This includes pelvic ultrasound to exclude uterine or ovarian 
disease, routine PAP-smear and vaginal inspection in 45° semi-upright position for staging 
uterovaginal prolapse by a POP-Q examination. The POP-Q system has been developed by 
the international Continence Society and is a reliable and specific method to measure organ 
support [19,20]. Maximum prolapse is demonstrated and identified by asking the patient to 
cough and to perform a Valsava manoeuvre while each vaginal wall is individually exposed. 
At inclusion all patients are requested to fill in validated quality of life questionnaires (RAND 
36, Euroqol 5D, Urogenital Distress Inventory, Defecatory Distress Inventory, Incontinence 
Impact Questionnaire) [21-26] and two questionnaires regarding sexual functioning (Pelvic 
Organ Prolapse/Urinary Incontinence Sexual Questionnaire and selected items from the 
'Vragenlijst Seksuele disfuncties') [27-29]. Preoperative urodynamic evaluation is only 
performed in women with bladder dysfunction. During hospitalisation and the first 6 weeks 
after surgery patients keep a diary which contains the following items: post-operative pain 
measured by the Visual Analogue Score (VAS), used pain medication and the Recovery 
Index-10 (RI-10) which is a validated quality-of life questionnaire measuring subjective 
postoperative recovery [30]. After surgery patients will visit the hospital at 6 weeks (routine 
post-operative consultation), 6 months, 12 months and yearly thereafter till 60 months follow-
up. 
 
Interventions 
Eligible women will be randomly allocated to receive either a sacrospinous fixation or a 
vaginal hysterectomy. All procedures will be performed under general anesthesia or spinal 
analgesia according to the preference of patient and anesthesiologist. All women receive 
peri-operative antibiotics and thrombosis prophylaxis. Post-operatively a bladder catheter is 
placed and removed according to local hospital protocol. Patients will receive analgesics if 
necessary in accordance with local hospital protocol. All patients are advised to abstain from 
heavy physical work for a minimal period of 6 weeks. 
 
Sacrospinous fixation 
At least twenty procedures must have been performed by participating gynaecologists to 
eliminate a learning curve effect. All procedures are performed unilaterally to the right 
sacrospinous ligament. Access to sacrospinous ligament is obtained through the pararectal 
space. The posterior vaginal wall will be incised and separated from the rectum. The right 
ischial spine will be localised digitally and after retractor positioning the ligament is made 
visible through blunt dissection. Two permanent sutures (Prolene 1.0, Ethicon, Somerville, 
NJ, USA) will be placed through the right sacrospinous ligament at least 2 cm from the ischial 
spine. Hereafter, an additional anterior and/or posterior colporrhaphy or incontinence 
surgery can be performed. The permanent sutures will be placed through the posterior side 
of the cervix and two thirds of the posterior vaginal wall will be closed with absorbable 
sutures (Vicryl 2, Ethicon, Somerville, NJ, USA). The permanent sutures will be tightened and 
the cervix redressed. The remainder of the vaginal wall will be closed. 
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Vaginal hysterectomy 
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uterus, the adnexa are inspected and the surgical pedicles are inspected for bleeding. The 
peritoneum is closed in a purse-string manner using a delayed-absorbable suture (Vicryl 1.0). 
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Surgical failure (recurrence) is defined as the presence of prolapse stage 2 or more in the 
middle compartment with prolapse complaints and/or redo surgery at one-year follow-up. 
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limit of the 95% confidence interval lies above the non-inferiority margin of -7% (this is 
equivalent to performing a one-sided hypothesis test at the 0.025 level of significance, based 
on the null hypothesis that sacrospinous fixation is inferior to vaginal hysterectomy). If the 
95% confidence interval for the difference in recurrence rates not only lies above the non-
inferiority margin, but also above zero then it will be concluded that there is evidence of 
superiority of sacrospinous fixation over vaginal hysterectomy in terms of statistical 
significance at the 2-sided 5% level (p < 0.05). 
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Committees of the participating centers. Prior to randomization informed consent will be 
obtained. 
	  
Data collection 
All patients will undergo routine gynaecological examination which is part of standard 
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disease, routine PAP-smear and vaginal inspection in 45° semi-upright position for staging 
uterovaginal prolapse by a POP-Q examination. The POP-Q system has been developed by 
the international Continence Society and is a reliable and specific method to measure organ 
support [19,20]. Maximum prolapse is demonstrated and identified by asking the patient to 
cough and to perform a Valsava manoeuvre while each vaginal wall is individually exposed. 
At inclusion all patients are requested to fill in validated quality of life questionnaires (RAND 
36, Euroqol 5D, Urogenital Distress Inventory, Defecatory Distress Inventory, Incontinence 
Impact Questionnaire) [21-26] and two questionnaires regarding sexual functioning (Pelvic 
Organ Prolapse/Urinary Incontinence Sexual Questionnaire and selected items from the 
'Vragenlijst Seksuele disfuncties') [27-29]. Preoperative urodynamic evaluation is only 
performed in women with bladder dysfunction. During hospitalisation and the first 6 weeks 
after surgery patients keep a diary which contains the following items: post-operative pain 
measured by the Visual Analogue Score (VAS), used pain medication and the Recovery 
Index-10 (RI-10) which is a validated quality-of life questionnaire measuring subjective 
postoperative recovery [30]. After surgery patients will visit the hospital at 6 weeks (routine 
post-operative consultation), 6 months, 12 months and yearly thereafter till 60 months follow-
up. 
 
Interventions 
Eligible women will be randomly allocated to receive either a sacrospinous fixation or a 
vaginal hysterectomy. All procedures will be performed under general anesthesia or spinal 
analgesia according to the preference of patient and anesthesiologist. All women receive 
peri-operative antibiotics and thrombosis prophylaxis. Post-operatively a bladder catheter is 
placed and removed according to local hospital protocol. Patients will receive analgesics if 
necessary in accordance with local hospital protocol. All patients are advised to abstain from 
heavy physical work for a minimal period of 6 weeks. 
 
Sacrospinous fixation 
At least twenty procedures must have been performed by participating gynaecologists to 
eliminate a learning curve effect. All procedures are performed unilaterally to the right 
sacrospinous ligament. Access to sacrospinous ligament is obtained through the pararectal 
space. The posterior vaginal wall will be incised and separated from the rectum. The right 
ischial spine will be localised digitally and after retractor positioning the ligament is made 
visible through blunt dissection. Two permanent sutures (Prolene 1.0, Ethicon, Somerville, 
NJ, USA) will be placed through the right sacrospinous ligament at least 2 cm from the ischial 
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D I S C U S S I O N  
This is a protocol for a randomised trial comparing sacrospinous fixation and vaginal 
hysterectomy for the treatment of uterine prolapse POP-Q stage 2 or higher with regard to 
anatomical outcome, post-operative recovery, length of hospital stay, complications and 
sexual functioning. The findings of this trial will contribute to answer the question which 
surgical treatment is preferable in women with symptomatic uterine prolapse POP-Q stage 2 
or higher. If equivalence in anatomical outcome is found, the comparison of the secondary 
outcomes will be essential in selecting the preferred strategy. 
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This is a protocol for a randomised trial comparing sacrospinous fixation and vaginal 
hysterectomy for the treatment of uterine prolapse POP-Q stage 2 or higher with regard to 
anatomical outcome, post-operative recovery, length of hospital stay, complications and 
sexual functioning. The findings of this trial will contribute to answer the question which 
surgical treatment is preferable in women with symptomatic uterine prolapse POP-Q stage 2 
or higher. If equivalence in anatomical outcome is found, the comparison of the secondary 
outcomes will be essential in selecting the preferred strategy. 
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I N T R O D U C T I O N  
Pelvic organ prolapse is a common health problem. The prevalence of such prolapse is as 
much as 40% in women aged more than 45 years, with millions of women affected 
worldwide, and the incidence is still rising as a result of aging populations and increasing 
obesity rates [1]. Pelvic organ prolapse has a negative influence on women’s quality of life 
and is associated with physical, psychological, and sexual problems. 
The lifetime risk for prolapse surgery is 11-20%, and worldwide vaginal hysterectomy is the 
most commonly performed surgical procedure for uterine prolapse [2-6]. Performing a 
hysterectomy for uterine prolapse is not an evidence based practice and whether or not the 
uterus should be removed is debatable. Uterus preserving procedures such as vaginal 
sacrospinous hysteropexy, in which the uterus is attached to the sacrospinous ligament, are 
becoming more popular. In a recent study we found a trend towards more uterus 
preservation in the Netherlands, which is in line with more women opting to retain their 
uterus in case of an equal outcome with hysterectomy [6-9]. Uterus preservation is thought to 
be less invasive, and in prospective non-randomised and retrospective cohort studies 
sacrospinous hysteropexy was as effective as vaginal hysterectomy, with a similar rate of 
recurrence and repeat surgery but with a shorter operating time, less blood loss, faster 
recovery, and fewer complications [10-12]. A hysterectomy has known benefits as well: it 
prevents the development of uterine cancer and stops menstrual bleeding in premenopausal 
women. After vaginal hysterectomy, however, women may be at increased risk of recurrent 
prolapse since hysterectomy disrupts the supportive structures of the pelvic floor [13]. To 
prevent future prolapse of the vaginal vault after hysterectomy additional vault suspension is 
recommended [14,15]. Randomised controlled trials comparing uterus preserving 
techniques and hysterectomy with vault suspension are limited. One randomised controlled 
trial found more recurrent uterine prolapse with sacrospinous hysteropexy after 12 months, 
but the recurrence rate was only a secondary endpoint [16]. Another randomised controlled 
trial found no differences in sexual functioning after six months but did not report on 
anatomical outcomes [17]. 
Owing to a lack of well executed randomised controlled trials and clear guidelines on the 
treatment of uterine prolapse, the variation in surgical management of uterine prolapse is 
enormous and a Cochrane meta-analysis on surgery for pelvic organ prolapse concluded that 
more research on this subject is needed [18]. We tested the hypothesis that sacrospinous 
hysteropexy is non-inferior to vaginal hysterectomy with suspension of the uterosacral 
ligaments for surgical failure after 12 months’ follow-up. 
 
M E T H O D S  
S t u d y  d e s i g n  
A detailed version of the trial protocol has been published previously [19]. In short, all 
women with uterine prolapse at stage 2 or higher (uterine prolapse 1 cm above the hymen or 
beyond) requiring surgery were invited to participate. Participants were randomly assigned 
to sacrospinous hysteropexy or vaginal hysterectomy with suspension of the uterosacral 
ligaments in a non-blinded multicentre randomised controlled non-inferiority trial. 
Women with coexisting prolapse of the anterior or posterior vaginal wall, or both were able 
to participate, and cervical elongation together with uterine prolapse was no reason for 
	  
A B S T R A C T  
 
O b j e c t i v e :  To investigate whether uterus preserving vaginal sacrospinous hysteropexy is non-
inferior to vaginal hysterectomy with suspension of the uterosacral ligaments in the surgical 
treatment of uterine prolapse. 
D e s i g n :  Multicentre randomised controlled non-blinded non-inferiority trial. 
S e t t i n g :  4 non-university teaching hospitals, the Netherlands. 
P a r t i c i p a n t s :  208 healthy women with uterine prolapse stage 2 or higher requiring surgery 
and no history of pelvic floor surgery. 
I n t e r v e n t i o n s :  Treatment with sacrospinous hysteropexy or vaginal hysterectomy with 
suspension of the uterosacral ligaments. The predefined non-inferiority margin was an 
increase in surgical failure rate of 7%. 
Ma i n  o u t c om e  m e a s u r e s :  Primary outcome was recurrent prolapse stage 2 or higher of the 
uterus or vaginal vault (apical compartment) evaluated by the pelvic organ prolapse 
quantification system in combination with bothersome bulge symptoms or repeat surgery for 
recurrent apical prolapse at 12 months’ follow-up. Secondary outcomes were overall 
anatomical recurrences, including recurrent anterior compartment (bladder) and/or posterior 
compartment (bowel) prolapse, functional outcome, complications, hospital stay, 
postoperative recovery, and sexual functioning. 
R e s u l t s :  Sacrospinous hysteropexy was non-inferior for anatomical recurrence of the apical 
compartment with bothersome bulge symptoms or repeat surgery (n=0, 0%) compared with 
vaginal hysterectomy with suspension of the uterosacral ligaments (n=4, 4.0%, difference 
−3.9%, 95% confidence interval for difference −8.6% to 0.7%). At 12 months, overall 
anatomical recurrences, functional outcome, quality of life, complications, hospital stay, 
measures on postoperative recovery, and sexual functioning did not differ between the two 
groups. Five serious adverse events were reported during hospital stay. None was 
considered to be related to the type of surgery. 
C o n c l u s i o n s :  Uterus preservation by sacrospinous hysteropexy was non-inferior to vaginal 
hysterectomy with suspension of the uterosacral ligaments for surgical failure of the apical 
compartment at 12 months’ follow-up. 
T r i a l  r e g i s t r a t i o n :  trialregister.nl NTR1866. 
90
CHAPTER 7
501420-L-bw-Detollenaere
	  
I N T R O D U C T I O N  
Pelvic organ prolapse is a common health problem. The prevalence of such prolapse is as 
much as 40% in women aged more than 45 years, with millions of women affected 
worldwide, and the incidence is still rising as a result of aging populations and increasing 
obesity rates [1]. Pelvic organ prolapse has a negative influence on women’s quality of life 
and is associated with physical, psychological, and sexual problems. 
The lifetime risk for prolapse surgery is 11-20%, and worldwide vaginal hysterectomy is the 
most commonly performed surgical procedure for uterine prolapse [2-6]. Performing a 
hysterectomy for uterine prolapse is not an evidence based practice and whether or not the 
uterus should be removed is debatable. Uterus preserving procedures such as vaginal 
sacrospinous hysteropexy, in which the uterus is attached to the sacrospinous ligament, are 
becoming more popular. In a recent study we found a trend towards more uterus 
preservation in the Netherlands, which is in line with more women opting to retain their 
uterus in case of an equal outcome with hysterectomy [6-9]. Uterus preservation is thought to 
be less invasive, and in prospective non-randomised and retrospective cohort studies 
sacrospinous hysteropexy was as effective as vaginal hysterectomy, with a similar rate of 
recurrence and repeat surgery but with a shorter operating time, less blood loss, faster 
recovery, and fewer complications [10-12]. A hysterectomy has known benefits as well: it 
prevents the development of uterine cancer and stops menstrual bleeding in premenopausal 
women. After vaginal hysterectomy, however, women may be at increased risk of recurrent 
prolapse since hysterectomy disrupts the supportive structures of the pelvic floor [13]. To 
prevent future prolapse of the vaginal vault after hysterectomy additional vault suspension is 
recommended [14,15]. Randomised controlled trials comparing uterus preserving 
techniques and hysterectomy with vault suspension are limited. One randomised controlled 
trial found more recurrent uterine prolapse with sacrospinous hysteropexy after 12 months, 
but the recurrence rate was only a secondary endpoint [16]. Another randomised controlled 
trial found no differences in sexual functioning after six months but did not report on 
anatomical outcomes [17]. 
Owing to a lack of well executed randomised controlled trials and clear guidelines on the 
treatment of uterine prolapse, the variation in surgical management of uterine prolapse is 
enormous and a Cochrane meta-analysis on surgery for pelvic organ prolapse concluded that 
more research on this subject is needed [18]. We tested the hypothesis that sacrospinous 
hysteropexy is non-inferior to vaginal hysterectomy with suspension of the uterosacral 
ligaments for surgical failure after 12 months’ follow-up. 
 
M E T H O D S  
S t u d y  d e s i g n  
A detailed version of the trial protocol has been published previously [19]. In short, all 
women with uterine prolapse at stage 2 or higher (uterine prolapse 1 cm above the hymen or 
beyond) requiring surgery were invited to participate. Participants were randomly assigned 
to sacrospinous hysteropexy or vaginal hysterectomy with suspension of the uterosacral 
ligaments in a non-blinded multicentre randomised controlled non-inferiority trial. 
Women with coexisting prolapse of the anterior or posterior vaginal wall, or both were able 
to participate, and cervical elongation together with uterine prolapse was no reason for 
	  
A B S T R A C T  
 
O b j e c t i v e :  To investigate whether uterus preserving vaginal sacrospinous hysteropexy is non-
inferior to vaginal hysterectomy with suspension of the uterosacral ligaments in the surgical 
treatment of uterine prolapse. 
D e s i g n :  Multicentre randomised controlled non-blinded non-inferiority trial. 
S e t t i n g :  4 non-university teaching hospitals, the Netherlands. 
P a r t i c i p a n t s :  208 healthy women with uterine prolapse stage 2 or higher requiring surgery 
and no history of pelvic floor surgery. 
I n t e r v e n t i o n s :  Treatment with sacrospinous hysteropexy or vaginal hysterectomy with 
suspension of the uterosacral ligaments. The predefined non-inferiority margin was an 
increase in surgical failure rate of 7%. 
Ma i n  o u t c om e  m e a s u r e s :  Primary outcome was recurrent prolapse stage 2 or higher of the 
uterus or vaginal vault (apical compartment) evaluated by the pelvic organ prolapse 
quantification system in combination with bothersome bulge symptoms or repeat surgery for 
recurrent apical prolapse at 12 months’ follow-up. Secondary outcomes were overall 
anatomical recurrences, including recurrent anterior compartment (bladder) and/or posterior 
compartment (bowel) prolapse, functional outcome, complications, hospital stay, 
postoperative recovery, and sexual functioning. 
R e s u l t s :  Sacrospinous hysteropexy was non-inferior for anatomical recurrence of the apical 
compartment with bothersome bulge symptoms or repeat surgery (n=0, 0%) compared with 
vaginal hysterectomy with suspension of the uterosacral ligaments (n=4, 4.0%, difference 
−3.9%, 95% confidence interval for difference −8.6% to 0.7%). At 12 months, overall 
anatomical recurrences, functional outcome, quality of life, complications, hospital stay, 
measures on postoperative recovery, and sexual functioning did not differ between the two 
groups. Five serious adverse events were reported during hospital stay. None was 
considered to be related to the type of surgery. 
C o n c l u s i o n s :  Uterus preservation by sacrospinous hysteropexy was non-inferior to vaginal 
hysterectomy with suspension of the uterosacral ligaments for surgical failure of the apical 
compartment at 12 months’ follow-up. 
T r i a l  r e g i s t r a t i o n :  trialregister.nl NTR1866. 
91
SACROSPINOUS HYSTEROPEXY VERSUS VAGINAL HYSTERECTOMY
7
501420-L-bw-Detollenaere
	  
 
Sacrospinous hysteropexy—Vaginal sacrospinous hysteropexy was performed unilaterally to 
the right sacrospinous ligament. The posterior vaginal wall was incised and the sacrospinous 
ligament accessed through the pararectal space. Two permanent sutures (Prolene 1.0; 
Ethicon, Somerville, NJ) were placed under direct vision through the sacrospinous ligament 
at least 2 cm from the ischial spine. Additional anterior or posterior vaginal wall repair or 
incontinence surgery was performed if indicated. The permanent sutures were also placed 
through the posterior side of the cervix and tightened and the uterus redressed. The 
posterior vaginal wall was closed with absorbable sutures (Vicryl 2; Ethicon, Somerville, NJ). 
(Also see www.youtube.com/watch?v=ySSfy2A1_RM and 
www.youtube.com/watch?v=wjct1r37sTw). 
 
Vaginal hysterectomy—The vaginal wall around the cervix was circumcised. After bladder and 
bowel dissection the anterior and posterior peritoneum were opened. The uterosacral 
ligaments—strong supportive ligaments that attach the cervix to the sacrum—were identified, 
ligated, and transected. The uterus was released in several steps using clamps and sutures. 
After removal of the uterus, the surgical pedicles were inspected for haemostasis and the 
adnexa inspected. The peritoneum was closed using a delayed absorbable suture (Vicryl 1.0; 
Ethicon, Somerville, NJ). Additional vault suspension in this study was performed by 
suspension of the uterosacral ligaments. Such suspension involves the attachment of the 
uterosacral ligaments to the vaginal vault, thereby restoring normal support to the apical 
compartment [21]. Concomitant anterior or posterior vaginal wall repair and anti-
incontinence surgery were performed afterwards if indicated. 
 
Mea s u r em en t s  a n d  p r o c e d u r e s  
Gynaecological examination before surgery included pelvic ultrasonography to exclude 
uterine or ovarian disease, a cervical smear test, and vaginal inspection in 45° semi-upright 
position for staging pelvic organ prolapse using the pelvic organ prolapse quantification 
system (POP-Q) [22]. This system involves quantitative measurements of various points of the 
vaginal wall, using the hymen as a reference point. The degree of prolapse of the anterior 
vaginal wall, posterior vaginal wall, and uterus or vaginal vault is measured in centimetres 
either above or proximal to the hymen (negative number) or beyond, or distal to the hymen 
(positive number), with the plane of the hymen being defined as zero. The genital hiatus, 
perineal body, and total vaginal length are also measured. Based on these measurements, a 
stage (0-4) is determined for each compartment. The overall stage is equal to the stage of the 
most severely prolapsed compartment. The women came to the hospital to be examined for 
pelvic organ prolapse stage at baseline and at six weeks, six months, and 12 months after 
surgery and annually thereafter until 60 months’ follow-up. At the time of the follow-up visits 
women completed validated health related and disease specific quality of life questionnaires: 
short form-36, Euroqol 5D, urogenital distress inventory, defecatory distress inventory, and 
incontinence impact questionnaire [23-26]. We defined the presence of bothersome bulge 
symptoms after surgery as a positive answer to any of the following two questions from the 
urogenital distress inventory: “Do you experience a sensation of bulging or protrusion from 
the vagina?” and “Do you have a bulge or something falling out that you can see in the 
	  
exclusion. Concomitant repair of anterior or posterior vaginal prolapse (colporrhaphy) was 
allowed, including anti-incontinence surgery. We excluded women with previous pelvic floor 
or prolapse surgery, known malignancy or an abnormal cervical smear test result, a wish to 
preserve fertility, language barriers, immunological or haematological disorders interfering 
with recovery after surgery, abnormal ultrasound findings of the uterus or ovaries, or 
abnormal uterine bleeding, and those who were unwilling to return for follow-up. 
All four participating centres were Dutch large non-university teaching hospitals. Centres had 
to offer both treatment modalities, and we invited them to participate if they were known to 
perform the interventions in the same standardised manner. All gynaecologists were 
experienced and had performed a minimum of 20 procedures of each intervention before 
the start of the trial. As the participating hospitals were teaching hospitals, residents were 
allowed to perform procedures under direct supervision of the gynaecologist. 
Gynaecologists and residents of the participating centres assessed the eligibility of patients. 
The decision to treat uterine prolapse surgically was a shared decision by the woman and her 
gynaecologist. We gave the women written information and obtained informed consent  
before randomisation. The women were randomly allocated in a 1:1 ratio using a web based 
application with computer generated randomisation tables in blocks of four, stratified by 
hospital and stage of uterine prolapse. The trial was non-blinded as it was impossible to blind 
surgeons and women to the allocated surgical procedure. An independent doctor who was 
not involved in treatment carried out the 12 month follow-up. 
 
O u t c om e  m e a s u r e s  
Initially the primary outcome was surgical failure at the 12 month follow-up. As outcome 
definitions to evaluate prolapse surgery were improved after the start of this trial, we 
changed the primary outcome during enrolment and before data analysis into the composite 
outcome measure of recurrent pelvic organ prolapse stage 2 or higher in the apical 
compartment (uterus or vaginal vault) with bothersome bulge symptoms or repeat surgery 
for recurrent apical prolapse at the 12 month follow-up. Isala hospital’s medical ethical 
committee approved this change, and during enrolment we published the protocol in an 
open access online journal [19].  
We evaluated the original primary outcome, overall anatomical failure (pelvic organ prolapse 
stage 2 or higher in any compartment), as a secondary outcome together with two additional 
definitions of surgical failure or success. Firstly, a composite outcome of success, defined as 
no prolapse beyond the hymen, no bothersome bulge symptoms, and no repeat surgery or 
pessary use for recurrent prolapse within 12 months. Secondly, overall surgical failure: pelvic 
organ prolapse stage 2 or higher, pessary use, or repeat surgery for recurrent prolapse in any 
compartment within 12 months [20]. Other secondary outcomes were functional outcome, 
quality of life, complications, hospital stay, postoperative recovery, and sexual functioning. 
 
I n t e r v e n t i o n s  
We referred to a detailed description of the study interventions to ensure a uniform 
technique among the surgeons [19]. All women received perioperative antibiotics, 
prophylaxis against thrombosis, and a bladder catheter according to local hospital protocol. 
Analgesics were given postoperatively in accordance with each hospital’s protocol. The 
women were advised to abstain from heavy physical work for six weeks. 
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P a t i e n t  i n v o l v em e n t  
No patients were involved in the design and implementation of the study, the dissemination 
of the results, setting the research question or the outcome measures, or recruitment. 
 
R E S U L T S  
Between 27 November 2009 and 12 March 2012, 208 women were randomly assigned to 
sacrospinous hysteropexy (n=103) or to vaginal hysterectomy (n=105). The figure shows the 
flow of women through the study. Baseline characteristics were similar between the groups 
(table 1) and pelvic measurements and characteristics did not differ at baseline (table 2). 
 
 
 
Flow of women through study. *Intention to treat: two patients allocated to vaginal hysterectomy (VH) received sacrospinous 
hysteropexy (SH) and were analysed in the VH group. Data at six and 12 month follow up were missing in one patient after 
SH and six patients after VH; one patient after VH had recurrent apical prolapse but pelvic organ prolapse quantification 
(POP-Q) score was missing, this patient was included in the intention to treat-last observation carried forward analysis. 
†Missed data imputed as failure. ‡Per protocol analysis: two patients did not receive intended treatment. Excluded per 
protocol analysis: lost for follow-up at 12 months (n=8), missing or incomplete POP-Q score (n=5), and major protocol 
deviations (n=9); two patients met two criteria to be excluded from per protocol analysis 
 
 
 
 
	  
vagina?” in combination with a response “somewhat bothered” to “very much bothered” to 
the question “how much does this bother you?” To assess sexual functioning, we used the 12 
item pelvic organ prolapse/urinary incontinence sexual questionnaire, translated from the 
validated questionnaire but not validated for Dutch language [27]. 
During hospital admission and the first six weeks after surgery, the women kept a diary to 
evaluate postoperative pain (range 0-10), measured by a validated visual analogue scale; 
analgesics; and postoperative recovery, measured with the validated recovery index-10 [28]. 
Data were entered and registered using a web based application facilitated by the Dutch 
consortium for studies in women’s health and reproductivity (www.studies-obsgyn.nl). 
 
S t a t i s t i c a l  a n a l y s i s  
The sample size for this trial was based on the primary outcome. Recurrence rates in the 
apical compartment after vaginal hysterectomy vary from 0-12% [29], so that a failure rate 
including bothersome symptoms and repeat surgery after sacrospinous hysteropexy of 10% 
or more might be regarded as high. As we expected a failure rate of 3% based on outcomes 
of vaginal hysterectomy in a previous randomised study [16,30], we set the non-inferiority 
margin at 7%. This means that when the upper limit of the 95% confidence interval for the 
estimated difference in recurrence rate after sacrospinous hysteropexy versus vaginal 
hysterectomy exceeds 7%, sacrospinous hysteropexy is inferior to vaginal hysterectomy. 
Assuming an absolute recurrence rate of 3% in both groups and a two sided α risk of 0.05, 
with two groups of 94 women each the trial had 80% power with a prespecified non-
inferiority margin of 7% to assess non-inferiority of sacrospinous hysteropexy. Considering a 
10% loss to follow-up, we required 208 women—104 in each study arm. 
We assessed study outcomes by intention to treat analysis. In case of missing data on 
anatomical outcome at 12 months we applied two strategies. For the first by intention to treat 
analysis, we used the last observation carried forward with data at the six month follow-up 
visit if available. If these data were not available, we left the women out of the intention to 
treat-last observation carried forward analysis. For the second by intention to treat analysis 
we applied conservative imputation for all women with missing data at 12 months (worst case 
scenario, failure). In the case of missing questionnaires, we obtained information on the 
presence or absence of bothersome bulge symptoms from the 12 month follow-up visit. 
We also carried out a per protocol analysis on the primary and secondary outcomes for 
anatomical and surgical failure. This analysis included women who completed the entire 
treatment protocol as originally planned, with availability of the pelvic organ prolapse 
quantification scores at 12 months and absence of major deviations from the protocol. The 
Agresti-Coull method was used to calculate 95% confidence intervals for differences in 
proportions [31]. For exploratory purposes we used Fisher’s exact tests and Mann-Whitney U 
tests to compare proportions and continuous variables between the groups. We used paired 
sample t tests to compare mean continuous data within groups. After Bonferroni multiple 
testing adjustment, we considered a P value of less than 0.002 to be significant [32]. All 
statistical analyses were performed with SPSS for windows (version 22.0.0.1). 
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protocol analysis: lost for follow-up at 12 months (n=8), missing or incomplete POP-Q score (n=5), and major protocol 
deviations (n=9); two patients met two criteria to be excluded from per protocol analysis 
 
 
 
 
	  
vagina?” in combination with a response “somewhat bothered” to “very much bothered” to 
the question “how much does this bother you?” To assess sexual functioning, we used the 12 
item pelvic organ prolapse/urinary incontinence sexual questionnaire, translated from the 
validated questionnaire but not validated for Dutch language [27]. 
During hospital admission and the first six weeks after surgery, the women kept a diary to 
evaluate postoperative pain (range 0-10), measured by a validated visual analogue scale; 
analgesics; and postoperative recovery, measured with the validated recovery index-10 [28]. 
Data were entered and registered using a web based application facilitated by the Dutch 
consortium for studies in women’s health and reproductivity (www.studies-obsgyn.nl). 
 
S t a t i s t i c a l  a n a l y s i s  
The sample size for this trial was based on the primary outcome. Recurrence rates in the 
apical compartment after vaginal hysterectomy vary from 0-12% [29], so that a failure rate 
including bothersome symptoms and repeat surgery after sacrospinous hysteropexy of 10% 
or more might be regarded as high. As we expected a failure rate of 3% based on outcomes 
of vaginal hysterectomy in a previous randomised study [16,30], we set the non-inferiority 
margin at 7%. This means that when the upper limit of the 95% confidence interval for the 
estimated difference in recurrence rate after sacrospinous hysteropexy versus vaginal 
hysterectomy exceeds 7%, sacrospinous hysteropexy is inferior to vaginal hysterectomy. 
Assuming an absolute recurrence rate of 3% in both groups and a two sided α risk of 0.05, 
with two groups of 94 women each the trial had 80% power with a prespecified non-
inferiority margin of 7% to assess non-inferiority of sacrospinous hysteropexy. Considering a 
10% loss to follow-up, we required 208 women—104 in each study arm. 
We assessed study outcomes by intention to treat analysis. In case of missing data on 
anatomical outcome at 12 months we applied two strategies. For the first by intention to treat 
analysis, we used the last observation carried forward with data at the six month follow-up 
visit if available. If these data were not available, we left the women out of the intention to 
treat-last observation carried forward analysis. For the second by intention to treat analysis 
we applied conservative imputation for all women with missing data at 12 months (worst case 
scenario, failure). In the case of missing questionnaires, we obtained information on the 
presence or absence of bothersome bulge symptoms from the 12 month follow-up visit. 
We also carried out a per protocol analysis on the primary and secondary outcomes for 
anatomical and surgical failure. This analysis included women who completed the entire 
treatment protocol as originally planned, with availability of the pelvic organ prolapse 
quantification scores at 12 months and absence of major deviations from the protocol. The 
Agresti-Coull method was used to calculate 95% confidence intervals for differences in 
proportions [31]. For exploratory purposes we used Fisher’s exact tests and Mann-Whitney U 
tests to compare proportions and continuous variables between the groups. We used paired 
sample t tests to compare mean continuous data within groups. After Bonferroni multiple 
testing adjustment, we considered a P value of less than 0.002 to be significant [32]. All 
statistical analyses were performed with SPSS for windows (version 22.0.0.1). 
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T a b l e  2 .  Pelvic measurements and characteristics at baseline. Values are numbers (percentages) of women 
 
Characteristics Sacrospinous  hysteropexy  (n=103) 
Vaginal hysterectomy  
(n=105) 
POPQ stage uterine prolapse  (point C)*:   
   2 67 (65) 66 (63) 
   3 28 (28) 29 (28) 
   4 8 (8) 10 (10) 
POP-Q stage 2-4:   
   Anterior prolapse (Ba ≥-1)  94 (94) 95 (92) 
   Posterior prolapse (Bp ≥-1) 29 (29) 33 (32) 
Prolapse beyond the hymen:   
   Apical (POP-Q C > 0) 48 (48) 43 (42) 
   Anterior (POP-Q Aa or Ba > 0) 71 (71) 72 (70) 
   Posterior (POP-Q Ap or Bp > 0) 11 (11) 11 (11) 
Overall POP-Q stage prolapse* n=100 n=103 
   2 25 (25) 36 (35) 
   3 70 (70) 62 (60) 
   4 5 (5) 5 (5) 
Vaginal bulge symptoms   
   Any 94/101 (93) 98/103 (95) 
   Bothersome 93/100 (93)† 96/101 (95) 
 
POP-Q=pelvic organ prolapse quantification. Percentages were calculated using non-missing data. All patients were 
analysed as allocated. Five POP-Q scores were missing at baseline. 
 
*System involves quantitative measurements of various points of vaginal wall with hymen as reference point. Degree of 
prolapse of anterior vaginal wall (Aa and Ba), posterior vaginal wall (Ap and Bp), and uterus or vaginal vault (C) measured in 
centimetres both above or proximal to hymen (negative number) or beyond or distal to hymen (positive number), with plane 
of hymen defined as zero. A represents the descent of a measurement point 3 cm proximal to the hymen on the anterior (Aa) 
and posterior (Ap) vaginal wall. B is the most descended edge on the anterior (Ba) and posterior (Bp) vaginal wall. POP-Q 
stage 2: most distal prolapse is between 1 cm above and 1 cm beyond hymen; stage 3: most distal prolapse is prolapsed >1 
cm beyond hymen but no further than 2 cm less than total vaginal length; stage 4: total prolapse. 
†Not all women reported bothersome symptoms at baseline. Questionnaire was provided after women consented to 
participate, therefore amount of bother as reported at outpatient clinic could differ. 
 
Table 4 shows the intraoperative and postoperative details of the women, including the 
secondary outcomes of complication rate and length of hospital stay. Five serious adverse 
events were reported during hospital stay: two after vaginal hysterectomy and three after 
sacrospinous hysteropexy. One woman developed paralytic ileus after vaginal hysterectomy. 
She had also experienced this problem after orthopaedic 
surgery. She aspirated gastric contents eight days after surgery, developed aspiration 
pneumonia, and died because of multi-organ failure. The other serious adverse events were 
atrial fibrillation, which required cardioversion (vaginal hysterectomy); stroke two days after 
surgery, but with full recovery and no loss of function (sacrospinous hysteropexy); 
postoperative pneumonia (sacrospinous hysteropexy); and anaphylactic reaction to 
prophylactic antibiotics before the surgical procedure (sacrospinous hysteropexy); in this last 
woman the surgical procedure was postponed for several months, without any problems. 
None of the serious adverse events were judged to be related to the type of surgery 
	  
T a b l e  1 .  Baseline characteristics of women. Values are number (percentages) unless stated otherwise 
 
Characteristics Sacrospinous hysteropexy  (n=103) 
Vaginal hysterectomy 
(n=105) 
Median (range) age (years) 62.7 (45-85) 61.9 (33-82) 
Highest educational level:   
   Primary  / secondary school 14 (14) 7 (7) 
   High school 78 (77) 82 (80) 
   Bachelor, master or academic degree 9 (9) 13 (13) 
Comorbidity:   
   Cardiovascular disease 39 (38) 32 (31) 
   Diabetes mellitus 5 (5) 5 (5) 
   Respiratory disease 3 (3) 7 (7) 
Current smoker 13 (14) 9 (10) 
Median (range), No of vaginal deliveries 2 (0-7) 3 (0-7) 
Median (range), No of caesarean deliveries 0 (0-1) 0 (0-2) 
Mean (SD) body mass index 26.0 (3.3) 25.9 (3.5) 
 
Percentages were calculated using non-missing data. All patients were analysed as allocated. 
 
Table 3 presents the results on the primary outcome and the additional definitions of surgical 
failure. Sacrospinous hysteropexy was non-inferior to vaginal hysterectomy for anatomical 
recurrence of the apical compartment with bothersome bulge symptoms or repeat surgery 
for recurrent apical prolapse: sacrospinous hysteropexy 0% (n=0) versus vaginal 
hysterectomy 4.0% (n=4), difference −3.9% (95% confidence interval −8.6% to 0.7%) for the 
intention to treat-last observation carried forward approach. Non-inferiority of sacrospinous 
hysteropexy was also shown in the intention to treat analysis with conservative imputation 
and the per protocol analysis. The original primary outcome variable of overall anatomical 
failure occurred in 50% of the women after sacrospinous hysteropexy compared with 44% 
after vaginal hysterectomy (95% confidence interval for difference −7.4% to 20.1%). No 
notable differences were found for anatomical recurrences in the different compartments, 
except for the posterior vaginal wall: sacrospinous hysteropexy 4% versus vaginal 
hysterectomy 14% (95% confidence interval for difference −18.2% to −1.8%). 
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stage 2: most distal prolapse is between 1 cm above and 1 cm beyond hymen; stage 3: most distal prolapse is prolapsed >1 
cm beyond hymen but no further than 2 cm less than total vaginal length; stage 4: total prolapse. 
†Not all women reported bothersome symptoms at baseline. Questionnaire was provided after women consented to 
participate, therefore amount of bother as reported at outpatient clinic could differ. 
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events were reported during hospital stay: two after vaginal hysterectomy and three after 
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She had also experienced this problem after orthopaedic 
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Table 3 presents the results on the primary outcome and the additional definitions of surgical 
failure. Sacrospinous hysteropexy was non-inferior to vaginal hysterectomy for anatomical 
recurrence of the apical compartment with bothersome bulge symptoms or repeat surgery 
for recurrent apical prolapse: sacrospinous hysteropexy 0% (n=0) versus vaginal 
hysterectomy 4.0% (n=4), difference −3.9% (95% confidence interval −8.6% to 0.7%) for the 
intention to treat-last observation carried forward approach. Non-inferiority of sacrospinous 
hysteropexy was also shown in the intention to treat analysis with conservative imputation 
and the per protocol analysis. The original primary outcome variable of overall anatomical 
failure occurred in 50% of the women after sacrospinous hysteropexy compared with 44% 
after vaginal hysterectomy (95% confidence interval for difference −7.4% to 20.1%). No 
notable differences were found for anatomical recurrences in the different compartments, 
except for the posterior vaginal wall: sacrospinous hysteropexy 4% versus vaginal 
hysterectomy 14% (95% confidence interval for difference −18.2% to −1.8%). 
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T a b l e  4 .  Intra- and postoperative details  
 
Characteristics Sacrospinous hysteropexy  (n=103) 
Vaginal hysterectomy 
 (n=105) Difference (95%) 
I N T R A o p e r a t i v e  p e r i o d  
Mean (SD) operating time (min) 59 (13) 72 (21) -13.5 (-18.5 to -8.6) 
Mean (SD) estimated blood loss (mL) 202 (74) 209 (112) -6.5 (-32.8 to 20.0) 
Complications:    
   Related to use antibiotics 1 (1) 0 (0) 1.0 (-2.2 to 4.2) 
   Related to surgery  0 (0) 1 (1)* -1.0 (-4.2 to 2.2) 
Concomitant surgery:    
   Anti-incontinence 4 (4) 4 (4) 0.1 (-5.7 to 5.8) 
   Anterior colporrhaphy 100 (97) 104 (99) -1.9 (-6.5 to 2.6) 
   Posterior colporrhaphy 30 (29) 52 (50) -20 (-33.0 to -7.0) 
   Anterior and posterior colporrhaphy 30 (29) 52 (50) -20 (-33.0 to -7.0) 
Surgeon:    
   Gynaecologist 98 (97) 85 (82) 13.9 (5.1 to 22.7) 
   Resident 3 (3) 19 (18) -14.9 (-23.2 to -6.6) 
P o s t o p e r a t i v e  p e r i o d  
Mean (SD) length of hospital stay (days)  3 (1) 3 (1) -0.1 (-0.4 to 0.2) 
Complications during hospital stay:    
   Death 0 (0) 1 (1) -1.0 (-4.2 to 2.2) 
   Reoperation because of bleeding 0 (0) 1 (1) -1.0 (-4.2 to 2.2) 
   Cerebrovascular accident 1 (1) 0 (0) 1.0 (-2.2 to 4.2) 
   Buttock pain 9 (9) 0 (0) 8.6 (2.6 to 14.5) 
   Urinary retention 15 (15) 12 (11) 3.1 (-6.2 to 12.4) 
   Infection needing antibiotics 3 (3) 0 (0) 2.9 (-1.3 to 7.0) 
Endometrial carcinoma 1 (1) 0 (0) 1.0 (-2.2 to 4.2) 
 
Percentages were calculated using non-missing data. All women were analysed as allocated (intention to treat). 
*Bowel injury during abdominal hysterectomy. 
 
Tables 5 and 6 provide details on the other secondary outcomes. Functional outcome and 
quality of life did not differ significantly between the groups (table 5). Postoperative recovery 
was similar after both interventions, with comparable recovery index-10 scores at 1, 2, 4, and 
6 weeks after surgery (table 6). Among the patients who completed the pelvic organ 
prolapse/urinary incontinence sexual questionnaire before and after surgery, there was 
significant improvement in scores in both surgical groups (P<0.002 each) but no significant 
difference in total scores between both interventions (table 6). 
	  
T a b l e  3 .  Outcome for pelvic organ prolapse at 12 month follow-up. Values are numbers (percentages) of women unless 
stated otherwise 
 
Outcomes Sacrospinous hysteropexy Vaginal hysterectomy Difference (95%CI) 
P r i m a r y  o u t c o m e *  
ITT analysis with LOCF 0/102 (0) 4/100 (4) -3.9 (-8.6 to 0.7) 
ITT analysis with conservative imputation 6/103 (6) 10/105 (10) -3.6 (-11.2 to 3.9) 
Per protocol analysis 0/98 (0) 3/90 (3) -3.3 (-8.0 to 1.3) 
O v e r a l l  s u r g i c a l  f a i l u r e † 
ITT analysis with LOCF  52/102 (51) 49/100 (49) 1.9 (-11.8 to 15.7) 
ITT analysis with conservative imputation 55/103 (53) 54/105 (51) 1.9 (-11.6 to 15.5) 
Per protocol analysis 51/98 (52) 44/90 (49) 3.1 (-11.2 to 17.4) 
C O M P O S I T E  O U T C O M E  S U C C E S S ‡ 
ITT analysis with LOCF  91/102 (89) 83/100 (83) 6.1 (-3.6 to 15.8) 
ITT analysis with conservative imputation 87/103 (85) 82/105 (78) 6.2 (-4.5 to 16.9) 
Per protocol analysis 87/98 (89) 75/90 (83) 5.3 (-4.7 to 15.5) 
A n a T O M I C A L  F A I L U R E § 
Overall anatomical failure 51/101 (51) 44/100 (44) 6.4 (-7.4 to 20.1) 
  Apical compartment 2/102 (2) 7/100 (7) -5.0 (-11.1 to 1.2) 
  Anterior compartment 47/101 (47) 33/99 (33) 12.9 (-0.5 to 26.4) 
  Posterior compartment 4/101 (4) 14/99 (14) -10.0 (-18.2 to -1.8) 
P R O L A P S E  b e y o n d  T h e  h y m e n ¶    
Apical (POP-Q C > 0)  0/102 (0) 4/100 (4) -3.9 (-8.6 to 0.7) 
Anterior (POP-Q Ba > 0) 8/101 (8) 6/99 (6) 1.8 (-5.6 to 9.2) 
Posterior (POP-Q Bp > 0) 0/101 (0) 2/99 (2) -2.0 (-5.9 to 1.9) 
R e p e a t  s u r g e r y ¶ 
Recurrent prolapse 1/102 (1) 4/102 (4) -2.9 (-7.8 to 2.0) 
   Apical compartment 0/102 (0) 2/102 (2) -1.9 (-5.7 to 1.8) 
   Anterior compartment 1/102 (1) 4/102 (4) -2.9 (-7.8 to 2.0) 
   Posterior compartment 0/102 (0) 1/102 (1) -1.0 (-4.2 to 2.3) 
Primary surgery different site** 0/102 (0) 3/102 (3) -2.9 (-7.1 to 1.3) 
S U R G e r y  f o r  n o n - p r o l a p s e  c o n d i t i o n s   
Anti-incontinence 1/102 (1) 4/102 (4) -2.9 (-7.8 to 2.0) 
Hysterectomy 2/100 (2) - - 
 
ITT=intention to treat; LOCF=last observation carried forward; POP-Q=pelvic organ prolapse quantification. 
Percentages were calculated using non-missing data. Agresti-Coull method used to calculate 95% confidence intervals.31 
 
*Recurrent apical prolapse stage ≥2 with bothersome symptoms or repeat surgery for apical prolapse. 
†Prolapse POP-Q stage ≥2 (any compartment) or repeat surgery or pessary use. 
‡No prolapse beyond hymen, absence of bothersome bulge symptoms, and no repeat surgery or pessary use. 
§Prolapse POP-Q stage ≥2 
¶ ITT with LOCF. 
**Reoperation for pelvic organ prolapse in non-operated compartment. 
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*Recurrent apical prolapse stage ≥2 with bothersome symptoms or repeat surgery for apical prolapse. 
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**Reoperation for pelvic organ prolapse in non-operated compartment. 
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T a b l e  6 .  Postoperative recovery and sexual functioning after sacrospinous hysteropexy and vaginal hysterectomy at 12 
month follow-up. Values are means (standard deviations) unless stated otherwise 
 
Sascrospinous hysteropexy Vaginal hysterectomy 
Time point of assessment 
No of women Mean (SD) score No of women Mean (SD) score 
P value* 
Recovery index-10†:      
   Week 1 99 32 (7) 99 33 (6) 0.66 
   Week 2  100 34 (7) 99 34 (7) 0.58 
   Week 4 98 36 (7) 98 36 (6) 0.82 
   Week 6 98 38 (8) 99 38 (9) 0.87 
      
PISQ-12‡:      
   Total score at baseline  56 33 (6) 64 35 (5) 0.05 
   Total score at 12 months  49 37 (5)§ 56 37 (4)§ 0.62 
 
PISQ-12=pelvic organ prolapse/urinary incontinence sexual questionnaire. 
 
*P value for exploratory purposes: independent samples t test of sacrospinous hysteropexy versus vaginal hysterectomy. 
†10 item questionnaire measuring postoperative recovery on 5 point Likert scale. Summary scale score ranges from 10 to 
50, where 50 indicates perfect recovery. 
‡Total scores range from 0, which represents poorest sexual function, to 48 best sexual function. 
§Not shown: paired sample test baseline score and follow-up score (sacrospinous hysteropexy P<0.002 and vaginal 
hysterectomy P<0.002) 
 
Fourteen protocol deviations occurred: two women received sacrospinous hysteropexy 
instead of vaginal hysterectomy owing to technical difficulties during surgery (crossovers). In 
one woman allocated to vaginal hysterectomy, laparoscopic cystectomy before vaginal 
hysterectomy showed intra-abdominal adhesions, and an abdominal hysterectomy was 
performed. In two women an exclusion criterion was ignored before randomisation: one 
woman had had previous pelvic floor surgery (repair of posterior vaginal wall prolapse) and 
another had primary sclerosing cholangitis with thrombocytopenia. Three women who were 
assigned to sacrospinous hysteropexy had abnormal smear test results and were treated with 
electrosurgical excision (n=2) during prolapse surgery or follow-up. In six of 102 women (6%) 
apical suspension after vaginal hysterectomy was performed using a McCall procedure 
instead of suspension of the uterosacral ligaments. The other 96 women underwent 
suspension of the uterosacral ligaments (94%). According to the intention to treat principle, 
we included these women in the intention to treat analysis, with all women analysed as 
randomised. In the per protocol analysis we excluded these women, except for those classed 
as crossovers (n=2), as the primary outcome was related to efficacy and these women had no 
other protocol deviations, and those with abnormal smear test results (n=3), as this was 
regarded as a minor protocol deviation. 
Residents performed three of the procedures in the sacrospinous hysteropexy group (3%) 
and 19 in the vaginal hysterectomy group (18%). Overall surgical failure rate (recurrent 
prolapse, pessary use, or repeat surgery) did not differ significantly by gynaecologist or 
resident (91 failures out of 180 procedures (50.6%) versus nine failures out of 19 procedures 
(47.4%), respectively, P=0.81). Endometrial cancer was diagnosed during follow-up in one 
woman in the sacrospinous hysteropexy group (1.0%), and a laparoscopic hysterectomy was 
performed. Urinary retention, defined as more than 150 mL urine retention after removal of 
the catheter, was similar between the groups (table 4). Affected women received a 
	  
T a b l e  5 .  Functional outcome and quality of life after sacrospinous hysteropexy and vaginal hysterectomy at 12 months 
follow up. Values are medians (interquartile ranges) of domain scores unless stated otherwise  
 
Before surgery 12 months after surgery 
 Domains Sacrospinous 
hysteropexy  
(n=101) 
Vaginal 
hysterectomy 
(n=104) 
Sacrospinous 
hysteropexy  
(n=97) 
Vaginal 
hysterectomy  
(n=99) 
P value* 
Urogenital distress inventory†:      
   Overactive bladder 0 (0-44) 22 (0-33) 0 (0-11) 0 (0-11) 0.34 
   Urinary incontinence 17 (0-33) 17 (0-33) 0 (0-17) 0 (0-7) 0.11 
   Obstructive micturition 8 (0-33) 17 (0-33) 0 (0-0) 0 (0-0) 0.71 
   Genital prolapse 50 (33-67) 67 (33-67) 0 (0-0) 0 (0-0) 0.86 
   Pain 17 (0-33) 17 (0-33) 0 (0-0) 0 (0-0) 0.86 
Defecatory distress inventory†:      
   Obstipation 0 (0-17) 0 (0-17) 0 (0-0) 0 (0-0) 0.65 
   Obstructive defecation 0 (0-17) 0 (0-10) 0 (0-8) 0 (0-8) 0.85 
   Pain 0 (0-0) 0 (0-0) 0 (0-0) 0 (0-0) 0.42 
   Incontinence 0 (0-0) 0 (0-0) 0 (0-0) 0 (0-0) 0.38 
   Flatus 33 (0-33) 33 (0-33) 0 (0-33) 33 (0-33) 0.20 
Incontinence impact 
questionnaire‡: 
     
   Mobility 11 (0-33) 11 (0-22) 0 (0-11) 0 (0-11) 0.50 
   Physical 0 (0-33) 0 (0-33) 0 (0-0) 0 (0-0) 0.81 
   Social 11 (0-22) 0 (0-11) 0 (0-0) 0 (0-0) 0.99 
   Embarrasment 0 (0-17) 0 (0-17) 0 (0-0) 0 (0-0) 0.12 
   Emotion 0 (0-33) 0 (0-22) 0 (0-0) 0 (0-0) 0.56 
Short form-36§:      
   Physical functioning 80 (55-90) 80 (65-90) 90 (75-100) 85 (70-95) 0.27 
   Social functioning 94 (75-100) 88 (75-100) 100 (88-100) 100 (75-100) 0.20 
   Role limitations physical 75 (6-100) 100 (50-100) 100 (100-100) 100 (75-100) 0.89 
   Role limitations emotional 100 (75-100) 100 (100-100) 100 (100-100) 100 (100-100) 0.78 
   Mental health 84 (72-92) 84 (72-88) 84 (76-92) 84 (72-92) 0.57 
   Vitality 70 (50-80) 70 (55-80) 75 (55-80) 75 (65-80) 0.39 
   Bodily pain 78 (59-100) 80 (67-100) 100 (67-100) 100 (78-100) 0.92 
   General health perception 75 (55-85) 75 (61-85) 75 (60-90) 75 (60-90) 0.72 
   Health change 50 (25-50) 50 (50-50) 75 (50-100) 75 (50-100) 0.52 
 
All patients were analysed as allocated. 
 
*P value for exploratory purposes: Mann-Whitney U test of sacrospinous hysteropexy versus vaginal hysterectomy. 
†0=no symptoms or not bothersome to 100=most bothersome symptoms. 
‡0=best quality of life to 100=worst quality of life. 
§0=worst quality of life to 100=best quality of life. 
	  
Pain scores on the visual analogue scale did not differ notably between both interventions, 
except for day 14 in favour of hysterectomy. In eight out of nine women who experienced 
buttock pain, a typically reported problem after sacrospinous hysteropexy, the pain resolved 
(visual analogue scale score <2) spontaneously within the first six weeks. One woman 
underwent suture cutting and vaginal hysterectomy after four months because of persistent 
pain localised at the place of the sacrospinous hysteropexy sutures. After this procedure she 
was free of symptoms. 
 
 
100
CHAPTER 7
501420-L-bw-Detollenaere
	  
T a b l e  6 .  Postoperative recovery and sexual functioning after sacrospinous hysteropexy and vaginal hysterectomy at 12 
month follow-up. Values are means (standard deviations) unless stated otherwise 
 
Sascrospinous hysteropexy Vaginal hysterectomy 
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No of women Mean (SD) score No of women Mean (SD) score 
P value* 
Recovery index-10†:      
   Week 1 99 32 (7) 99 33 (6) 0.66 
   Week 2  100 34 (7) 99 34 (7) 0.58 
   Week 4 98 36 (7) 98 36 (6) 0.82 
   Week 6 98 38 (8) 99 38 (9) 0.87 
      
PISQ-12‡:      
   Total score at baseline  56 33 (6) 64 35 (5) 0.05 
   Total score at 12 months  49 37 (5)§ 56 37 (4)§ 0.62 
 
PISQ-12=pelvic organ prolapse/urinary incontinence sexual questionnaire. 
 
*P value for exploratory purposes: independent samples t test of sacrospinous hysteropexy versus vaginal hysterectomy. 
†10 item questionnaire measuring postoperative recovery on 5 point Likert scale. Summary scale score ranges from 10 to 
50, where 50 indicates perfect recovery. 
‡Total scores range from 0, which represents poorest sexual function, to 48 best sexual function. 
§Not shown: paired sample test baseline score and follow-up score (sacrospinous hysteropexy P<0.002 and vaginal 
hysterectomy P<0.002) 
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assigned to sacrospinous hysteropexy had abnormal smear test results and were treated with 
electrosurgical excision (n=2) during prolapse surgery or follow-up. In six of 102 women (6%) 
apical suspension after vaginal hysterectomy was performed using a McCall procedure 
instead of suspension of the uterosacral ligaments. The other 96 women underwent 
suspension of the uterosacral ligaments (94%). According to the intention to treat principle, 
we included these women in the intention to treat analysis, with all women analysed as 
randomised. In the per protocol analysis we excluded these women, except for those classed 
as crossovers (n=2), as the primary outcome was related to efficacy and these women had no 
other protocol deviations, and those with abnormal smear test results (n=3), as this was 
regarded as a minor protocol deviation. 
Residents performed three of the procedures in the sacrospinous hysteropexy group (3%) 
and 19 in the vaginal hysterectomy group (18%). Overall surgical failure rate (recurrent 
prolapse, pessary use, or repeat surgery) did not differ significantly by gynaecologist or 
resident (91 failures out of 180 procedures (50.6%) versus nine failures out of 19 procedures 
(47.4%), respectively, P=0.81). Endometrial cancer was diagnosed during follow-up in one 
woman in the sacrospinous hysteropexy group (1.0%), and a laparoscopic hysterectomy was 
performed. Urinary retention, defined as more than 150 mL urine retention after removal of 
the catheter, was similar between the groups (table 4). Affected women received a 
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follow up. Values are medians (interquartile ranges) of domain scores unless stated otherwise  
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   Social functioning 94 (75-100) 88 (75-100) 100 (88-100) 100 (75-100) 0.20 
   Role limitations physical 75 (6-100) 100 (50-100) 100 (100-100) 100 (75-100) 0.89 
   Role limitations emotional 100 (75-100) 100 (100-100) 100 (100-100) 100 (100-100) 0.78 
   Mental health 84 (72-92) 84 (72-88) 84 (76-92) 84 (72-92) 0.57 
   Vitality 70 (50-80) 70 (55-80) 75 (55-80) 75 (65-80) 0.39 
   Bodily pain 78 (59-100) 80 (67-100) 100 (67-100) 100 (78-100) 0.92 
   General health perception 75 (55-85) 75 (61-85) 75 (60-90) 75 (60-90) 0.72 
   Health change 50 (25-50) 50 (50-50) 75 (50-100) 75 (50-100) 0.52 
 
All patients were analysed as allocated. 
 
*P value for exploratory purposes: Mann-Whitney U test of sacrospinous hysteropexy versus vaginal hysterectomy. 
†0=no symptoms or not bothersome to 100=most bothersome symptoms. 
‡0=best quality of life to 100=worst quality of life. 
§0=worst quality of life to 100=best quality of life. 
	  
Pain scores on the visual analogue scale did not differ notably between both interventions, 
except for day 14 in favour of hysterectomy. In eight out of nine women who experienced 
buttock pain, a typically reported problem after sacrospinous hysteropexy, the pain resolved 
(visual analogue scale score <2) spontaneously within the first six weeks. One woman 
underwent suture cutting and vaginal hysterectomy after four months because of persistent 
pain localised at the place of the sacrospinous hysteropexy sutures. After this procedure she 
was free of symptoms. 
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as their involvement in treatment of pelvic organ prolapse is common in Dutch 
urogynaecological practice. 
 
C omp a r i s o n  w i t h  o t h e r  s t u d i e s  
The anatomical outcome after sacrospinous hysteropexy in our study is in line with that of 
previous studies [16,37], although the only previous randomised study showed opposite 
results: Dietz and colleagues found a higher rate of anatomical recurrence of the apical 
compartment after sacrospinous hysteropexy (7 of 34 (21%) versus 1 in 31 (3%) after vaginal 
hysterectomy, P=0.03) after 12 months’ follow-up. Possible explanations for this difference 
might relate to a different surgical protocol or skills, precise definition of the recurrence 
outcome, and sample size. The primary outcome in the study reported by Dietz and 
colleagues was recovery time instead of anatomical outcome. These authors considered a 
pelvic organ prolapse stage 2 or higher of the uterus or vaginal vault as a recurrence. 
Recurrent prolapse was defined in our study as prolapse of the apical compartment stage 2 
or higher (evaluated by pelvic organ prolapse quantification system) in combination with 
bothersome bulge symptoms or repeat surgery for recurrent apical prolapse. In our opinion, 
this composite outcome measure is more clinically relevant than outcome in terms of 
objective pelvic organ prolapse quantification scores alone. Barber and colleagues reported 
on different definitions of success after surgery for pelvic organ prolapse in 2009 [20]. 
Treatment success varied widely depending on the definition used, but definitions that 
included the absence of vaginal bulge symptoms had the strongest relation with the 
women’s assessment of overall improvement and treatment success. Furthermore, the 
authors concluded that the hymen is an important cut-off point for development of 
symptoms. As new trials probably will use these updated outcome definitions, we also 
analysed our data using the hymen as an anatomical threshold and also used the composite 
outcome measure of Barber and colleagues, making this trial in the future comparable to that 
of others. 
Although the presence of posterior vaginal wall prolapse in both groups was similar before 
surgery, more repairs of the posterior vaginal wall (colporrhaphies) were performed in the 
vaginal hysterectomy group. The surgeons were free to decide on concomitant surgery and 
in general this was decided during surgery. One explanation might be that the surgeons 
thought that the more dorsal axis of the vagina after sacrospinous hysteropexy already 
protected against a recurrent prolapse of the posterior vaginal wall. Despite the higher 
number of posterior colporrhaphies, more anatomical recurrences of the posterior 
compartment occurred after hysterectomy with suspension of the uterosacral ligaments, 
which supports this view. The risk for recurrent prolapse of the anterior vaginal wall after 
sacrospinous hysteropexy is often discussed. We found no difference in occurrence of 
prolapse of the anterior vaginal wall. This is in line with previous studies: a retrospective study 
by Smilen and colleagues found that the occurrence of prolapse of the anterior vaginal wall 
was not altered by sacrospinous hysteropexy and the randomised study performed by Dietz 
and colleagues did not find a higher rate of prolapse of the anterior vaginal wall after 
sacrospinous hysteropexy (51%) compared with vaginal hysterectomy (64%) after one       
year [12,38]. 
Reoperation rates for (recurrent) pelvic organ prolapse did not differ. Two women ended up 
	  
transurethral catheter or were instructed to perform clean intermittent self catheterisation. In 
all women spontaneous micturition was achieved after a maximum length of catheterisation 
of 40 days (median 5.0 days, range 1-40 days). Subsequent surgical treatment for stress 
urinary incontinence after 12 months was carried out in 1 of 102 women (1.0%) after 
sacrospinous hysteropexy and 4 of 102 women (3.9%) after vaginal hysterectomy (P=0.37). 
 
D I S C U S S I O N  
Treatment with sacrospinous hysteropexy was non-inferior to vaginal hysterectomy with 
suspension of the uterosacral ligaments for surgical failure of the apical compartment in both 
an intention to treat analysis and a per protocol analysis. We found no notable differences in 
overall anatomical and surgical failure, functional outcome, quality of life, complications, 
postoperative recovery, length of hospital stay, and sexual functioning between the 
interventions. Women who underwent sacrospinous hysteropexy reported more buttock pain 
after surgery, but pain scores on the visual analogue scale were low and in most cases the 
pain resolved within six weeks. 
 
S t r e n g t h s  a n d  l i m i t a t i o n s  o f  t h i s  s t u d y  
A major strength of this study is its randomised multicentre design and sufficient study 
population. This is to our best knowledge the first randomised trial to compare uterus 
preservation with hysterectomy on a large scale using clinically relevant outcome measures. 
The study also has some limitations. Firstly, our findings are based on a relatively short follow-
up period of 12 months. However, results from registry studies suggest that the highest risk 
of prolapse surgery after hysterectomy is in the first two postoperative years. Furthermore, 
not only is long term surgical outcome important but also short term secondary outcomes, 
such as complication rate and postoperative recovery [33,34]. The women consented to 
follow-up for 60 months after surgery, and these data will be further analysed. 
After vaginal hysterectomy the ligatures of the uterosacral ligaments were to be sutured to 
the vaginal vault to aid in long term vaginal support. However, the protocol was ignored in six 
women and the McCall procedure was performed instead of suspension of the uterosacral 
ligaments [35]. Both procedures rely on the uterosacral ligaments for support of the vaginal 
apex but are considered different treatment modalities for suspension of the vaginal vault, 
which could have led to differences between treatments. As far as we know, strong evidence 
on the best technique for vault suspension after vaginal hysterectomy is lacking in the 
literature, and a recent published trial found similar outcomes after suspension of the 
uterosacral ligaments and sacrospinous fixation for apical prolapse [36]. In the per protocol 
analysis these women were excluded, but this did not alter the conclusions. 
Another limitation might be that residents were allowed to perform sacrospinous 
hysteropexy or vaginal hysterectomy under direct supervision of a gynaecologist because of 
their training position. Surgery by residents may have led to variation in procedures. In the 
hysterectomy group more procedures were performed by residents. No statistically 
significant difference was found in surgical failure rate in women who underwent surgery by 
either gynaecologist or resident, but the higher number of procedures performed by 
residents could have contributed to a longer operation time in the vaginal hysterectomy 
group. Surgery performed by residents may improve the generalisability of the trial findings 
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as their involvement in treatment of pelvic organ prolapse is common in Dutch 
urogynaecological practice. 
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The anatomical outcome after sacrospinous hysteropexy in our study is in line with that of 
previous studies [16,37], although the only previous randomised study showed opposite 
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compartment after sacrospinous hysteropexy (7 of 34 (21%) versus 1 in 31 (3%) after vaginal 
hysterectomy, P=0.03) after 12 months’ follow-up. Possible explanations for this difference 
might relate to a different surgical protocol or skills, precise definition of the recurrence 
outcome, and sample size. The primary outcome in the study reported by Dietz and 
colleagues was recovery time instead of anatomical outcome. These authors considered a 
pelvic organ prolapse stage 2 or higher of the uterus or vaginal vault as a recurrence. 
Recurrent prolapse was defined in our study as prolapse of the apical compartment stage 2 
or higher (evaluated by pelvic organ prolapse quantification system) in combination with 
bothersome bulge symptoms or repeat surgery for recurrent apical prolapse. In our opinion, 
this composite outcome measure is more clinically relevant than outcome in terms of 
objective pelvic organ prolapse quantification scores alone. Barber and colleagues reported 
on different definitions of success after surgery for pelvic organ prolapse in 2009 [20]. 
Treatment success varied widely depending on the definition used, but definitions that 
included the absence of vaginal bulge symptoms had the strongest relation with the 
women’s assessment of overall improvement and treatment success. Furthermore, the 
authors concluded that the hymen is an important cut-off point for development of 
symptoms. As new trials probably will use these updated outcome definitions, we also 
analysed our data using the hymen as an anatomical threshold and also used the composite 
outcome measure of Barber and colleagues, making this trial in the future comparable to that 
of others. 
Although the presence of posterior vaginal wall prolapse in both groups was similar before 
surgery, more repairs of the posterior vaginal wall (colporrhaphies) were performed in the 
vaginal hysterectomy group. The surgeons were free to decide on concomitant surgery and 
in general this was decided during surgery. One explanation might be that the surgeons 
thought that the more dorsal axis of the vagina after sacrospinous hysteropexy already 
protected against a recurrent prolapse of the posterior vaginal wall. Despite the higher 
number of posterior colporrhaphies, more anatomical recurrences of the posterior 
compartment occurred after hysterectomy with suspension of the uterosacral ligaments, 
which supports this view. The risk for recurrent prolapse of the anterior vaginal wall after 
sacrospinous hysteropexy is often discussed. We found no difference in occurrence of 
prolapse of the anterior vaginal wall. This is in line with previous studies: a retrospective study 
by Smilen and colleagues found that the occurrence of prolapse of the anterior vaginal wall 
was not altered by sacrospinous hysteropexy and the randomised study performed by Dietz 
and colleagues did not find a higher rate of prolapse of the anterior vaginal wall after 
sacrospinous hysteropexy (51%) compared with vaginal hysterectomy (64%) after one       
year [12,38]. 
Reoperation rates for (recurrent) pelvic organ prolapse did not differ. Two women ended up 
	  
transurethral catheter or were instructed to perform clean intermittent self catheterisation. In 
all women spontaneous micturition was achieved after a maximum length of catheterisation 
of 40 days (median 5.0 days, range 1-40 days). Subsequent surgical treatment for stress 
urinary incontinence after 12 months was carried out in 1 of 102 women (1.0%) after 
sacrospinous hysteropexy and 4 of 102 women (3.9%) after vaginal hysterectomy (P=0.37). 
 
D I S C U S S I O N  
Treatment with sacrospinous hysteropexy was non-inferior to vaginal hysterectomy with 
suspension of the uterosacral ligaments for surgical failure of the apical compartment in both 
an intention to treat analysis and a per protocol analysis. We found no notable differences in 
overall anatomical and surgical failure, functional outcome, quality of life, complications, 
postoperative recovery, length of hospital stay, and sexual functioning between the 
interventions. Women who underwent sacrospinous hysteropexy reported more buttock pain 
after surgery, but pain scores on the visual analogue scale were low and in most cases the 
pain resolved within six weeks. 
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A major strength of this study is its randomised multicentre design and sufficient study 
population. This is to our best knowledge the first randomised trial to compare uterus 
preservation with hysterectomy on a large scale using clinically relevant outcome measures. 
The study also has some limitations. Firstly, our findings are based on a relatively short follow-
up period of 12 months. However, results from registry studies suggest that the highest risk 
of prolapse surgery after hysterectomy is in the first two postoperative years. Furthermore, 
not only is long term surgical outcome important but also short term secondary outcomes, 
such as complication rate and postoperative recovery [33,34]. The women consented to 
follow-up for 60 months after surgery, and these data will be further analysed. 
After vaginal hysterectomy the ligatures of the uterosacral ligaments were to be sutured to 
the vaginal vault to aid in long term vaginal support. However, the protocol was ignored in six 
women and the McCall procedure was performed instead of suspension of the uterosacral 
ligaments [35]. Both procedures rely on the uterosacral ligaments for support of the vaginal 
apex but are considered different treatment modalities for suspension of the vaginal vault, 
which could have led to differences between treatments. As far as we know, strong evidence 
on the best technique for vault suspension after vaginal hysterectomy is lacking in the 
literature, and a recent published trial found similar outcomes after suspension of the 
uterosacral ligaments and sacrospinous fixation for apical prolapse [36]. In the per protocol 
analysis these women were excluded, but this did not alter the conclusions. 
Another limitation might be that residents were allowed to perform sacrospinous 
hysteropexy or vaginal hysterectomy under direct supervision of a gynaecologist because of 
their training position. Surgery by residents may have led to variation in procedures. In the 
hysterectomy group more procedures were performed by residents. No statistically 
significant difference was found in surgical failure rate in women who underwent surgery by 
either gynaecologist or resident, but the higher number of procedures performed by 
residents could have contributed to a longer operation time in the vaginal hysterectomy 
group. Surgery performed by residents may improve the generalisability of the trial findings 
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undergoing hysterectomy after uterine preservation. In one woman this was because of 
persistent buttock pain. The overall rate of buttock pain after sacrospinous hysteropexy in our 
study (9%) is in line with that of other studies and in most women the pain resolved 
spontaneously [30]. Preoperative counselling should include information about the potential 
risk of buttock pain. Endometrial carcinoma was found in one woman during follow-up (1%). 
A previous retrospective analysis of disease findings after prolapse surgery with 
hysterectomy showed premalignant or malignant abnormalities in 17 of 644 patients (2.6%) 
[39]. In that study, two women (0.3%) had endometrial cancer diagnosed. Because of the low 
incidence and the early diagnosis of endometrial cancer owing to blood loss, we believe that 
future risk of malignancy should not be regarded as a valid reason for removal of the uterus. 
 
C l i n i c a l  i m p l i c a t i o n s  a n d  f u t u r e  r e s e a r c h  
Uterus preservation has gained popularity among gynaecologists and patients during the 
past years [6-9]. A recent trial among 213 women from multiple study sites throughout the 
United States found that 36% of the women preferred uterus preservation, 20% preferred 
hysterectomy, and 44% had no preference, assuming equal outcomes after both procedures 
[7]. Another preference study among 100 women showed that 60% would decline 
hysterectomy if an equally efficacious alternative was available [8]. This trial provides 
evidence for sacrospinous hysteropexy being such an alternative and therefore this study has 
important implications for clinical practice. Women who want to avoid hysterectomy and 
preserve their uterus can be reassured that sacrospinous hysteropexy was equally effective as 
vaginal hysterectomy after short term follow-up. However, longer follow-up is necessary, and 
also randomised controlled trials comparing other uterus preserving procedures are needed. 
 
C o n c l u s i o n s  
Based on analysis of 12 months’ follow-up, we conclude that sacrospinous hysteropexy is 
non-inferior to vaginal hysterectomy with suspension of the uterosacral ligaments for 
recurrent prolapse of the apical compartment with bothersome bulge symptoms or repeat 
surgery for recurrent apical prolapse. Overall anatomical outcome, functional outcome, 
hospital stay, complications, postoperative recovery, and sexual functioning did not differ. 
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I N T R O D U C T I O N  
Pelvic organ prolapse (POP) is one of the most common benign gynecological disorders with 
an increasing incidence due to increased life expectancy. The lifetime risk for POP surgery is 
up to 20% and approximately 16 to 30% of the patients needs repeat surgery because of 
recurrent POP or urinary incontinence [1-5]. Up to 60% of sexually active women with POP 
awaiting pelvic reconstructive surgery reported that their sex life was negatively affected by 
their prolapse and one cohort study including 1.267 sexually active women reported that 
women with POP had lower scores on the Pelvic Organ Prolapse Urinary Incontinence Sexual 
Questionnaire short form (PISQ-12) than woman without POP [6,7].   
In general sexual function improves after POP surgery, although there are some studies that 
have shown conflicting evidence [8-10].  POP has anatomical, functional and psychological 
aspects. The physical and anatomical cure of POP may result in less physical bother during 
sexual intercourse.  On the other hand POP surgery may be accompanied by negative side 
effects. Vaginal narrowing and scarring as well as damage to vascularisation and innervation 
can lead to sexual dysfunction including dyspareunia, vaginal dryness and/or orgasmic 
problems and therefore diminished satisfaction and frequency of intercourse. Associated 
dysfunctions such as stress urinary incontinence during intercourse may change after surgery 
and may thus also change the perception of sexuality.  Surgical repair of POP may relieve 
symptoms by improvement of women’s body image [11,12].  
It is known that the type or route of hysterectomy (abdominal versus vaginal hysterectomy) 
does not play a role in sexual function after hysterectomy [13]. Controversy exists on the 
effect of uterus preservation versus hysterectomy in POP repair on sexual function. Two 
randomized controlled trials measured sexual function after sacrospinous hysteropexy versus 
vaginal hysterectomy and found no differences between the two groups [14,15]. However, no 
validated questionnaires were used in these studies and follow-up was only performed after 
six and twelve months follow-up with limited sample size. Another prospective cohort study 
by Constantini et al. showed that 12 months after surgery uterus-sparing surgery versus 
hysterectomy with sacrocolpopexy, uterus preservation was associated with a greater 
improvement in the desire, arousal and orgasm sexual domains [16]. No large randomized 
trials with long-term follow-up are available evaluating sexual functioning after uterus 
preservation versus hysterectomy in treatment of uterine prolapse.  This is the report on a 
secondary analysis of a large RCT comparing sexual function after sacrospinous hysteropexy 
and vaginal hysterectomy with suspension of the uterosacral ligaments in treatment of 
uterine prolapse.  
 
A I M S  
The aim of the secondary analysis was to evaluate and compare sexual function in women 
who were randomized between sacrospinous hysteropexy versus vaginal hysterectomy with 
suspension of the uterosacral ligaments in treatment of uterine prolapse stage two or higher.   
 
 
 
 
 
	  
A B S T R A C T  
 
I n t r o d u c t i o n :  Studies on pelvic organ prolapse (POP) surgery show conflicting evidence 
regarding the impact of uterus preservation and hysterectomy on sexual function and no 
large randomized trials with long-term follow-up have been published on this topic. 
A im :  The aim of this secondary analysis was to evaluate and compare sexual function after 
sacrospinous hysteropexy and vaginal hysterectomy with suspension of the uterosacral 
ligaments in women with uterine prolapse. 
Me t h o d s :  This is a secondary analysis of the SAVE U trial data, a multicenter trial in four non-
university hospitals in the Netherlands comparing sacrospinous hysteropexy and vaginal 
hysterectomy with suspension of the uterosacral ligaments in primary surgery of uterine 
prolapse stage two or higher. Primary outcome of the original study was recurrent prolapse 
stage two or higher of the uterus or vaginal vault (apical compartment) evaluated by POP-Q 
examination in combination with bothersome bulge symptoms or repeat surgery for 
recurrent apical prolapse at 12 months follow-up. Secondary outcomes were overall 
anatomical recurrences, functional outcome, complications, hospital stay, post-operative 
recovery, and sexual functioning. Data from patients who had completed the POP/urinary 
incontinence sexual questionnaire (PISQ-12) at baseline and 24 months after surgery were 
used in the present trial. Total, subscale and individual question analyses were performed. 
The SAVE U trial is registered in the Dutch trial registry, number NTR1866.   
Ma i n  o u t c om e  m e a s u r e s :  Differences and changes in sexual function 24 months after surgery, 
measured by the PISQ-12 questionnaire. 
R e s u l t s :  Between November 2009 and March 2012, 208 women were randomized between 
sacrospinous hysteropexy  (n=103) and vaginal hysterectomy with suspension of the 
uterosacral ligaments (n=105). 99 women completed questionnaires at baseline and after 24 
months follow-up and were included in the present study. During a follow-up period of 24 
months, no significant differences in total PISQ-12 scores were observed between the 
groups. After both interventions the item ‘avoidance of intercourse due to prolapse’ 
significantly improved as well as the physical subscale of the PISQ-12 questionnaire.  
C o n c l u s i o n s :  There was no statistically significant difference in overall sexual functioning 
(total PISQ-12 scores) between uterus preserving sacrospinous hysteropexy and vaginal 
hysterectomy with suspension of the uterosacral ligaments after a follow-up period of 24 
months.  
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I N T R O D U C T I O N  
Pelvic organ prolapse (POP) is one of the most common benign gynecological disorders with 
an increasing incidence due to increased life expectancy. The lifetime risk for POP surgery is 
up to 20% and approximately 16 to 30% of the patients needs repeat surgery because of 
recurrent POP or urinary incontinence [1-5]. Up to 60% of sexually active women with POP 
awaiting pelvic reconstructive surgery reported that their sex life was negatively affected by 
their prolapse and one cohort study including 1.267 sexually active women reported that 
women with POP had lower scores on the Pelvic Organ Prolapse Urinary Incontinence Sexual 
Questionnaire short form (PISQ-12) than woman without POP [6,7].   
In general sexual function improves after POP surgery, although there are some studies that 
have shown conflicting evidence [8-10].  POP has anatomical, functional and psychological 
aspects. The physical and anatomical cure of POP may result in less physical bother during 
sexual intercourse.  On the other hand POP surgery may be accompanied by negative side 
effects. Vaginal narrowing and scarring as well as damage to vascularisation and innervation 
can lead to sexual dysfunction including dyspareunia, vaginal dryness and/or orgasmic 
problems and therefore diminished satisfaction and frequency of intercourse. Associated 
dysfunctions such as stress urinary incontinence during intercourse may change after surgery 
and may thus also change the perception of sexuality.  Surgical repair of POP may relieve 
symptoms by improvement of women’s body image [11,12].  
It is known that the type or route of hysterectomy (abdominal versus vaginal hysterectomy) 
does not play a role in sexual function after hysterectomy [13]. Controversy exists on the 
effect of uterus preservation versus hysterectomy in POP repair on sexual function. Two 
randomized controlled trials measured sexual function after sacrospinous hysteropexy versus 
vaginal hysterectomy and found no differences between the two groups [14,15]. However, no 
validated questionnaires were used in these studies and follow-up was only performed after 
six and twelve months follow-up with limited sample size. Another prospective cohort study 
by Constantini et al. showed that 12 months after surgery uterus-sparing surgery versus 
hysterectomy with sacrocolpopexy, uterus preservation was associated with a greater 
improvement in the desire, arousal and orgasm sexual domains [16]. No large randomized 
trials with long-term follow-up are available evaluating sexual functioning after uterus 
preservation versus hysterectomy in treatment of uterine prolapse.  This is the report on a 
secondary analysis of a large RCT comparing sexual function after sacrospinous hysteropexy 
and vaginal hysterectomy with suspension of the uterosacral ligaments in treatment of 
uterine prolapse.  
 
A I M S  
The aim of the secondary analysis was to evaluate and compare sexual function in women 
who were randomized between sacrospinous hysteropexy versus vaginal hysterectomy with 
suspension of the uterosacral ligaments in treatment of uterine prolapse stage two or higher.   
 
 
 
 
 
	  
A B S T R A C T  
 
I n t r o d u c t i o n :  Studies on pelvic organ prolapse (POP) surgery show conflicting evidence 
regarding the impact of uterus preservation and hysterectomy on sexual function and no 
large randomized trials with long-term follow-up have been published on this topic. 
A im :  The aim of this secondary analysis was to evaluate and compare sexual function after 
sacrospinous hysteropexy and vaginal hysterectomy with suspension of the uterosacral 
ligaments in women with uterine prolapse. 
Me t h o d s :  This is a secondary analysis of the SAVE U trial data, a multicenter trial in four non-
university hospitals in the Netherlands comparing sacrospinous hysteropexy and vaginal 
hysterectomy with suspension of the uterosacral ligaments in primary surgery of uterine 
prolapse stage two or higher. Primary outcome of the original study was recurrent prolapse 
stage two or higher of the uterus or vaginal vault (apical compartment) evaluated by POP-Q 
examination in combination with bothersome bulge symptoms or repeat surgery for 
recurrent apical prolapse at 12 months follow-up. Secondary outcomes were overall 
anatomical recurrences, functional outcome, complications, hospital stay, post-operative 
recovery, and sexual functioning. Data from patients who had completed the POP/urinary 
incontinence sexual questionnaire (PISQ-12) at baseline and 24 months after surgery were 
used in the present trial. Total, subscale and individual question analyses were performed. 
The SAVE U trial is registered in the Dutch trial registry, number NTR1866.   
Ma i n  o u t c om e  m e a s u r e s :  Differences and changes in sexual function 24 months after surgery, 
measured by the PISQ-12 questionnaire. 
R e s u l t s :  Between November 2009 and March 2012, 208 women were randomized between 
sacrospinous hysteropexy  (n=103) and vaginal hysterectomy with suspension of the 
uterosacral ligaments (n=105). 99 women completed questionnaires at baseline and after 24 
months follow-up and were included in the present study. During a follow-up period of 24 
months, no significant differences in total PISQ-12 scores were observed between the 
groups. After both interventions the item ‘avoidance of intercourse due to prolapse’ 
significantly improved as well as the physical subscale of the PISQ-12 questionnaire.  
C o n c l u s i o n s :  There was no statistically significant difference in overall sexual functioning 
(total PISQ-12 scores) between uterus preserving sacrospinous hysteropexy and vaginal 
hysterectomy with suspension of the uterosacral ligaments after a follow-up period of 24 
months.  
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M A I N  O U T C O M E  M E A S U R E S  
In this study sexual function at 24 months follow-up as measured with the PISQ-12 was 
considered as primary outcome. The primary outcome in the original study was recurrent 
prolapse POP-Q stage 2 or higher in the apical compartment (uterus or vaginal vault) with 
bothersome bulge symptoms or repeat surgery for recurrent apical prolapse at 12 months 
follow-up. Secondary outcomes were functional outcome, quality of life, complications, 
hospital stay, post-operative recovery, and sexual functioning.  
 
Statistical Analyses 
All statistical analyses were performed using SPSS for Windows version 22.0.0.1 (SPSSInc., 
Chicago, IL, USA). To compare mean continuous data within groups, paired sample t-tests 
were used and for comparison between groups, independent sample t-tests were used. 
Pearson’s chi-square or Fisher exact test were used for categorical variables. Women were 
found to have an improvement in PISQ-12 score in case the postoperative score was at least 
one point higher than the preoperative score, and deterioration was defined as at least one 
point lower than the preoperative score [24].   
The aim of the original study was to determine if sacrospinous hysteropexy was non-inferior 
to vaginal hysterectomy with suspension of the uterosacral ligaments after 12 months follow-
up. Therefore sample size calculation for this secondary analysis was also based on the non-
inferiority principle.  As we expected the total PISQ-scores to be equal after 24 months with a 
standard deviation of 5.7 points [24], 34 patients, 17 in each group, were required to be 80% 
sure that the lower limit of a one-sided 95% confidence interval will be above the non-
inferiority limit of -5 points as this difference was found to be clinically relevant. To determine 
clinical relevance of statistically significant changes in PISQ-12 sores and subscales, we 
calculated effect sizes (ESs) using Cohen’s d. ESs were defined as small if Cohen’s d = 0.2, 
medium if d = 0.5, and large in case d ≥ 0.8. P values <0.05 were considered statistically 
significant.  
 
R E S U L T S  
Between November 27, 2009, and March 12, 2012 208 women with uterine prolapse stage 
two or higher were randomly assigned to sacrospinous hysteropexy (n=103) or vaginal 
hysterectomy (n=105).  Details on follow-up and numbers of sexual active women during 
follow-up are shown in Figure 1. Two patients in the sacrospinous hysteropexy group did not 
fill out the questionnaire. Women were sexually inactive at baseline because of the following 
reasons: no partner including widow (n=21, 29.6%), age (n=1, 1.4%), partner related illness 
(n=6, 8.5%), prolapse (n=5, 7.0%), reason unknown (n=37, 49.3%). Seven women became 
sexually inactive after 24 months follow-up (3.7%), of whom three women stated that they 
became widowed, three reported that their sexual inactivity was due to partner related illness 
and/or problems (erectile dysfunction) and one woman did not specify a reason. After 24 
months five women after sacrospinous hysteropexy and four women after vaginal 
hysterectomy with uterosacral ligament suspension were lost to follow-up for various reasons 
and ten women did not fill out the questionnaire.  
 
	  
M E T H O D S  
The SAVE U trial was designed to compare surgical failure after 12 months follow-up 
between sacrospinous hysteropexy and vaginal hysterectomy with suspension of the 
uterosacral ligaments. These results have been published previously [17]. In short, women 
with symptomatic uterine prolapse POP-Q stage two or higher (uterine prolapse 1cm above 
the hymen or beyond) requiring surgery were randomly assigned to sacrospinous 
hysteropexy and vaginal hysterectomy in an open-label multicenter non-inferiority trial [18]. 
The surgical procedures were performed according to guidelines described in previous trials 
[17,18]. Patients with previous pelvic floor or POP surgery, known malignancy or abnormal 
cervical smears, a wish to preserve fertility, language barriers, presence of immunological or 
haematological disorders interfering with recovery after surgery, abnormal ultrasound 
findings of the uterus or ovaries or abnormal uterine bleeding, and those who were unwilling 
to return for follow-up were excluded from the study.  
Gynecological consultation prior to surgery included pelvic ultrasonography to exclude 
uterine or ovarian disease, a cervical smear test and vaginal inspection in 45° semi-upright 
position for staging uterovaginal prolapse by POP-Q examination. Preoperative urodynamic 
evaluation was only performed when indicated. During the first six weeks after surgery 
patients kept a diary to evaluate post-operative pain measured by the Visual Analogue Scale 
(VAS) score. All patients consulted the hospital for follow-up/POP-Q examination at 12 
months after surgery and annually thereafter. At baseline and at the follow-up visit all patients 
completed the validated disease-specific quality of life questionnaires: Short Form-36 (SF-
36), Urogenital Distress Inventory (UDI), Defecatory Distress Inventory (DDI), and 
Incontinence Impact Questionnaire (IIQ) [19-21]. Patients were considered to be sexually 
active if they responded with ‘yes’ to the question ‘ are you having sexual contact with your 
partner?’ To assess sexual functioning the Pelvic Organ Prolapse/Urinary Incontinence Sexual 
Questionnaire (PISQ-12), translated from the validated questionnaire but not validated for 
Dutch language, was used. Data from patients who had completed the POP/urinary 
incontinence sexual questionnaire (PISQ-12) at baseline and 24 months after surgery were 
used in the present trial This PISQ-12 questionnaire is a shorter version of the original PISQ 
questionnaire and is validated for assessment of sexual function in women with POP [22,23]. 
PISQ-12 individual question scores range from 0 to 4. Total PISQ-12 scores ranges from 0, 
which represents poorest sexual function, to 48, best sexual function. A questionnaire was 
considered valid if there were no more than two missing items and total scores were 
corrected for the number of answered questions. The behavioral/ emotive subscale was 
calculated using questions 1, 2, 3, 4 and 9 (desire, arousal, emotions), the physical subscale 
by questions 5, 6, 7, and 8 (pain, urinary and/or fecal incontinence and bulge symptoms) and 
the partner related subscale by questions 10, 11 and 12 (erection, premature ejaculation, and 
intensity of orgasm).  
Data were entered and registered using a web-based application facilitated by the Dutch 
consortium for studies in women’s health and reproductivity (www.studies-obsgyn.nl). The 
trial was approved by the medical ethical committee of Isala hospital (MEC 09-625) and the 
local ethical committees of the participating centres.  The trial was registered: trialregister.nl, 
number NTR1866.  
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M A I N  O U T C O M E  M E A S U R E S  
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The aim of the original study was to determine if sacrospinous hysteropexy was non-inferior 
to vaginal hysterectomy with suspension of the uterosacral ligaments after 12 months follow-
up. Therefore sample size calculation for this secondary analysis was also based on the non-
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inferiority limit of -5 points as this difference was found to be clinically relevant. To determine 
clinical relevance of statistically significant changes in PISQ-12 sores and subscales, we 
calculated effect sizes (ESs) using Cohen’s d. ESs were defined as small if Cohen’s d = 0.2, 
medium if d = 0.5, and large in case d ≥ 0.8. P values <0.05 were considered statistically 
significant.  
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two or higher were randomly assigned to sacrospinous hysteropexy (n=103) or vaginal 
hysterectomy (n=105).  Details on follow-up and numbers of sexual active women during 
follow-up are shown in Figure 1. Two patients in the sacrospinous hysteropexy group did not 
fill out the questionnaire. Women were sexually inactive at baseline because of the following 
reasons: no partner including widow (n=21, 29.6%), age (n=1, 1.4%), partner related illness 
(n=6, 8.5%), prolapse (n=5, 7.0%), reason unknown (n=37, 49.3%). Seven women became 
sexually inactive after 24 months follow-up (3.7%), of whom three women stated that they 
became widowed, three reported that their sexual inactivity was due to partner related illness 
and/or problems (erectile dysfunction) and one woman did not specify a reason. After 24 
months five women after sacrospinous hysteropexy and four women after vaginal 
hysterectomy with uterosacral ligament suspension were lost to follow-up for various reasons 
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the hymen or beyond) requiring surgery were randomly assigned to sacrospinous 
hysteropexy and vaginal hysterectomy in an open-label multicenter non-inferiority trial [18]. 
The surgical procedures were performed according to guidelines described in previous trials 
[17,18]. Patients with previous pelvic floor or POP surgery, known malignancy or abnormal 
cervical smears, a wish to preserve fertility, language barriers, presence of immunological or 
haematological disorders interfering with recovery after surgery, abnormal ultrasound 
findings of the uterus or ovaries or abnormal uterine bleeding, and those who were unwilling 
to return for follow-up were excluded from the study.  
Gynecological consultation prior to surgery included pelvic ultrasonography to exclude 
uterine or ovarian disease, a cervical smear test and vaginal inspection in 45° semi-upright 
position for staging uterovaginal prolapse by POP-Q examination. Preoperative urodynamic 
evaluation was only performed when indicated. During the first six weeks after surgery 
patients kept a diary to evaluate post-operative pain measured by the Visual Analogue Scale 
(VAS) score. All patients consulted the hospital for follow-up/POP-Q examination at 12 
months after surgery and annually thereafter. At baseline and at the follow-up visit all patients 
completed the validated disease-specific quality of life questionnaires: Short Form-36 (SF-
36), Urogenital Distress Inventory (UDI), Defecatory Distress Inventory (DDI), and 
Incontinence Impact Questionnaire (IIQ) [19-21]. Patients were considered to be sexually 
active if they responded with ‘yes’ to the question ‘ are you having sexual contact with your 
partner?’ To assess sexual functioning the Pelvic Organ Prolapse/Urinary Incontinence Sexual 
Questionnaire (PISQ-12), translated from the validated questionnaire but not validated for 
Dutch language, was used. Data from patients who had completed the POP/urinary 
incontinence sexual questionnaire (PISQ-12) at baseline and 24 months after surgery were 
used in the present trial This PISQ-12 questionnaire is a shorter version of the original PISQ 
questionnaire and is validated for assessment of sexual function in women with POP [22,23]. 
PISQ-12 individual question scores range from 0 to 4. Total PISQ-12 scores ranges from 0, 
which represents poorest sexual function, to 48, best sexual function. A questionnaire was 
considered valid if there were no more than two missing items and total scores were 
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F i g u r e  1 . Number of sexual (in) active women at baseline and after 24 months follow-up 
Table 1 shows baseline characteristics stratified by sexual activity. In sexually active women 
there were no differences in baseline characteristics between the interventions. Women who 
were not sexually active were significantly older (p< 0.01) and had higher stage uterine 
prolapse (p<0.01). 99 women completed the PISQ-12 questionnaire both at baseline and 
after 24 months follow-up. No differences in baseline characteristics were found between 
sacrospinous hysteropexy (n= 43) and vaginal hysterectomy (n=56).
In table 2 total PISQ-12 scores and individual items are shown at baseline and after 24 
months follow-up. No significant differences in total PISQ-12 scores were found at baseline 
and after 24 months between intervention and control group. PISQ-12 scores improved 
significantly after 24 months in both groups. Independent sample t test on the difference 
between the groups in change of preoperative minus postoperative scores also revealed no 
statistical significant difference after 24 months follow-up (p=0.80). A significant 
improvement was found in both groups with respect to the PISQ-12 items ‘avoidance of 
intercourse due to prolapse’. Significant improvement was also observed in the physical 
subscale in both groups. Statistically significant differences (but no improvement as the 
scores were not one point higher than the preoperative score) were found in both groups 
regarding PISQ-12 items: ‘occurrence of urinary incontinence’, ‘negative emotional reactions’ 
and ‘orgasmic level’ (both interventions). After sacrospinous hysteropexy fear of incontinence 
was significantly lower. The behavioural/emotive subscale in the hysterectomy group and 
partner related subscale in the sacrospinous hysteropexy group were significantly higher 
after 24 months but did not meet the definition of improvement. 
Anatomical success (defined as no prolapse beyond the hymen, no bothersome bulge 
symptoms and no repeat surgery after 24 months) was similar in women who completed 
PISQ-questionnaires: 32 out of 42 women (76.2%) in the sacrospinous hysteropexy group 
and 38 out of 53 women (71.7%) in the vaginal hysterectomy group (p=0.62).
114
CHAPTER 8
501420-L-bw-Detollenaere
	  
T a b l e  1 .  Baseline characteristics sexually active and sexually inactive women 
 
Sexually active (n=135) Sexually inactive (n=70)  
Characteristic Sacrospinous 
hysteropexy 
(n=63) 
Vaginal 
hysterectomy 
(n=72) 
Overall 
(n=135) 
Sacrospinous 
hysteropexy 
(n=37) 
Vaginal 
hysterectomy 
(n=33) 
Overall 
(n=70) 
P* 
Age, years 59.4 (7.4) 58.8 (9.4) 59.1 (8.5) 68.1 (8.2) 68.3 (7.5) 68.2 (7.8) <0.01 
Body mass index 25.8 (3.0) 25.6 (2.9) 25.7 (2.9) 26.1 (3.9) 26.6 (4.5) 26.4 (4.1) 0.19 
Parity  2.8 (0.2) 2.9 (1.2) 2.9 (1.2) 2.8 (2.0) 2.9 (1.0) 2.9 (1.3) 0.99 
Smoking  9/56 
(16.1) 
5/62 
(8.1) 
14/118 
(11.9) 
4/32 
(12.5) 
4/28 
(14.3) 
8/60 
(13.3) 
0.75 
Pre-operative 
uterine prolapse 
stage: 
      <0.01 
2 42/63 
(66.7%) 
52/72 
(72.2%) 
94/135 
(69.6%) 
23/37 
(62.2%) 
14/33 
(42.4%) 
37/70 
(52.9%) 
 
3 17/63 
(27.0%) 
18/72 
(25.0%) 
35/135 
(25.9%) 
11/37 
(29.7%) 
11/33 
(33.3%) 
22/70 
(31.4%) 
 
4 4/63 
(6.3%) 
2/72 
(2.8%) 
6/135 
(4.4%) 
3/37 
(8.1%) 
8/33 
(24.2%) 
11/70 
(15.7%) 
 
VAS general 
health (0-100)a 
72.9 
(15.6) 
72.5 
(18.1) 
72,7 
(16.9) 
70.4 
(17.5) 
70.1 
(19.6) 
70.2 
(18.4) 
0.37 
UDI prolapse  
(0-100) b 
52.6 
(26.4) 
54.0 
(27.7) 
53.3 
(27.0) 
51.0 
(29.1) 
60.8 
(26.4) 
55.7 
(28.0) 
0.57 
SUI c 
27/63 
(43%) 
30/73 
(41%) 
57/135 
(42%) 
20/37 
(54%) 
13/32 
(41%) 
33/69 
(48%) 
0.45 
UUI c 
28/63 
(44%) 
28/71 
(39%) 
56/134 
(42%) 
16/36 
(44%) 
16/32 
(50%) 
32/68 
(47%) 
0.48 
Obstipation 
26/63 
(41%) 
20/72 
(28%) 
46/135 
(34%) 
9/37 
(24%) 
8/32 
(25%) 
17/69 
(25%) 
0.17 
 
VAS: visual analogue scale score; UDI: urogenital distress inventory; Data are presented as mean (SD) or number (%); 
Percentages were calculated using non-missing data.  
a VAS general health: 0= worst quality of health and 100=best quality of health 
b UDI: 0=no symptoms or not bothersome and 100=most bothersome symptoms 
* P values calculated using independent T-test or Fisher's exact test comparing sexually active and sexually inactive women. 
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prolapse (p<0.01). 99 women completed the PISQ-12 questionnaire both at baseline and 
after 24 months follow-up. No differences in baseline characteristics were found between 
sacrospinous hysteropexy (n= 43) and vaginal hysterectomy (n=56). 
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significantly after 24 months in both groups. Independent sample t test on the difference 
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statistical significant difference after 24 months follow-up (p=0.80). A significant 
improvement was found in both groups with respect to the PISQ-12 items ‘avoidance of 
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was significantly lower. The behavioural/emotive subscale in the hysterectomy group and 
partner related subscale in the sacrospinous hysteropexy group were significantly higher 
after 24 months but did not meet the definition of improvement.  
Anatomical success (defined as no prolapse beyond the hymen, no bothersome bulge 
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study using the PISQ-12 questionnaire to study the effect of POP surgery on sexual 
functioning showed an improvement in sexual function [26]. Sexual functioning after POP 
surgery with and without hysterectomy was compared in a non-randomized prospective trial. 
Uterus preservation was associated with a greater improvement. However limitations of that 
study were the non-randomized design and no use of a condition-specific questionnaire in 
the evaluation of sexual function [16]. A cohort study among 1.267 women reported that 
women with POP had lower PISQ-12 scores than controls [7]. That study found that POP had 
no effect on certain aspects of sexual function such as orgasm and sexual satisfaction. In our 
study, we confirmed that POP surgery does not significantly improves these aspects. There 
was no significant change in the individual items sexual desire, orgasm, sexual excitement 
and sexual satisfaction. However, improvement after surgery in our study can be explained 
by the improvement in the avoidance of sexual intercourse due to prolapse and physical 
cure.  
Strength of this study is the randomized design. As far as we know, this is the first large 
randomized study reporting on sexual functioning after uterus preservation and 
hysterectomy two years after surgery. Second we used the best available condition specific 
and validated questionnaire. The PISQ and its short form PISQ-12 were the only validated 
female sexual function questionnaires specifically developed to assess sexual function in 
women with POP and UI at the time of the study. Recently this questionnaire has been 
validated for Dutch language [27]. The PISQ-12 however, has its limitations. Roos et al. 
showed that the PISQ is complete in representing the positive effects of surgery but most 
negative effects are not included [28]. They concluded that with the cure of POP and/or UI 
after surgery it is logical that questions such as ‘Do you avoid sexual intercourse because of 
bulging in the vagina?’, ‘Are you incontinent of urine with sexual activity?’, and ‘Does fear of 
incontinence restrict your sexual activity?’ improved which was also the case in our study. 
However negative aspects of surgery such as fear of damaging the repair, disappointing 
result after surgery and pain due to surgery are missing in the questionnaire. The 
International Urogynecological Association (IUGA) published a revised version of the PISQ: 
PISQ-IUGA-revised (PISQ-IR). This questionnaire also addresses the following issues: impact 
of pelvic floor dysfunction on a women’s decision not to be sexually active and also creating a 
condition-specific measure of sexual function for women with anal incontinence. However the 
PISQ-IR fails to address the possible negative effects of surgery. Another disadvantage was 
that only sexual function in sexual active women is evaluated in the questionnaire. Sexually 
inactive women were not asked about their satisfaction being sexually inactive.  With longer 
follow-up changes unrelated to surgery may influence sexual function as well, especially in a 
group of ageing women. Possible reasons to become sexually inactive are for example 
ageing, illness and becoming a widow, which is unrelated to surgery. In our study, we did not 
ask for these factors, which would have been appropriate when evaluating sexual function in 
an ageing group.   
Women’s self-perceived body image and degree of bother from POP may influence total 
PISQ-12 scores. It is thus interesting to know if uterus preservation is associated with better 
body image after POP surgery than hysterectomy and whether uterus preservation thereby 
improves sexual function. Recent studies show that the majority of women disagree to a 
statement that the uterus is important for body image and sexuality. A study among 213 
	  
T a b l e  2 .  Total PISQ-12 scores at baseline and after 24 months follow-up 
 
 Sacrospinous hysteropexy (n=43) Vaginal hysterectomy (n=56) 
  Baseline 24 months P Effect 
size 
Baseline 24 months P Effect 
size 
T o t a l  p i s q - 1 2  s c o r e  a,b 33.7 (5.5) 36.8 (4.6) <0.01 0.61 34.7 (5.0) 37.5 (3.3) <0.01 0.66 
p i s q - 1 2  s u b s c a l e  a n d  
i n d i v i d u a l  q u e s t i o n  s c o r e s :   
        
Behavioural/emotive c 13.7 (2.5) 14.5 (2.2) 0.08 - 13.6 (2.5) 14.5 (1.6) <0.01 0.43 
Q1. Sexual desire 1.9 (0.9) 1.9 (0.9) 1.0 - 2.1 (0.7) 2.2 (0.7) 0.86 - 
Q2. Climax (orgasm) 2.5 (1.0) 2.8 (0.9) 0.11 - 2.6 (1.0) 2.5 (0.8) 0.32 - 
Q3. Sexual excitement 2.8 (0.8) 2.8 (0.7) 1.0 - 2.8 (0.7) 2.8 (0.5) 0.57 - 
Q4. Sexual satisfaction with sexual 
activities 
3.2 (0.7) 3.1 (0.6) 0.58 - 3.0 (0.8) 3.1 (0.6) 0.06 - 
Q9. Negative emotional reactions 
(fear, disgust, shame, guilt) 
during sexual activity 
3.3 (0.9) 3.7 (0.6) <0.01 0.52 3.2 (1.1) 3.8 (0.5) <0.01 0.70 
         
Physical d 12.1 (2.9) 14.7 (1.3) <0.01 1.16 12.9 (2.5) 14.6 (1.5) <0.01 0.82 
Q5. Pain during intercourse 2.9 (1.1) 3.0 (1.0) 0.47 - 2.8 (1.2) 3.0 (1.0) 0.18 - 
Q6. Urinary incontinence during 
sexual activity 
3.5 (0.9) 3.9 (0.3) 0.01 0.60 3.7 (0.7) 3.8 (0.4) 0.04 0.18 
Q7. Fear of incontinence (urinary 
or faecal) during sexual activity 
3.5 (1.1) 3.9 (0.4) 0.02 0.48 3.7 (0.7) 3.9 (0.4) 0.05 - 
Q8. Avoidance of intercourse due 
to prolapse 
2.4 (1.4) 3.9 (0.5) <0.01 1.42 2.7 (1.2) 3.9 (0.4) <0.01 1.34 
         
Partner related e 8.0 (1.5) 8.9 (1.5) <0.01 0.60 8.1 (1.6) 8.3 (1.9) 0.42 - 
Q10. Erection problems of 
partner 
3.3 (0.9) 3.4 (0.9) 0.32 - 3.3 (0.8) 3.3 (0.9) 0.76 - 
Q11. Premature ejaculation of 
partner 
3.6 (0.7) 3.7 (0.6) 0.60 - 3.4 (0.8) 3.3 (0.9) 0.39 - 
Q12. Comparison of orgasmic 
level between past and present 
1.0 (0.7) 1.7 (0.7) <0.01 1.0 1.4 (0.7) 1.8 (0.8) 0.02 0.53 
 
PISQ-12: pelvic organ prolapse/urinary incontinence sexual questionnaire; Data are presented as mean (SD). Total PISQ-12 
scores ranges from 0, which represents poorest sexual function, to 48 best sexual function.  
P value: paired sample test baseline score and follow-up score, effect size: small Cohen’s d=0.2, medium if d=0.5, large if d 
≥ 0.8 
a not showed: independent sample T-test on the differences between groups in total PISQ-12 scores showed no difference at 
baseline (difference -1 point, 95% CI -3 to 1.1, p=0.35) and after 24 months (difference -0.7 point, 95% CI -2.3 to 0.9, p=0.37) 
b not showed: independent sample T-test on the difference between groups in change of preoperative minus postoperative 
follow-up score showed no statistical significant difference (p=0.80) 
c Behavioural/emotive subscale: questions 1, 2, 3, 4, and 9 (desire, arousal, emotions). 
d Physical subscale: questions 5, 6, 7, and 8 (pain, urinary and/or faecal incontinence and bulge symptoms). 
e Partner related subscale: questions 10, 11, and 12 (erection, premature ejaculation, and intensity of orgasm). 
 
D I S C U S S I O N  
In the present study sexual function evaluated by the PISQ-12 questionnaire improved 
significantly after surgery (overall PISQ-12 scores) but was not different between 
sacrospinous hysteropexy and vaginal hysterectomy with suspensions of the uterosacral 
ligaments during a follow-up period of 24 months. Improvement was found in the avoidance 
of sexual intercourse due to prolapse and the physical subscale of the PISQ-12 after both 
procedures. The percentage of women who became sexual (in)active after 24 months was 
similar.  
A recent systematic review concluded that sexual functioning is significantly improved and 
dyspareunia significantly reduced following native tissue prolapse surgery [25]. Likewise, a 
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study using the PISQ-12 questionnaire to study the effect of POP surgery on sexual 
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ask for these factors, which would have been appropriate when evaluating sexual function in 
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Women’s self-perceived body image and degree of bother from POP may influence total 
PISQ-12 scores. It is thus interesting to know if uterus preservation is associated with better 
body image after POP surgery than hysterectomy and whether uterus preservation thereby 
improves sexual function. Recent studies show that the majority of women disagree to a 
statement that the uterus is important for body image and sexuality. A study among 213 
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Q5. Pain during intercourse 2.9 (1.1) 3.0 (1.0) 0.47 - 2.8 (1.2) 3.0 (1.0) 0.18 - 
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sexual activity 
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Q7. Fear of incontinence (urinary 
or faecal) during sexual activity 
3.5 (1.1) 3.9 (0.4) 0.02 0.48 3.7 (0.7) 3.9 (0.4) 0.05 - 
Q8. Avoidance of intercourse due 
to prolapse 
2.4 (1.4) 3.9 (0.5) <0.01 1.42 2.7 (1.2) 3.9 (0.4) <0.01 1.34 
         
Partner related e 8.0 (1.5) 8.9 (1.5) <0.01 0.60 8.1 (1.6) 8.3 (1.9) 0.42 - 
Q10. Erection problems of 
partner 
3.3 (0.9) 3.4 (0.9) 0.32 - 3.3 (0.8) 3.3 (0.9) 0.76 - 
Q11. Premature ejaculation of 
partner 
3.6 (0.7) 3.7 (0.6) 0.60 - 3.4 (0.8) 3.3 (0.9) 0.39 - 
Q12. Comparison of orgasmic 
level between past and present 
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PISQ-12: pelvic organ prolapse/urinary incontinence sexual questionnaire; Data are presented as mean (SD). Total PISQ-12 
scores ranges from 0, which represents poorest sexual function, to 48 best sexual function.  
P value: paired sample test baseline score and follow-up score, effect size: small Cohen’s d=0.2, medium if d=0.5, large if d 
≥ 0.8 
a not showed: independent sample T-test on the differences between groups in total PISQ-12 scores showed no difference at 
baseline (difference -1 point, 95% CI -3 to 1.1, p=0.35) and after 24 months (difference -0.7 point, 95% CI -2.3 to 0.9, p=0.37) 
b not showed: independent sample T-test on the difference between groups in change of preoperative minus postoperative 
follow-up score showed no statistical significant difference (p=0.80) 
c Behavioural/emotive subscale: questions 1, 2, 3, 4, and 9 (desire, arousal, emotions). 
d Physical subscale: questions 5, 6, 7, and 8 (pain, urinary and/or faecal incontinence and bulge symptoms). 
e Partner related subscale: questions 10, 11, and 12 (erection, premature ejaculation, and intensity of orgasm). 
 
D I S C U S S I O N  
In the present study sexual function evaluated by the PISQ-12 questionnaire improved 
significantly after surgery (overall PISQ-12 scores) but was not different between 
sacrospinous hysteropexy and vaginal hysterectomy with suspensions of the uterosacral 
ligaments during a follow-up period of 24 months. Improvement was found in the avoidance 
of sexual intercourse due to prolapse and the physical subscale of the PISQ-12 after both 
procedures. The percentage of women who became sexual (in)active after 24 months was 
similar.  
A recent systematic review concluded that sexual functioning is significantly improved and 
dyspareunia significantly reduced following native tissue prolapse surgery [25]. Likewise, a 
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women seeking care for POP symptoms reported on patients’ attitudes toward the uterus 
and the role in surgery [29]. The authors found that women had relatively neutral attitudes on 
the uterus being beneficial to sexuality or femininity. A recent study by our research group 
demonstrated that 80% of women referred to a gynecologist for POP complaints thought that 
there would be no effect of uterus preservation versus hysterectomy regarding sexuality and 
body image (article under review).  
Taking women’s preferences and believes into account in combination with the results of the 
PISQ-12 questionnaires, we argue that uterus preservation and vaginal hysterectomy are 
both adequate treatments for POP with regard to improvement of sexual functioning. Based 
on our study women can be adequately counseled on sexual functioning after both 
interventions. In this study improvement was found in overall PISQ-12 scores after both 
interventions and no difference was found in total PISQ-12 scores between the groups after 
24 months follow-up. The percentage of women who became sexual (in) active after surgery 
was the same, less avoidance of sexual intercourse due to prolapse was found and the 
physical subscale of the PISQ-12 improved.  
 
C o n c l u s i o n s  
There was no difference in improvement of sexual functioning two years after POP surgery 
when comparing sacrospinous hysteropexy and vaginal hysterectomy with suspension of the 
uterosacral ligaments.  
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the uterus being beneficial to sexuality or femininity. A recent study by our research group 
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there would be no effect of uterus preservation versus hysterectomy regarding sexuality and 
body image (article under review).  
Taking women’s preferences and believes into account in combination with the results of the 
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on our study women can be adequately counseled on sexual functioning after both 
interventions. In this study improvement was found in overall PISQ-12 scores after both 
interventions and no difference was found in total PISQ-12 scores between the groups after 
24 months follow-up. The percentage of women who became sexual (in) active after surgery 
was the same, less avoidance of sexual intercourse due to prolapse was found and the 
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This thesis focuses on the surgical management of uterine prolapse with emphasis on 
whether the uterus should be preserved or removed. We aimed to answer the following 
research questions about this type of surgery: What do women want? What do doctors do 
and what should be done? In this chapter we have summarized the main outcomes, discuss 
the clinical implications and propose topics for future research.  
 
W h a t  d o  w o m e n  w a n t ?   
Dutch women’s attitudes and preferences regarding surgical management of uterine 
prolapse were studied in a cross-sectional study using a questionnaire (c h a p t e r  5 ). In case 
outcomes after hysterectomy and uterus preserving surgery were expected to be equal, 
more women expressed preference for uterus preservation (43%) compared to hysterectomy 
(27%). After counselling on outcomes, risks and recovery time even more women preferred 
uterus preservation (65%) over hysterectomy (13%). The majority of patients expected a 
similar improvement in sexuality and body image after both treatment modalities. Treatment 
success, risk of urinary incontinence after surgery and complication risk were the most 
important factors when choosing a surgical intervention. The future risk of endometrial 
cancer was for the majority of women not a reason to choose for hysterectomy when surgery 
was necessary.  
 
Discussion on patient preferences 
Overall our results are in line with two preference studies from the USA [1,2]. From literature 
we know that women with POP tend to be more focused on the pros and cons of the 
treatments themselves, rather than on the effect of the outcome of treatment on their quality 
of life [3]. Another study found that the majority of women scheduled for POP surgery feared 
de novo symptoms, particularly urinary incontinence [4]. The risk of urinary incontinence may 
have increased the preference for uterus preservation after counseling in our study, as we 
stated that hysterectomy might be more often associated with urinary incontinence. 
Unfortunately, we didn’t use counter-factual statements providing advantages of 
hysterectomy over uterine preservation.  
Better understanding of women’s preferences and thoughts on uterus preservation or 
hysterectomy makes it possible to come to a process of shared-decision making regarding 
women’s attitudes in case of POP surgery. A study on women’s expectations of POP surgery 
reported a strong desire to return to ‘normality’ [5]. The women in that study consider surgery 
as a way to come to ‘a state of normal self’. Women in our study preferred uterus preservation 
because they wanted to stay ‘as complete as possible’ and women thought ‘it was not 
necessary to remove a healthy organ’. Unfortunately, even today there are gynaecologists 
who argue that the uterus is an atrophic, non-functional organ and that uterus preservation 
on cultural or ideological grounds should be rejected. In our opinion this reflects a serious 
lack of respect for women’s attitudes and feelings.  
 
W h a t  d o  w e  d o  a s  g y n a e c o l o g i s t s ?   
Since no clear guidelines were available and different studies stated that uterus preserving 
procedures were becoming more popular, we studied the preferences of 
(uro)gynaecologists in the Netherlands (c h a p t e r  3 ). Main findings were that surgical policy in 
case of uterine descent was very variable per hospital, with overall no clear preference for 
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beliefs on indications for surgery [15]. Another possible cause of variation may be differences 
in the characteristics of local clinicians and clinician behavior arising from the interaction with 
financial reimbursement systems. Furthermore differences in extent to which doctors 
incorporate patient preferences into treatment decisions may be an important factor in 
practice variation. Procedure rates for preference-sensitive conditions such as preserving the 
uterus or not, tend to vary considerably more than rates of other interventions like 
appendectomy [15]. Studies evaluating the effects of decision aids suggest that surgical 
intervention rates are strongly influenced by the extent to which patients are involved in their 
own treatment decisions. Decision aids and interactive “shared decision making” tools 
provide patients with detailed information on the risks and benefits of different treatments for 
specific conditions. A systematic review of randomised controlled trials evaluating such tools 
concluded that they improve patient knowledge, promote a more accurate perception of 
risks and benefits, and increase consistency between the patient’s informed values and the 
treatment chosen. No studies have assessed whether decision aids reduce variation in 
procedure rates but several trials have shown significant decreases in overall surgery rates 
following their implementation [16-18]. Randomised controlled trials like the SAVE U study 
could not only help to establish evidence-based guidelines, but also help to develop a 
decision tool for “shared decision making’ to reduce practice pattern variation.   
 
W h a t  s h o u l d  w e  d o ?  
Since large randomised studies comparing a uterus preserving procedure with hysterectomy 
were lacking, we initiated the SAVE U study (SAcrospinous hysteropexy VErsus vaginal 
hysterectomy in treatment of Uterine prolapse) in 2009. Women with uterine prolapse stage 
two or higher without previous POP surgery were randomised between sacrospinous 
hysteropexy and vaginal hysterectomy with suspension of the uterosacral ligaments 
(c h a p t e r  6  a n d  7 ). Main findings were that after a follow-up period of 12 months, 
sacrospinous hysteropexy was non-inferior regarding anatomical recurrence in the apical 
compartment with bothersome symptoms or repeat surgery compared to vaginal 
hysterectomy with suspension of the uterosacral ligaments. There were no statistically 
significant differences in overall anatomical recurrences, functional outcome, quality of life, 
complications, hospital stay, measures on post-operative recovery and sexual functioning 
between the two groups after 12 months follow-up period. Sexual functioning was also 
evaluated after 24 months follow-up and no difference in sexual functioning as assessed with 
the PISQ-12 questionnaire was found (c h a p t e r  8 ).  
 
Discussion on the SAVE U trial 
The main primary outcome of the SAVE U trial (anatomical recurrence with complaints or 
repeat surgery) was evaluated at 12 months. This is a short follow-up period for a treatment 
that should last a lifetime and recurrences that may further develop during longer follow-up. 
As stated in our study protocol we will follow women further until 60 months after surgery. 
Data from some registry studies suggest that the highest risk for POP surgery after 
hysterectomy is in the first year(s) after surgery [19-21]. A study on 154.882 women who 
underwent hysterectomy for benign conditions during the period 1977 – 2009 in Denmark 
showed that POP as the indication for hysterectomy was associated with a significantly higher 
(p=0.000) cumulative incidence of POP surgery after 32 years’ follow-up than all other 
 
either hysterectomy or uterus preservation. There was a clear increase in hospital admissions 
and POP procedures in the last decade with a trend towards more uterus preservation.  
In line with the conclusion that (uro)gynaecologists in The Netherlands had no clear 
preference for treatment of uterine prolapse, we  observed a high practice pattern variation 
in the surgical management of POP and UI in 2010 (c h a p t e r  4 ). 
 
Discussion on surgical management of uterine prolapse in the Netherlands 
During the last decade more gynaecologists in the Netherlands tended to preserve the 
uterus more often. We can only speculate on the reason why, as clear scientific evidence on 
this topic was lacking during that period. The finding that more gynaecologists tend to 
preserve the uterus is in contrast with published studies from Australia, New Zealand and the 
UK but in line with studies from Taiwan and the USA [6-9]. One explanation could be that 
gynaecologists in the Netherlands are more familiar with uterus preserving procedures such 
as sacrospinous hysteropexy and the Manchester–Fothergill procedure than gynaecologists 
in other countries. The recent published studies from the Netherlands comparing vaginal 
hysterectomy with uterus preserving surgery might be a reflection of this interest  [10-14]. 
Furthermore training programs in the Netherlands compared with other countries may be 
different.The stage of uterine descent before surgery influenced the choice of a surgical 
intervention: in case of a lower stage uterine prolapse (stage one and two) 68% of the Dutch 
urogynaecologists preferred an uterus preserving procedure and only 13% a hysterectomy. 
However in case of higher stage uterine prolapse (stages three and four) 40% preferred a 
hysterectomy and 40% a uterus preserving procedure. No clear evidence is available on 
applying different surgical techniques according to the stage of uterine prolapse. One 
randomised controlled Dutch study found higher recurrence rates after uterus preservation 
in women with higher preoperative stage POP compared to hysterectomy [10]. It is possible 
that Dutch gynaecologists therefore more often choose a hysterectomy in women with higher 
stage uterine prolapse. In the SAVE U study equal rates in overall anatomical recurrence were 
found in the various preoperative POP stages after sacrospinous hysteropexy and vaginal 
hysterectomy with suspension of the uterosacral ligaments with respect to preoperative POP 
stage. Although women with uterine prolapse stage 4 were more likely to have an anatomical 
recurrence in one of the compartments after 12 months follow-up compared to women with 
uterine prolapse stage 2 (unpublished data), there was no difference between both 
treatment modalities. Therefore, the results of the SAVE U study does not support the idea 
that hysterectomy is being preferred in case of a higher stage uterine prolapse. 
Evaluating the practice pattern variation in the Netherlands, we found that patient’s odds of 
undergoing surgery for POP and UI seemed to depend more on where the patient lived and 
to which hospital she was referred than on clinical circumstances. Of course some practice 
pattern variation is inevitable. The complex question is which level of practice pattern 
variation is acceptable? Are hospitals or gynaecologists with high surgery rates 
overproviding, or are the low ones underproviding? What is the optimal ratio between 
conservative therapy and surgery? The absence of clearly defined guidelines regarding 
indications for conservative and surgical treatment and the use of different types of surgical 
techniques may contribute to the high practice pattern variation. In literature the most 
obvious reason for variation in surgery rates is that physicians have different attitudes and 
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hysteropexy in case of a solitary anterior or posterior compartment prolapse without uterine 
prolapse remains also to be established. 
One major difficulty in evaluating results after POP surgery is that significant variation exists 
on how outcomes were reported [22]. Historically the focus was on anatomical improvement 
but nowadays more emphasis is placed on symptom relief and improvement of quality of life. 
However, it is difficult to establish what is the most relevant outcome measure in POP 
surgery. Barber and colleagues reported on different definitions of success after surgery for 
POP in 2009 [23]. Treatment success varied widely depending on the definition used, but 
definitions that included the absence of vaginal bulge symptoms had the strongest relation 
with the women’s assessment of overall improvement and treatment success. We have 
chosen a composite outcome measure including anatomical outcome of the central 
compartment, absence of bothersome bulge complaints and repeat surgery. Furthermore we 
reported on outcomes in the different compartments and also reported on an outcome 
measure using the hymen as the threshold for success. An independent assessor without any 
conflict of interest performed the follow-up assessment but this person was not blinded as 
the presence or absence of the uterus was easy to assess during POP-Q examination. 
Furthermore we used valid questionnaires to evaluate functional outcome and quality of life.  
Another issue for discussion is the preferred method of vault suspension after hysterectomy. 
Level 1 support of the vaginal apex by the cardinal and uterosacral ligaments aims at the 
prevention of prolapse of the vaginal apex.  Since the uterosacral/cardinal ligament complex 
is divided during hysterectomy, loss of level 1 support can lead to subsequent prolapse of 
the vaginal vault and inadequate vaginal vault suspension is recognized to be associated with 
higher risk to recurrent POP. Although resuspension of the vaginal apex is recommended, 
performing such procedure is not common practice. One study in a tertiary hospital included 
2465 hysterectomies for POP and found that in only 1358 cases (55.1%) concurrent apical 
support procedures were carried out [24]. Cases without apical procedures were more likely 
to undergo cystocele repair (23.8% vs 9.4%, p<000.1), but less likely to have rectocele 3.4% 
vs. 12.2%, p<000.1) or combined cystocele/rectocele repair (16.4% vs. 25.6%, p<0.001) for 
recurrent prolapse. Of those without apical procedures, 95.7% were performed by 
generalists. Surgeons practicing > 10 years were less likely to perform apical procedures 
than those practicing < 5 years. The median number of hysterectomies performed for POP by 
each surgeon over the 11-year interval was only 6, with a very wide range of 1-308. Different 
methods for vaginal vault suspension after hysterectomy exist: sacral colpopexy, McCall 
culdoplasty, uterosacral ligament suspension and sacrospinous ligament fixation. When the 
SAVE U trial study protocol was designed in 2008, no clear evidence was available on how 
the vaginal vault should be suspended after hysterectomy. Therefore we have chosen the 
most applied technique in our country, suspension of the uterosacral ligaments to the vaginal 
vault. A recently published randomised study compared outcomes after sacrospinous 
ligament fixation (n=186) and uterosacral ligament suspension (n=188) in women 
undergoing surgery to treat both apical vaginal prolapse and stress urinary incontinence [25]. 
Women in this study were also randomised for perioperative pelvic floor muscle training 
(PFMT). Two years after surgery, no surgical suspension procedure was superior to the other 
regarding anatomic, functional or adverse outcomes. Perioperative PFMT did not improve 
urinary symptoms at 6 months or prolapse outcomes at 2 years follow-up. However, all 
 
indications [6]. Furthermore there was a steep increase in incidence during the first 2 years 
after hysterectomy (figure 1). Subsequent POP repair was performed predominantly in the 
posterior compartment  
 
 
 
F i g u r e  1 .  Kaplan-Meier plot of cumulative incidence of pelvic organ prolapse surgery following hysterectomy for different 
groups of indications. AUB=abnormal uterine bleeding; POP=pelvic organ prolapse 
(From Lykke et al. The indication for hysterectomy as a risk factor for subsequent pelvic organ prolapse repair. Int Urogyn J. 
2015;26:1661-5) 
 
Although the presence of posterior vaginal wall prolapse in the SAVE U trial was similar in 
both study groups prior to surgery, more posterior vaginal wall repairs (colporrhaphies) were 
performed in the vaginal hysterectomy group. One explanation may be that the surgeons felt 
that the more dorsal axis of the vagina after sacrospinous hysteropexy already protected 
against a recurrent posterior vaginal wall prolapse. Indeed, despite the higher number of 
posterior colporrhaphies more anatomical recurrences of the posterior compartment were 
found after hysterectomy with suspension of the uterosacral ligaments. Based on our results 
and the previous mentioned studies we believe that gynaecologists should be aware that the 
posterior compartment is at risk for (recurrent) POP after hysterectomy. The SAVE U trial 
focused on the apical compartment and randomisation was stratified for pre-operative stage 
uterine prolapse. Although not statistically significant, a trend towards more anterior 
compartment recurrences was found after sacrospinous hysteropexy and significant more 
recurrences were found in the posterior compartment after vaginal hysterectomy. The 
question is whether the surgical treatment of POP should be individualised with respect to 
preoperative stage POP in the anterior and posterior compartment. One could hypothesize 
that for example women with a strongly dominant anterior compartment prolapse are better 
off with a hysterectomy and women with a high stage posterior compartment with a 
sacrospinous hysteropexy. The role of a prophylactic hysterectomy or sacrospinous 
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vs. 12.2%, p<000.1) or combined cystocele/rectocele repair (16.4% vs. 25.6%, p<0.001) for 
recurrent prolapse. Of those without apical procedures, 95.7% were performed by 
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than those practicing < 5 years. The median number of hysterectomies performed for POP by 
each surgeon over the 11-year interval was only 6, with a very wide range of 1-308. Different 
methods for vaginal vault suspension after hysterectomy exist: sacral colpopexy, McCall 
culdoplasty, uterosacral ligament suspension and sacrospinous ligament fixation. When the 
SAVE U trial study protocol was designed in 2008, no clear evidence was available on how 
the vaginal vault should be suspended after hysterectomy. Therefore we have chosen the 
most applied technique in our country, suspension of the uterosacral ligaments to the vaginal 
vault. A recently published randomised study compared outcomes after sacrospinous 
ligament fixation (n=186) and uterosacral ligament suspension (n=188) in women 
undergoing surgery to treat both apical vaginal prolapse and stress urinary incontinence [25]. 
Women in this study were also randomised for perioperative pelvic floor muscle training 
(PFMT). Two years after surgery, no surgical suspension procedure was superior to the other 
regarding anatomic, functional or adverse outcomes. Perioperative PFMT did not improve 
urinary symptoms at 6 months or prolapse outcomes at 2 years follow-up. However, all 
 
indications [6]. Furthermore there was a steep increase in incidence during the first 2 years 
after hysterectomy (figure 1). Subsequent POP repair was performed predominantly in the 
posterior compartment  
 
 
 
F i g u r e  1 .  Kaplan-Meier plot of cumulative incidence of pelvic organ prolapse surgery following hysterectomy for different 
groups of indications. AUB=abnormal uterine bleeding; POP=pelvic organ prolapse 
(From Lykke et al. The indication for hysterectomy as a risk factor for subsequent pelvic organ prolapse repair. Int Urogyn J. 
2015;26:1661-5) 
 
Although the presence of posterior vaginal wall prolapse in the SAVE U trial was similar in 
both study groups prior to surgery, more posterior vaginal wall repairs (colporrhaphies) were 
performed in the vaginal hysterectomy group. One explanation may be that the surgeons felt 
that the more dorsal axis of the vagina after sacrospinous hysteropexy already protected 
against a recurrent posterior vaginal wall prolapse. Indeed, despite the higher number of 
posterior colporrhaphies more anatomical recurrences of the posterior compartment were 
found after hysterectomy with suspension of the uterosacral ligaments. Based on our results 
and the previous mentioned studies we believe that gynaecologists should be aware that the 
posterior compartment is at risk for (recurrent) POP after hysterectomy. The SAVE U trial 
focused on the apical compartment and randomisation was stratified for pre-operative stage 
uterine prolapse. Although not statistically significant, a trend towards more anterior 
compartment recurrences was found after sacrospinous hysteropexy and significant more 
recurrences were found in the posterior compartment after vaginal hysterectomy. The 
question is whether the surgical treatment of POP should be individualised with respect to 
preoperative stage POP in the anterior and posterior compartment. One could hypothesize 
that for example women with a strongly dominant anterior compartment prolapse are better 
off with a hysterectomy and women with a high stage posterior compartment with a 
sacrospinous hysteropexy. The role of a prophylactic hysterectomy or sacrospinous 
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factors. Childbirth is an inciting factor and decompensating risk factors are ageing and poor 
mobility. Promoting risk factors include a high body mass index, smoking, and constipation. 
As the predisposing, inciting and decompensating risk factors are hard to influence, the 
focus to prevent POP could be on the promoting risk factors. Interventions such as weight 
loss, treatment of chronic constipation and avoidance of jobs that require heavy lifting are 
often advised to women to avoid the development, progression or recurrence of POP. 
However, POP prevention strategies, before and/or after surgery, have not been extensively 
studied.  
Although the Netherlands is the only country in which the World Health Organisation (WHO) 
predicts a decline in obesity rates in 2030, obesity is still a problem. In 2011, 43% of the 
women was overweight and 13% obese [29]. Women who seeked medical attention for POP 
have a higher body mass index (BMI) than the average population [30-32]. Obesity causes 
continuous high intra-abdominal pressure. To evaluate the relationship between change in 
weight and POP progression/regression in postmenopausal women, Kudish et al. performed 
a cohort analysis among 16.608 women aged 50 to 79 [32]. During a 5-year time period, the 
majority of women (9,251, 55.7%) gained weight (mean 4.43 kg, ± 5.95 kg), and the overall 
rate of POP increased from 40.9% at baseline to 43.8% at year 5 of evaluation. Controlling for 
age, parity, race, and other health/physical variables, being overweight (BMI between 25 and 
29.9) or obese (BMI of at least 30) at baseline was associated with progression in cystocele, 
rectocele, and uterine prolapse compared with women with healthy BMIs. However, a 10% 
weight loss was associated with minimal change in overall POP. They concluded that being 
overweight or obese is associated with progression of POP. However, weight loss does not 
appear to be significantly associated with regression of POP, suggesting that damage to the 
pelvic floor related to weight gain might be irreversible. Obesity is also an independent risk 
factor for urinary incontinence and the prevalence of daily UI has been reported to increase 
significantly with higher BMI [33]. A randomised controlled trial among 378 
overweight/obese women who were allocated to behavioral weight loss or structured 
education programs concluded that weight reduction provides improvement in episodes of 
UI, decreases the incidence of drops of urine leakage and increases quality of life related to 
pelvic floor symptoms. However little changes were found in the parameters of the POP-Q 
system. Only genital hiatus, perineal body, and Ap measurements were significantly lower in 
the weight loss group than in the control group after 6 months [34]. A systematic review 
regarding risk factors for POP and recurrence of POP after surgery concluded that a higher 
BMI was a risk factor for primary POP, but it was not a significant risk factor for POP 
recurrence [35]. Therefore at this moment it is unclear whether the effect of weight loss 
before/ and or after POP surgery is effective in long-term surgical outcomes. Weight loss 
helps to improve overall health but can be very difficult for women and hard to maintain. We 
propose a randomised controlled trial in overweight and obese women to evaluate the costs 
and effects of a structured lifestyle program aimed at weight loss before POP surgery 
compared with usual care. 
Some randomised controlled trials found that conservative management with PFMT leads to 
improvement of POP stage and quality of life [36-38]. To date, perioperative PMFT is not 
routinely recommended before and/or after surgery. A systematic review on this topic 
evaluated whether the use of PMFT together with POP surgery was superior to surgery alone 
 
women in this study underwent a concomitant midurethal sling procedure and therefore 
these data suggest that there are no differences, but cannot be 100% extrapolated to our 
study group. Randomised studies to compare different methods of apical suspension after 
hysterectomy performed for uterine prolapse are therefore recommended.  
Contra-indications for uterus preservation must be taken into account. For women with 
uterine abnormalities and familiar cancer (BRCA 1&2 and HNPCC mutation carriers) it is 
recommended to remove the uterus. Because of the low incidence and the early diagnosis of 
endometrial cancer due to blood loss, we believe that future risk of malignancy should not be 
regarded as a valid reason to remove the uterus. A previous retrospective analysis of 
pathology findings after POP surgery with hysterectomy showed premalignant or malignant 
abnormalities in 17 of 644 patients (2.6%) [26]. In that study, 2 patients (0.3%) had 
endometrial cancer diagnosed. Women after uterus preserving surgery are advised to 
continue participation in the national screening program for cervical cancer and they are also 
advised to seek medical help for any abnormal vaginal bleeding, as with any other non-
hysterectomized woman.  
In fertile women with uterine prolapse future childbearing may be an important issue. 
Pregnancies after sacrospinous hysteropexy have been described but very little data on this 
subject are available to give evidence-based recommendations. In our opinion conservative 
treatment with a pessary should be offered as first-line treatment in women with uterine 
prolapse and future child wish.  
Treatment of POP utilizes significant healthcare resources. The health care impact is likely to 
expand, based upon estimates of an increasing prevalence in the growing population of 
elderly women. At this moment the choice for surgical POP procedures mainly depends on 
the outcomes after these procedures, preferences and capabilities of the surgeon and 
patient preferences rather than on cost-effectiveness of the different POP procedures. A 
systematic review evaluating the economic costs associated with POP surgery concluded that 
in a single institution study, vaginal reconstructive surgery and pessary use were more cost-
effective than expectant management, traditional abdominal sacral colpopexy or robot-
assisted sacral colpopexy [27]. They also concluded that there is a lack of good economic 
data. Because it was not a secondary outcome of the SAVE U trial it is unclear whether uterus 
preserving surgery is cost-effective compared to hysterectomy.  However shorter operation 
time and perhaps less repeat surgery in the long term could certainly be beneficial from an 
economical point of view. 
 
F u t u r e  r e s e a r c h   
With respect to future research we would like to discuss the following topics: 
1. Strategies to prevent recurrent POP after surgical management 
2. Use of mesh materials in surgical management of uterine prolapse 
3. Minimally invasive laparoscopic uterus preserving procedures  
 
1. Strategies to prevent development of recurrent POP after surgical management 
The aetiology of POP is multifactorial. Bump and colleagues described a model that 
subdivides the risk factors of POP into predisposing, inciting, decompensating and 
promoting factors [28]. Ethnic background and genetics are considered to be predisposing 
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factors. Childbirth is an inciting factor and decompensating risk factors are ageing and poor 
mobility. Promoting risk factors include a high body mass index, smoking, and constipation. 
As the predisposing, inciting and decompensating risk factors are hard to influence, the 
focus to prevent POP could be on the promoting risk factors. Interventions such as weight 
loss, treatment of chronic constipation and avoidance of jobs that require heavy lifting are 
often advised to women to avoid the development, progression or recurrence of POP. 
However, POP prevention strategies, before and/or after surgery, have not been extensively 
studied.  
Although the Netherlands is the only country in which the World Health Organisation (WHO) 
predicts a decline in obesity rates in 2030, obesity is still a problem. In 2011, 43% of the 
women was overweight and 13% obese [29]. Women who seeked medical attention for POP 
have a higher body mass index (BMI) than the average population [30-32]. Obesity causes 
continuous high intra-abdominal pressure. To evaluate the relationship between change in 
weight and POP progression/regression in postmenopausal women, Kudish et al. performed 
a cohort analysis among 16.608 women aged 50 to 79 [32]. During a 5-year time period, the 
majority of women (9,251, 55.7%) gained weight (mean 4.43 kg, ± 5.95 kg), and the overall 
rate of POP increased from 40.9% at baseline to 43.8% at year 5 of evaluation. Controlling for 
age, parity, race, and other health/physical variables, being overweight (BMI between 25 and 
29.9) or obese (BMI of at least 30) at baseline was associated with progression in cystocele, 
rectocele, and uterine prolapse compared with women with healthy BMIs. However, a 10% 
weight loss was associated with minimal change in overall POP. They concluded that being 
overweight or obese is associated with progression of POP. However, weight loss does not 
appear to be significantly associated with regression of POP, suggesting that damage to the 
pelvic floor related to weight gain might be irreversible. Obesity is also an independent risk 
factor for urinary incontinence and the prevalence of daily UI has been reported to increase 
significantly with higher BMI [33]. A randomised controlled trial among 378 
overweight/obese women who were allocated to behavioral weight loss or structured 
education programs concluded that weight reduction provides improvement in episodes of 
UI, decreases the incidence of drops of urine leakage and increases quality of life related to 
pelvic floor symptoms. However little changes were found in the parameters of the POP-Q 
system. Only genital hiatus, perineal body, and Ap measurements were significantly lower in 
the weight loss group than in the control group after 6 months [34]. A systematic review 
regarding risk factors for POP and recurrence of POP after surgery concluded that a higher 
BMI was a risk factor for primary POP, but it was not a significant risk factor for POP 
recurrence [35]. Therefore at this moment it is unclear whether the effect of weight loss 
before/ and or after POP surgery is effective in long-term surgical outcomes. Weight loss 
helps to improve overall health but can be very difficult for women and hard to maintain. We 
propose a randomised controlled trial in overweight and obese women to evaluate the costs 
and effects of a structured lifestyle program aimed at weight loss before POP surgery 
compared with usual care. 
Some randomised controlled trials found that conservative management with PFMT leads to 
improvement of POP stage and quality of life [36-38]. To date, perioperative PMFT is not 
routinely recommended before and/or after surgery. A systematic review on this topic 
evaluated whether the use of PMFT together with POP surgery was superior to surgery alone 
 
women in this study underwent a concomitant midurethal sling procedure and therefore 
these data suggest that there are no differences, but cannot be 100% extrapolated to our 
study group. Randomised studies to compare different methods of apical suspension after 
hysterectomy performed for uterine prolapse are therefore recommended.  
Contra-indications for uterus preservation must be taken into account. For women with 
uterine abnormalities and familiar cancer (BRCA 1&2 and HNPCC mutation carriers) it is 
recommended to remove the uterus. Because of the low incidence and the early diagnosis of 
endometrial cancer due to blood loss, we believe that future risk of malignancy should not be 
regarded as a valid reason to remove the uterus. A previous retrospective analysis of 
pathology findings after POP surgery with hysterectomy showed premalignant or malignant 
abnormalities in 17 of 644 patients (2.6%) [26]. In that study, 2 patients (0.3%) had 
endometrial cancer diagnosed. Women after uterus preserving surgery are advised to 
continue participation in the national screening program for cervical cancer and they are also 
advised to seek medical help for any abnormal vaginal bleeding, as with any other non-
hysterectomized woman.  
In fertile women with uterine prolapse future childbearing may be an important issue. 
Pregnancies after sacrospinous hysteropexy have been described but very little data on this 
subject are available to give evidence-based recommendations. In our opinion conservative 
treatment with a pessary should be offered as first-line treatment in women with uterine 
prolapse and future child wish.  
Treatment of POP utilizes significant healthcare resources. The health care impact is likely to 
expand, based upon estimates of an increasing prevalence in the growing population of 
elderly women. At this moment the choice for surgical POP procedures mainly depends on 
the outcomes after these procedures, preferences and capabilities of the surgeon and 
patient preferences rather than on cost-effectiveness of the different POP procedures. A 
systematic review evaluating the economic costs associated with POP surgery concluded that 
in a single institution study, vaginal reconstructive surgery and pessary use were more cost-
effective than expectant management, traditional abdominal sacral colpopexy or robot-
assisted sacral colpopexy [27]. They also concluded that there is a lack of good economic 
data. Because it was not a secondary outcome of the SAVE U trial it is unclear whether uterus 
preserving surgery is cost-effective compared to hysterectomy.  However shorter operation 
time and perhaps less repeat surgery in the long term could certainly be beneficial from an 
economical point of view. 
 
F u t u r e  r e s e a r c h   
With respect to future research we would like to discuss the following topics: 
1. Strategies to prevent recurrent POP after surgical management 
2. Use of mesh materials in surgical management of uterine prolapse 
3. Minimally invasive laparoscopic uterus preserving procedures  
 
1. Strategies to prevent development of recurrent POP after surgical management 
The aetiology of POP is multifactorial. Bump and colleagues described a model that 
subdivides the risk factors of POP into predisposing, inciting, decompensating and 
promoting factors [28]. Ethnic background and genetics are considered to be predisposing 
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to hysterectomy with additional mesh use [44-46]. Randomised prospective studies are 
necessary to evaluate outcomes after and safety of vaginal mesh hysteropexy and vaginal 
hysterectomy. In April 2013, a multicentre trial started in the U.S., comparing mesh 
augmented hysteropexy versus vaginal hysterectomy and uterosacral ligament suspension 
(SUPeR)  [47]. In the Netherlands one multi-center RCT (Elevate Anterior trial) compares the 
combination of sacropinous hysteropexy and anterior vaginal wall repair to Elevate Anterior 
in primary apical and anterior vaginal wall prolapse [48]. 
 
3. Minimally invasive laparoscopic uterus preserving procedures  
Advances in minimally invasive techniques have led to the development of several 
laparoscopic approaches to treat uterine prolapse. The best-known laparoscopic procedures 
are the laparoscopic uterosacral hysteropexy and laparoscopic sacrohysteropexy. 
Laparoscopic uterosacral hysteropexy involves placing sutures through the uterosacral 
ligaments to suspend the cervix with permanent sutures. In laparoscopic sacrohysteropexy or 
robot-assisted laparoscopic sacrohysteropexy the uterus is suspended to the sacral 
promontory using a polypropylene mesh [49,50]. With regard to these procedures, no large 
randomised controlled trials are available comparing laparoscopic hysteropexy with vaginal 
hysterectomy or vaginal hysteropexy. Recently, a pilot study was published comparing 
laparoscopic hysteropexy with vaginal hysterectomy for the surgical management of uterine 
prolapse [51]. One year follow-up data were analyzed for 72 women. In this randomised 
study both procedures showed significant improvement in POP symptoms. Time before 
return to normal activity was significantly shorter, estimated blood loss was significantly less, 
pain score 24h post-operatively was significantly lower, and hospital stay was significantly 
shorter in the hysteropexy group compared with the vaginal hysterectomy group. Operation 
time was significantly longer in the hysteropexy group. After one year, more apical surgery 
was necessary in the vaginal hysterectomy group (14%) compared with the laparoscopic 
hysteropexy group (6%) and significantly more repeat vaginal repairs were required post-
hysteropexy (10%).  
In 2014 the LAVA-trial, a prospective, randomised controlled non-blinded clinical trial, was 
started in the Netherlands with the aim to determine non-inferiority of the primary endpoint 
(surgical success of the apical compartment) between laparoscopic sacrohysteropexy and 
vaginal sacrospinous hysteropexy [52].  
 
G e n e r a l  c o n c l u s i o n  
Vaginal hysterectomy is the standard treatment for uterine prolapse worldwide, but uterus 
preserving surgery is gaining popularity. This thesis provides evidence that women can avoid 
hysterectomy and opt for uterus preservation in case of surgical management for uterine 
prolapse. Long term follow-up of the SAVE U trial, more randomised trials to evaluate other 
surgical procedures and strategies to prevent POP recurrence are necessary to improve 
postoperative outcome of POP surgery. 
 
[39]. This study included 5 randomised controlled trials, which included 591 women, and 
found no significant improvement in POP symptoms, quality of life, or in the degree of POP 
between the treatment and control group. The authors of this review advise to perform 
adequately powered randomised controlled trials with a longer follow-up period to evaluate 
the long-term effect of perioperative PFMT and insufficient evidence is available at this 
moment to add perioperative PFMT to surgery.  
It is believed that increases in abdominal pressure by heavy lifting and long periods of 
standing, may cause progression of POP or higher risk of recurrence after surgery, and 
women in the SAVE U trial were advised to sustain from heavy lifting six weeks after surgery 
[40,41]. Rest and restricting activities are recommended after several different surgical 
interventions as this may promote postoperative healing and decrease surgical failure. The 
role of activity versus rest has been extensively studied after orthopedic surgery. In that field, 
evidence is available that controlled resumption of activity is favorable for restoration of 
function while prolonged rest delays recovery. In a review by Nygaard et al. it has been 
hypothesized that some pelvic loading caused by intra-abdominal pressure may promote 
tissue remodeling and muscle maintenance and thus excessive rest may be a risk for POP 
recurrence [42]. Because no randomised trials on this subject are available, the role of post-
operative activity remains to be established as well. 
  
2. Use of mesh materials in surgical management of uterine prolapse 
Surgical mesh is a medical device that is used to provide additional support repairing 
weakened or damaged tissue. Mesh can be used for POP surgery and procedures for stress 
urinary incontinence. Different types of reconstructive material (synthetic, autograft, allograft 
and xenograft) may be used and of the reconstructive materials, synthetic nonabsorbable 
polypropylene mesh has become the most used material.  
Mesh-augmented sacrospinous hysteropexy is a modification of the traditional sacrospinous 
hysteropexy (as performed in our study) that utilizes a polypropylene mesh to augment the 
repair. Several mesh kits were available to perform these procedures but since the U.S. Food 
an Drug Administration (FDA) issued a warning regarding the use of vaginal mesh for POP 
repair in 2008 and 2011, some were voluntarily removed from the market. In The 
Netherlands, the debate over safety and efficacy of vaginal mesh is ongoing. An important 
issue in this debate is the number of meshes placed per gynecologist. The high practice 
pattern variation and therefore limited experience of some gynecologists is one reason that 
recently formulated guidelines state that vaginal mesh placement is allowed only when a 
minimum of 20 procedures a year are performed.  
At this moment no data from randomised controlled trials and prospective studies 
comparing vaginal mesh hysteropexy to hysterectomy for uterine prolapse are available. The 
Prolift mesh system (Women’s Health and Urology/Ethicon, Somerville, NJ, USA) has been 
most studied but is no longer available. A medium-term retrospective assessment of clinical 
outcomes and complications after surgical POP repair in women with uterine prolapse stage 
3 or 4 concluded that after 2.5 years, pelvic reconstruction using Prolift with concomitant 
hysterectomy or uterine sparing surgery had the same anatomic and functional results [43]. 
Three other retrospective cohort studies confirmed the efficacy of vaginal mesh hysteropexy 
and this procedure was associated with shorter hospitalization and less blood loss compared 
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to hysterectomy with additional mesh use [44-46]. Randomised prospective studies are 
necessary to evaluate outcomes after and safety of vaginal mesh hysteropexy and vaginal 
hysterectomy. In April 2013, a multicentre trial started in the U.S., comparing mesh 
augmented hysteropexy versus vaginal hysterectomy and uterosacral ligament suspension 
(SUPeR)  [47]. In the Netherlands one multi-center RCT (Elevate Anterior trial) compares the 
combination of sacropinous hysteropexy and anterior vaginal wall repair to Elevate Anterior 
in primary apical and anterior vaginal wall prolapse [48]. 
 
3. Minimally invasive laparoscopic uterus preserving procedures  
Advances in minimally invasive techniques have led to the development of several 
laparoscopic approaches to treat uterine prolapse. The best-known laparoscopic procedures 
are the laparoscopic uterosacral hysteropexy and laparoscopic sacrohysteropexy. 
Laparoscopic uterosacral hysteropexy involves placing sutures through the uterosacral 
ligaments to suspend the cervix with permanent sutures. In laparoscopic sacrohysteropexy or 
robot-assisted laparoscopic sacrohysteropexy the uterus is suspended to the sacral 
promontory using a polypropylene mesh [49,50]. With regard to these procedures, no large 
randomised controlled trials are available comparing laparoscopic hysteropexy with vaginal 
hysterectomy or vaginal hysteropexy. Recently, a pilot study was published comparing 
laparoscopic hysteropexy with vaginal hysterectomy for the surgical management of uterine 
prolapse [51]. One year follow-up data were analyzed for 72 women. In this randomised 
study both procedures showed significant improvement in POP symptoms. Time before 
return to normal activity was significantly shorter, estimated blood loss was significantly less, 
pain score 24h post-operatively was significantly lower, and hospital stay was significantly 
shorter in the hysteropexy group compared with the vaginal hysterectomy group. Operation 
time was significantly longer in the hysteropexy group. After one year, more apical surgery 
was necessary in the vaginal hysterectomy group (14%) compared with the laparoscopic 
hysteropexy group (6%) and significantly more repeat vaginal repairs were required post-
hysteropexy (10%).  
In 2014 the LAVA-trial, a prospective, randomised controlled non-blinded clinical trial, was 
started in the Netherlands with the aim to determine non-inferiority of the primary endpoint 
(surgical success of the apical compartment) between laparoscopic sacrohysteropexy and 
vaginal sacrospinous hysteropexy [52].  
 
G e n e r a l  c o n c l u s i o n  
Vaginal hysterectomy is the standard treatment for uterine prolapse worldwide, but uterus 
preserving surgery is gaining popularity. This thesis provides evidence that women can avoid 
hysterectomy and opt for uterus preservation in case of surgical management for uterine 
prolapse. Long term follow-up of the SAVE U trial, more randomised trials to evaluate other 
surgical procedures and strategies to prevent POP recurrence are necessary to improve 
postoperative outcome of POP surgery. 
 
[39]. This study included 5 randomised controlled trials, which included 591 women, and 
found no significant improvement in POP symptoms, quality of life, or in the degree of POP 
between the treatment and control group. The authors of this review advise to perform 
adequately powered randomised controlled trials with a longer follow-up period to evaluate 
the long-term effect of perioperative PFMT and insufficient evidence is available at this 
moment to add perioperative PFMT to surgery.  
It is believed that increases in abdominal pressure by heavy lifting and long periods of 
standing, may cause progression of POP or higher risk of recurrence after surgery, and 
women in the SAVE U trial were advised to sustain from heavy lifting six weeks after surgery 
[40,41]. Rest and restricting activities are recommended after several different surgical 
interventions as this may promote postoperative healing and decrease surgical failure. The 
role of activity versus rest has been extensively studied after orthopedic surgery. In that field, 
evidence is available that controlled resumption of activity is favorable for restoration of 
function while prolonged rest delays recovery. In a review by Nygaard et al. it has been 
hypothesized that some pelvic loading caused by intra-abdominal pressure may promote 
tissue remodeling and muscle maintenance and thus excessive rest may be a risk for POP 
recurrence [42]. Because no randomised trials on this subject are available, the role of post-
operative activity remains to be established as well. 
  
2. Use of mesh materials in surgical management of uterine prolapse 
Surgical mesh is a medical device that is used to provide additional support repairing 
weakened or damaged tissue. Mesh can be used for POP surgery and procedures for stress 
urinary incontinence. Different types of reconstructive material (synthetic, autograft, allograft 
and xenograft) may be used and of the reconstructive materials, synthetic nonabsorbable 
polypropylene mesh has become the most used material.  
Mesh-augmented sacrospinous hysteropexy is a modification of the traditional sacrospinous 
hysteropexy (as performed in our study) that utilizes a polypropylene mesh to augment the 
repair. Several mesh kits were available to perform these procedures but since the U.S. Food 
an Drug Administration (FDA) issued a warning regarding the use of vaginal mesh for POP 
repair in 2008 and 2011, some were voluntarily removed from the market. In The 
Netherlands, the debate over safety and efficacy of vaginal mesh is ongoing. An important 
issue in this debate is the number of meshes placed per gynecologist. The high practice 
pattern variation and therefore limited experience of some gynecologists is one reason that 
recently formulated guidelines state that vaginal mesh placement is allowed only when a 
minimum of 20 procedures a year are performed.  
At this moment no data from randomised controlled trials and prospective studies 
comparing vaginal mesh hysteropexy to hysterectomy for uterine prolapse are available. The 
Prolift mesh system (Women’s Health and Urology/Ethicon, Somerville, NJ, USA) has been 
most studied but is no longer available. A medium-term retrospective assessment of clinical 
outcomes and complications after surgical POP repair in women with uterine prolapse stage 
3 or 4 concluded that after 2.5 years, pelvic reconstruction using Prolift with concomitant 
hysterectomy or uterine sparing surgery had the same anatomic and functional results [43]. 
Three other retrospective cohort studies confirmed the efficacy of vaginal mesh hysteropexy 
and this procedure was associated with shorter hospitalization and less blood loss compared 
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S u mm a r y  
This thesis focussed on the surgical management of uterine prolapse in women. Emphasis is 
placed on the comparison of uterus preservation versus hysterectomy. It comprises the 
results of the SAVE U study (sacrospinous hysteropexy versus vaginal hysterectomy trial).  
 
C h a p t e r  1  provides a general introduction on pelvic organ prolapse (POP) and the surgical 
management of uterine prolapse. POP is a common disorder affecting up to 50% of women 
with a lifetime risk for prolapse surgery 11-20%. Traditionally, vaginal hysterectomy was the 
standard treatment for uterine prolapse but uterus preservation is becoming more popular. 
In this thesis we questioned how uterine prolapse is surgically managed in The Netherlands 
and what the preference is of Dutch women, uterus preservation or hysterectomy. Main 
objective was to answer the question whether sacrospinous hysteropexy is an alternative to 
hysterectomy.  
 
C h a p t e r  2  describes the results from a systematic literature review regarding outcomes after 
uterus preserving procedures and vaginal hysterectomy in treatment of uterine prolapse. We 
searched Pubmed, Embase, the Cochrane Library and the reference lists of relevant 
publications to select articles, which compared uterus preserving procedures with a vaginal 
hysterectomy. For this review we focused on three categories of interventions, which includes 
the most common uterus preserving procedures: 1. vaginal surgery without the use of mesh 
(sacrospinous hysteropexy and Manchester-Fothergill procedure), 2. abdominal surgery with 
use of mesh (abdominal hysteropexy) and 3. vaginal surgery with the use of mesh 
(intravaginal slingplasty). There was no difference in subjective outcome after sacrospinous 
hysteropexy, Manchester-Fothergill procedure, abdominal hysteropexy and intravaginal 
slingplasty compared to vaginal hysterectomy. All procedures, except for sacrospinous 
hysteropexy, had similar anatomical outcomes compared with vaginal hysterectomy. Hospital 
stay was shorter after uterus preserving procedures except for Manchester-Fothergill 
procedure. However, the quality of the different studies was poor. Small numbers of patients 
were included, long term follow-up was lacking and there was evidence of selection bias due 
to the retrospective design of some studies. Main conclusion of this review was that based on 
the literature there was no clear preference for either uterus preserving surgery or 
hysterectomy in surgical treatment of uterine descent. We advised to start clinical 
randomized trials with long-term follow-up to investigate the value of uterus preserving 
procedures.  
 
In C h a p t e r  3  trends in surgical management of POP in the Netherlands and practice among 
Dutch gynaecologists are described. A questionnaire, including case scenarios, was sent to 
the members of the Dutch Urogynecological Society. Using a nationwide registry from the 
Netherlands, we assessed the number and type of surgical procedures performed for pelvic 
organ prolapse between 1997 and 2009. Vaginal hysterectomy, sacrospinous hysteropexy, 
and the Manchester-Fothergill procedure were the most frequently performed surgical 
interventions for uterine descent. In the case of lower stage uterine descent, uterus 
preservation was preferred, but in the case of higher stage there was wide variation.  
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Netherlands, we assessed the number and type of surgical procedures performed for pelvic 
organ prolapse between 1997 and 2009. Vaginal hysterectomy, sacrospinous hysteropexy, 
and the Manchester-Fothergill procedure were the most frequently performed surgical 
interventions for uterine descent. In the case of lower stage uterine descent, uterus 
preservation was preferred, but in the case of higher stage there was wide variation.  
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C h a p t e r  7  presents the results of the SAVE U trial. 208 healthy women with uterine prolapse 
stage two or higher requiring surgery, were randomised between sacrospinous hysteropexy 
(n=103) and vaginal hysterectomy with suspension of the uterosacral ligaments (n=105) in 
one of the four participating hospitals. By intention to treat, sacrospinous hysteropexy was 
non-inferior to vaginal hysterectomy with uterosacral ligament suspension regarding surgical 
failure of the apical compartment after 12 months. The failure rate was 0/102 (0%) in the 
sacrospinous hysteropexy group and 4/100 (4.0%) in the vaginal hysterectomy group 
(difference -3.9%; 95% CI for difference -8.6 to 0.7). A per protocol analysis also resulted in 
non-inferiority of the sacrospinous hysteropexy. There were no differences in overall 
anatomical recurrences, functional outcome, quality of life, complications, hospital stay, 
measures on post-operative recovery and sexual functioning between the two interventions. 
Five serious adverse events were reported during hospital stay. One death occurred in the 
vaginal hysterectomy group related to postoperative ileus and aspiration pneumonia. None 
of the events was assumed to be related to the type of surgery. Based on the analysis after 12 
months follow-up, we concluded that sacrospinous hysteropexy was non-inferior to vaginal 
hysterectomy with suspension of the uterosacral ligaments regarding recurrent prolapse of 
the apical compartment with bothersome bulge symptoms or repeat surgery for recurrent 
apical prolapse.  
 
In C h a p t e r  8  sexual functioning after sacrospinous hysteropexy was compared with vaginal 
hysterectomy with suspension of the uterosacral ligaments after two years follow-up. This 
study was a secondary analysis of the SAVE U trial data. Data from patients who had 
completed the POP/urinary incontinence sexual questionnaire (PISQ-12) at baseline and 24 
months after surgery (n=99) were used in the present trial. Total, subscale and individual 
question analyses were performed. During a follow-up period of 24 months, no significant 
differences in total PISQ-12 scores were observed between the groups. PISQ-12 scores 
improved significantly after 24 months in both groups. After both interventions the item 
‘avoidance of intercourse due to prolapse’ significantly improved as well as the physical 
subscale of the PISQ-12 questionnaire.  
 
C h a p t e r  9  discusses the main results of this thesis, its clinical implications and topics for future 
research. 
 
Two thirds of the respondents stated that in recent years they tended to save the uterus more 
often. The registered number of hospital admissions for uterine descent increased by 30% 
between 1997 and 2009 and the number of surgical procedures almost doubled. The 
number of vaginal hysterectomies performed because of uterine descent increased by only 
15% in this period, which reflects a trend toward uterine preserving surgery. 
 
The availability of many treatment modalities for POP can lead to variation in care between 
physicians and hospitals, the so-called practice pattern variation (PPV). In C h a p t e r  4  we 
studied practice pattern variation in Dutch hospitals in treatment of POP and UI. A high PPV 
per hospital and per region was found. In some hospitals, a hysterectomy was performed in 
all cases of POP, while in other hospitals, uterus preserving techniques were mostly 
performed. A high PPV of transvaginal mesh placement was also observed. These high levels 
of PPV are probably caused by the absence of clear defined guidelines.  
 
In literature it has been frequently stated that uterus preservation is becoming more popular 
because women want to retain their uterus more often. However evidence to support this 
statement is limited. In C h a p t e r  5  Dutch women’s attitudes and preferences for surgical 
treatment of uterine prolapse are described. In case outcomes after hysterectomy and uterus 
preserving surgery were expected to be equal, more women expressed preference for 
uterus preservation (43%, 44 out of 102 women) compared to hysterectomy (27%, 27 out of 
102 women). The majority of patients expected a similar improvement in sexuality and body 
image after the two treatment modalities. Treatment success, risk for urinary incontinence 
after surgery and complication risk were the most important factors. Taken the future risk of 
endometrial cancer into account 18% preferred hysterectomy because of this risk when 
surgery was necessary.  
 
C h a p t e r  6  describes a study protocol for a randomised clinical trial to investigate outcomes 
after sacrospinous hysteropexy and vaginal hysterectomy in women with uterine prolapse 
stage two or higher (SAVE U trial). The study was designed to test the hypothesis that 
sacrospinous hysteropexy was non-inferior to vaginal hysterectomy with suspension of the 
uterosacral ligaments regarding surgical failure after 12 months follow-up. Primary outcome 
was recurrent prolapse stage two or higher of the uterus or vaginal vault (apical 
compartment) evaluated by POP-Q examination in combination with bothersome bulge 
symptoms or repeat surgery for recurrent apical prolapse at 12 months follow-up. Secondary 
outcomes were overall anatomical recurrences, functional outcome, complications, hospital 
stay, post-operative recovery, and sexual functioning. All women with uterine prolapse POP-
Q stage two or higher without previous POP surgery were recruited for participation and 
concomitant repair of anterior and/or posterior vaginal prolapse was allowed including anti-
incontinence surgery. Procedures were performed or supervised by experienced 
gynaecologists familiar with both interventions and residents were allowed to perform 
sacrospinous hysteropexy or vaginal hysterectomy under direct supervision. Women with 
abnormal uterine bleeding or abnormal ultrasound findings of uterus or ovaries were 
excluded, as hysterectomy is being preferred in these patients. Also women with a wish to 
preserve fertility were excluded. 
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C h a p t e r  7  presents the results of the SAVE U trial. 208 healthy women with uterine prolapse 
stage two or higher requiring surgery, were randomised between sacrospinous hysteropexy 
(n=103) and vaginal hysterectomy with suspension of the uterosacral ligaments (n=105) in 
one of the four participating hospitals. By intention to treat, sacrospinous hysteropexy was 
non-inferior to vaginal hysterectomy with uterosacral ligament suspension regarding surgical 
failure of the apical compartment after 12 months. The failure rate was 0/102 (0%) in the 
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(difference -3.9%; 95% CI for difference -8.6 to 0.7). A per protocol analysis also resulted in 
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hysterectomy with suspension of the uterosacral ligaments regarding recurrent prolapse of 
the apical compartment with bothersome bulge symptoms or repeat surgery for recurrent 
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In C h a p t e r  8  sexual functioning after sacrospinous hysteropexy was compared with vaginal 
hysterectomy with suspension of the uterosacral ligaments after two years follow-up. This 
study was a secondary analysis of the SAVE U trial data. Data from patients who had 
completed the POP/urinary incontinence sexual questionnaire (PISQ-12) at baseline and 24 
months after surgery (n=99) were used in the present trial. Total, subscale and individual 
question analyses were performed. During a follow-up period of 24 months, no significant 
differences in total PISQ-12 scores were observed between the groups. PISQ-12 scores 
improved significantly after 24 months in both groups. After both interventions the item 
‘avoidance of intercourse due to prolapse’ significantly improved as well as the physical 
subscale of the PISQ-12 questionnaire.  
 
C h a p t e r  9  discusses the main results of this thesis, its clinical implications and topics for future 
research. 
 
Two thirds of the respondents stated that in recent years they tended to save the uterus more 
often. The registered number of hospital admissions for uterine descent increased by 30% 
between 1997 and 2009 and the number of surgical procedures almost doubled. The 
number of vaginal hysterectomies performed because of uterine descent increased by only 
15% in this period, which reflects a trend toward uterine preserving surgery. 
 
The availability of many treatment modalities for POP can lead to variation in care between 
physicians and hospitals, the so-called practice pattern variation (PPV). In C h a p t e r  4  we 
studied practice pattern variation in Dutch hospitals in treatment of POP and UI. A high PPV 
per hospital and per region was found. In some hospitals, a hysterectomy was performed in 
all cases of POP, while in other hospitals, uterus preserving techniques were mostly 
performed. A high PPV of transvaginal mesh placement was also observed. These high levels 
of PPV are probably caused by the absence of clear defined guidelines.  
 
In literature it has been frequently stated that uterus preservation is becoming more popular 
because women want to retain their uterus more often. However evidence to support this 
statement is limited. In C h a p t e r  5  Dutch women’s attitudes and preferences for surgical 
treatment of uterine prolapse are described. In case outcomes after hysterectomy and uterus 
preserving surgery were expected to be equal, more women expressed preference for 
uterus preservation (43%, 44 out of 102 women) compared to hysterectomy (27%, 27 out of 
102 women). The majority of patients expected a similar improvement in sexuality and body 
image after the two treatment modalities. Treatment success, risk for urinary incontinence 
after surgery and complication risk were the most important factors. Taken the future risk of 
endometrial cancer into account 18% preferred hysterectomy because of this risk when 
surgery was necessary.  
 
C h a p t e r  6  describes a study protocol for a randomised clinical trial to investigate outcomes 
after sacrospinous hysteropexy and vaginal hysterectomy in women with uterine prolapse 
stage two or higher (SAVE U trial). The study was designed to test the hypothesis that 
sacrospinous hysteropexy was non-inferior to vaginal hysterectomy with suspension of the 
uterosacral ligaments regarding surgical failure after 12 months follow-up. Primary outcome 
was recurrent prolapse stage two or higher of the uterus or vaginal vault (apical 
compartment) evaluated by POP-Q examination in combination with bothersome bulge 
symptoms or repeat surgery for recurrent apical prolapse at 12 months follow-up. Secondary 
outcomes were overall anatomical recurrences, functional outcome, complications, hospital 
stay, post-operative recovery, and sexual functioning. All women with uterine prolapse POP-
Q stage two or higher without previous POP surgery were recruited for participation and 
concomitant repair of anterior and/or posterior vaginal prolapse was allowed including anti-
incontinence surgery. Procedures were performed or supervised by experienced 
gynaecologists familiar with both interventions and residents were allowed to perform 
sacrospinous hysteropexy or vaginal hysterectomy under direct supervision. Women with 
abnormal uterine bleeding or abnormal ultrasound findings of uterus or ovaries were 
excluded, as hysterectomy is being preferred in these patients. Also women with a wish to 
preserve fertility were excluded. 
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S a m e n v a t t i n g  
Dit proefschrift richt zich op de operatieve behandeling van uterusprolaps 
(baarmoederverzakking) bij vrouwen. De nadruk ligt op de vergelijking tussen uterussparend 
opereren of het verwijderen van de uterus (hysterectomie).  Het beschrijft de resultaten van 
de SAVE U studie (SAcrospinous hysteropexy VErsus vaginal hysterectomy in treatment of 
Uterine prolapse trial).  
 
In h o o f d s t u k  1  wordt de achtergrond van uterusprolaps beschreven en komen operatieve 
behandelingen aan bod. Een prolaps is een veelvoorkomende aandoening die ongeveer 
50% van alle vrouwen treft en het levenslange risico om geopereerd te worden vanwege 
prolaps is 11-20%. Van oudsher was het verwijderen van de uterus de standaardbehandeling 
als deze verzakt was maar uterussparende chirurgie wordt steeds populairder. In dit 
proefschrift onderzochten we hoe een uterusprolaps wordt behandeld in Nederland, of 
vrouwen voorkeur hebben voor sparen of verwijderen van de uterus  en of een sacrospinale 
hysteropexie, waarbij de uterus behouden blijft , een geschikt alternatief is voor een vaginale 
hysterectomie.  
 
H o o f d s t u k  2  beschrijft de resultaten van systematisch literatuuronderzoek naar de uitkomsten 
van uterussparend opereren en vaginale hysterectomie in de behandeling van een 
uterusprolaps. We zochten in Pubmed, Embase en de Cochrane database en in de 
literatuurlijsten van gevonden publicaties naar relevante artikelen waarin uterussparende 
ingrepen werden vergeleken met een vaginale hysterectomie. We hebben ons daarbij 
gericht op drie groepen interventies die de meest toegepaste uterussparende procedures 
omvatten: 1. Vaginale chirurgie zonder toepassing van implantaten (sacrospinale 
hysteropexie en Manchester-Fothergill procedure), 2. abdominale chirurgie met toepassing 
van implantaat (abdominale hysteropexie) en 3. vaginale chirurgie met toepassing van 
implantaat (intravaginale slingplastiek). Er was geen verschil in subjectieve uitkomst na 
sacrospinale hysteropexie, Manchester-Fothergill procedure, abdominale hysteropexie en 
intravaginale-slingplastiek in vergelijking met een vaginale hysterectomie. Afgezien van een 
sacrospinale hysteropexie, hadden alle uterussparende ingrepen een gelijkwaardig 
anatomisch resultaat vergeleken met een vaginale hysterectomie. De opnameduur was 
korter bij de uterussparende ingrepen, behoudens de Manchester-Fothergill procedure. De 
methodologische kwaliteit van de meeste studies was laag. Vaak werden kleine groepen 
patiënten geïncludeerd, was er sprake van een korte follow-up en door het retrospectieve 
design van sommige studies was er mogelijk sprake van selectiebias. Belangrijkste conclusie 
van ons literatuuronderzoek was dat op basis van de literatuur geen duidelijke voorkeur kon 
worden uitgesproken voor het verwijderen dan wel sparen van de uterus als chirurgische 
behandeling van uterusprolaps. Prospectieve gerandomiseerde studies met langdurige 
follow-up werden nodig geacht om de waarde van uterussparende ingrepen vast te stellen.  
 
In h o o f d s t u k  3  beschrijven we trends in de operatieve behandeling van prolaps in Nederland 
en de werkwijze onder Nederlandse gynaecologen. Een vragenlijst met daarin verschillende 
scenario’s werd gestuurd naar leden van de Werkgroep Bekkenbodem van de Nederlandse 
Vereniging voor Obstetrie en Gynaecologie. Op basis van gegevens van een landelijke 
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seksueel functioneren. Alle vrouwen met een uterusprolaps POP-Q stadium twee of hoger 
zonder voorgaande prolapsoperatie werden gevraagd om deel te nemen. Het was 
toegestaan om gelijktijdig een chirurgische behandeling voor een blaas- en/of 
darmverzakking te verrichten en ook anti-incontinentie chirurgie was toegestaan. De 
behandeling werd uitgevoerd of gesuperviseerd door een ervaren gynaecoloog die bekend 
was met beide interventies en artsen in opleiding tot gynaecoloog (AIOS) mochten de 
ingreep uitvoeren onder directe supervisie van een gynaecoloog. Vrouwen met abnormaal 
bloedverlies of afwijkende echo bevindingen van de uterus of ovaria werden geëxcludeerd 
omdat een hysterectomie de voorkeur geniet bij deze vrouwen. Ook vrouwen met nog 
toekomstige kinderwens konden niet meedoen.  
 
In h o o f d s t u k  7  presenteren we de primaire en secundaire uitkomsten van de SAVE U studie. 
208 gezonde vrouwen met een uterusprolaps stadium twee of hoger werden 
gerandomiseerd tussen een sacrospinale hysteropexie (n=103) en een vaginale 
hysterectomie met suspensie van de sacro-uteriene ligamenten (n=105) in een van de vier 
participerende centra. De ‘intention-to-treat’-analyse liet zien dat een sacrospinale 
hysteropexie non–inferieur was aan een vaginale hysterectomie met sacro-uteriene ligament 
suspensie wat betreft chirurgisch falen van het middelste compartiment na 12 maanden 
follow-up. Het aantal vrouwen met een recidief verzakking stadium twee of hoger met 
hinderlijke klachten of een heroperatie vanwege recidief prolaps van het apicale 
compartiment was 0% (0/102) in de sacrospinale hysteropexie groep en 4,0% (4/100) in de 
vaginale hysterectomie groep (verschil -3,9%, 95% BI -8.6 to 0.7). Per protocol analyse liet 
ook zien dat een sacrospinale hysteropexie non-inferieur was. Er was geen verschil in het 
totaal aantal recidieven, subjectieve verbetering, kwaliteit van leven, complicaties, 
opnameduur, postoperatief herstel en seksueel functioneren tussen beide interventies. Vijf 
‘serious adverse events’ werden gerapporteerd tijdens ziekenhuisopname. Een patiënt in de 
vaginale hysterectomie groep overleed ten gevolge van een postoperatieve ileus en 
aspiratiepneumonie. De serious adverse events werden verondersteld niet gerelateerd te zijn 
aan het type chirurgie. Op basis van de analyse na 12 maanden concluderen wij dat een 
sacrospinale hysteropexie non-inferieur is aan een vaginale hysterectomie met sacro-uteriene 
ligament suspensie wat betreft recidief prolaps van het apicale compartiment met hinderlijke 
klachten of heroperatie vanwege prolaps van het middelste compartiment.  
 
In h o o f d s t u k  8  wordt seksueel functioneren na sacrospinale hysteropexie en vaginale 
hysterectomie met sacro-uteriene ligament suspensie vergeleken na twee jaar follow-up. 
Deze studie is een secundaire analyse van de SAVE U studie data. Vrouwen die de vragenlijst 
seksueel functioneren bij verzakking en ongewenst urineverlies (PISQ-12) zowel pre-operatief 
als na 24 maanden hadden ingevuld (n=99) werden geïncludeerd. We vonden, gebaseerd 
op PISQ-12 totaal scores, geen statistisch significante verschillen in seksueel functioneren 
tussen de groepen na een follow-up van 24 maanden. PISQ-12 scores verbeterden 
significant in beide groepen. Na beide interventies verbeterde het item’ vermijden van 
gemeenschap door prolaps’ significant net als de subschaal ‘fysiek’ van de PISQ-12 
vragenlijst.  
 
H o o f d s t u k  9  bespreekt de resultaten van dit proefschrift.  
 
registratie, hebben we het aantal en de verschillende type operaties verricht vanwege 
prolaps in 1997 en 2009 onderzocht. Een vaginale hysterectomie, sacrospinale hysteropexie 
en Manchester-Fothergill procedure waren de meest toegepaste chirurgische 
behandelingen voor een uterusprolaps. Bij een laag stadium uterusprolaps genoot een 
uterussparende operatie de voorkeur maar in geval van een hoog stadium verzakking was er 
veel variatie. Tweederde van de respondenten gaf aan dat ze de laatste jaren meer 
uterussparend waren gaan opereren. Het aantal geregistreerde ziekenhuisopnames 
vanwege een uterusprolaps steeg met 30% tussen 1997 en 2009 en het aantal chirurgische 
behandelingen verdubbelde bijna. Het aantal vaginale hysterectomie verricht vanwege een 
uterusprolaps nam slechts toe met 15% in deze periode, wat dus een trend naar meer 
uterussparende ingrepen laat zien.  
 
De beschikbaarheid van verschillende chirurgische behandelingen voor prolaps kan leiden 
tot variatie in behandeling tussen artsen en tussen ziekenhuizen, ook wel praktijkvariatie 
genoemd. In h o o f d s t u k  4  bestudeerden we praktijkvariatie in Nederlandse ziekenhuizen in 
de behandeling van prolaps en stress-incontinentie. We vonden een hoge praktijkvariatie 
per ziekenhuis en per regio. In sommige ziekenhuizen werd altijd een hysterectomie verricht 
in geval van een chirurgische behandeling terwijl in andere ziekenhuizen bijna altijd een 
uterussparende operatie werd verricht. Een hoge praktijkvariatie werd gezien in de 
toepassing van kunststofmaterialen. De geconstateerde praktijkvariatie zou kunnen komen 
door afwezigheid van een duidelijke richtlijn over de chirurgische behandeling van prolaps.    
 
In de literatuur wordt vaak beweerd dat het sparen van de uterus populairder wordt en dat 
vrouwen steeds vaker hun uterus willen behouden als een chirurgische behandeling nodig is. 
Echter het bewijs voor deze laatste bewering is beperkt. In h o o f d s t u k  5  beschrijven we de 
voorkeur en houding van Nederlandse vrouwen ten aanzien van uterussparend opereren en 
hysterectomie. Wanneer de uitkomst na een hysterectomie en uterussparende operatie gelijk 
zou zijn, hadden meer vrouwen een voorkeur voor het sparen van de uterus (43%, 44 van 102 
vrouwen) vergeleken met een hysterectomie (27%, 27 van 102 vrouwen). De meerderheid 
van de vrouwen verwachtte een gelijke verbetering in seksualiteit en lichaamsbeeld na beide 
behandelmethoden. Behandelsucces, risico op urine incontinentie en het risico op 
complicaties werden het belangrijkst bevonden. Het toekomstige risico op een maligniteit 
van de uterus was voor 18% van de vrouwen reden om te kiezen voor hysterectomie als een 
chirurgische behandeling nodig zou zijn.  
 
In h o o f d s t u k  6  beschrijven we het ontwerp van de SAVE U studie. Vrouwen met een 
uterusprolaps stadium twee of hoger werden gerandomiseerd om ofwel een uterussparende 
sacrospinale hysteropexie ofwel een vaginale hysterectomie met suspensie van de sacro-
uteriene ligamenten te ondergaan. Onze hypothese was dat een sacrospinale hysteropexie 
non-inferieur was aan een vaginale hysterectomie met sacro-uteriene ligament suspensie na 
12 maanden follow-up. De primaire uitkomst was recidief prolaps stadium twee of hoger van 
de uterus of vaginatop (apicale compartiment), vastgesteld middels POP-Q onderzoek, met 
daarbij hinderlijke prolapsklachten of een heroperatie vanwege recidief prolaps van het 
apicale compartiment. Als secundaire uitkomst werd gekozen voor recidief prolaps in alle 
compartiment, subjectieve verbetering, complicaties, opnameduur, postoperatief herstel en 
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seksueel functioneren. Alle vrouwen met een uterusprolaps POP-Q stadium twee of hoger 
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registratie, hebben we het aantal en de verschillende type operaties verricht vanwege 
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non-inferieur was aan een vaginale hysterectomie met sacro-uteriene ligament suspensie na 
12 maanden follow-up. De primaire uitkomst was recidief prolaps stadium twee of hoger van 
de uterus of vaginatop (apicale compartiment), vastgesteld middels POP-Q onderzoek, met 
daarbij hinderlijke prolapsklachten of een heroperatie vanwege recidief prolaps van het 
apicale compartiment. Als secundaire uitkomst werd gekozen voor recidief prolaps in alle 
compartiment, subjectieve verbetering, complicaties, opnameduur, postoperatief herstel en 
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L I S T  O F  A B B R E V I A T I O N S  
 
 
BMI  Body Mass Index 
CI  Confidence Interval 
CVV  Classificatie van verrichtingen (Dutch classification of procedures) 
DDI  Defecatory Distress Inventory 
EQ5D  Euroqol-5D 
ES  Effect size 
FDA  Food and Drug Administration 
ICD  International Classification of Diseases 
ICS  International Continence Society 
IFHRO  International Federation of Health Record Organizations 
IIQ   Incontinence Impact Questionnaire 
ITT  Intention to treat 
IVS  Intravaginal slingplasty 
IUGA  International Urogynaecological Association 
LMR  Dutch National Medical Register 
LOCF  Last observation carried forward 
LSULS  Laparoscopic uterosacral ligament suspension 
NIH  National Institute of Health 
NVMA  Dutch Society of Medical Administrators 
OR  Odds ratio 
PGI-I  Patients’ Global Impression of Improvement 
PISQ  Pelvic Organ Prolapse/ Urinary incontinence Sexual questionnaire 
PMFT   Pelvic floor muscle therapy 
POP  Pelvic Organ Prolapse  
POPQ  Pelvic Organ Prolapse Quantification 
PPV   Practice pattern variation 
RCT  Randomised Controlled Trial 
RI-10  Recovery index-10 
SF-36  Short Form-36 
SSF  Sacrospinous ligament fixation  
SD  Standard deviation 
SH  Sacrospinous hysteropexy 
SUI  Stress urinary incontinence 
UDI  Urogenital Distress Inventory 
UI  Urinary incontinence 
VAS  Visual Analogue Scale 
VH  Vaginal hysterectomy 
 
 
501420-L-bw-Detollenaere
 
L I S T  O F  A B B R E V I A T I O N S  
 
 
BMI  Body Mass Index 
CI  Confidence Interval 
CVV  Classificatie van verrichtingen (Dutch classification of procedures) 
DDI  Defecatory Distress Inventory 
EQ5D  Euroqol-5D 
ES  Effect size 
FDA  Food and Drug Administration 
ICD  International Classification of Diseases 
ICS  International Continence Society 
IFHRO  International Federation of Health Record Organizations 
IIQ   Incontinence Impact Questionnaire 
ITT  Intention to treat 
IVS  Intravaginal slingplasty 
IUGA  International Urogynaecological Association 
LMR  Dutch National Medical Register 
LOCF  Last observation carried forward 
LSULS  Laparoscopic uterosacral ligament suspension 
NIH  National Institute of Health 
NVMA  Dutch Society of Medical Administrators 
OR  Odds ratio 
PGI-I  Patients’ Global Impression of Improvement 
PISQ  Pelvic Organ Prolapse/ Urinary incontinence Sexual questionnaire 
PMFT   Pelvic floor muscle therapy 
POP  Pelvic Organ Prolapse  
POPQ  Pelvic Organ Prolapse Quantification 
PPV   Practice pattern variation 
RCT  Randomised Controlled Trial 
RI-10  Recovery index-10 
SF-36  Short Form-36 
SSF  Sacrospinous ligament fixation  
SD  Standard deviation 
SH  Sacrospinous hysteropexy 
SUI  Stress urinary incontinence 
UDI  Urogenital Distress Inventory 
UI  Urinary incontinence 
VAS  Visual Analogue Scale 
VH  Vaginal hysterectomy 
 
 
153
LIST OF ABBREVIATIONS
501420-L-bw-Detollenaere
 
V r a g e n l i j s t  w e r k g r o e p  b e k k e n b o d em  N V O G  
 
Voor u ligt de vragenlijst die u hebt ontvangen van uw behandelende gynaecoloog. De 
vragenlijst is bedoeld om meer inzicht te krijgen in uw problematiek en om het effect van de 
voorgestelde behandeling te kunnen meten. In Nederland wordt het gebruik van deze 
vragenlijst aanbevolen door de Werkgroep Bekkenbodem van de Nederlandse Vereniging 
voor Obstetrie en Gynaecologie. De vragenlijst bestaat uit een aantal onderdelen. Deze 
onderdelen bevatten soms vragen waarvan u misschien denkt dat ze niet van belang zijn. Wij 
verzoeken u echter wel om alle vragen in te vullen tenzij anders vermeld. Het invullen duurt 
ongeveer 10 minuten  
 
1. Wat is uw leeftijd? .................................. jaar  
 
2. Welke opleiding(en) heeft u voltooid? (meer dan één antwoord mogelijk)  
1. basisonderwijs / lagere school (of een deel daarvan) 
2. lager beroepsonderwijs (lts, lhno, leao, huishoudschool etc.) 
3. mavo, (m)ulo etc.  
4. middelbaar beroepsonderwijs (mts, meao, opleiding tot verpleegkundige etc.)  
5. vwo, havo, gymnasium, mms etc. 
6. hoger beroepsonderwijs (hts, heao, sociale academie etc.) 
7. wetenschappelijk onderwijs (doctoraal examen)  
 
3. Wat is uw huidige beroep of zijn uw werkzaamheden?  
 
4. a. Hebt u kinderen?  1. Ja   0. Nee  (ga door met vraag 5)  
b. Hoeveel kinderen heeft u?     (aantal) 
c. Hebt u een keizersnede gehad?    1. Ja (......keer)  0. Nee 
d. Hebt u een tang verlossing gehad?    1. Ja (......keer)  0. Nee 
e. Hebt u een vacuüm cup verlossing gehad?   1. Ja (......keer)  0. Nee 
f. Bent u tijdens de bevalling “ingeknipt”   1. Ja (......keer)  0. Nee 
g. Bent u tijdens de bevalling “ingescheurd”   1. Ja (......keer)  0. Nee  
h. Wanneer was uw laatste bevalling?    ....................... (dag/maand/jaar)  
e. Hoe oud was u tijdens de eerste bevalling   ........................(leeftijd in jaren)  
 
Bij de volgende vraag loopt de antwoordcategorie op van 1 (erg slecht) tot 6 (uitstekend). Wilt 
u het getal omcirkelen dat het meest op u van toepassing is?  
 
5. Hoe zou u uw algehele kwaliteit van leven gedurende de afgelopen week beoordelen?  
 
      1     2       3       4       5        6  
Erg slecht     uitstekend  
 
 
 
 
501420-L-bw-Detollenaere
 
V r a g e n l i j s t  w e r k g r o e p  b e k k e n b o d em  N V O G  
 
Voor u ligt de vragenlijst die u hebt ontvangen van uw behandelende gynaecoloog. De 
vragenlijst is bedoeld om meer inzicht te krijgen in uw problematiek en om het effect van de 
voorgestelde behandeling te kunnen meten. In Nederland wordt het gebruik van deze 
vragenlijst aanbevolen door de Werkgroep Bekkenbodem van de Nederlandse Vereniging 
voor Obstetrie en Gynaecologie. De vragenlijst bestaat uit een aantal onderdelen. Deze 
onderdelen bevatten soms vragen waarvan u misschien denkt dat ze niet van belang zijn. Wij 
verzoeken u echter wel om alle vragen in te vullen tenzij anders vermeld. Het invullen duurt 
ongeveer 10 minuten  
 
1. Wat is uw leeftijd? .................................. jaar  
 
2. Welke opleiding(en) heeft u voltooid? (meer dan één antwoord mogelijk)  
1. basisonderwijs / lagere school (of een deel daarvan) 
2. lager beroepsonderwijs (lts, lhno, leao, huishoudschool etc.) 
3. mavo, (m)ulo etc.  
4. middelbaar beroepsonderwijs (mts, meao, opleiding tot verpleegkundige etc.)  
5. vwo, havo, gymnasium, mms etc. 
6. hoger beroepsonderwijs (hts, heao, sociale academie etc.) 
7. wetenschappelijk onderwijs (doctoraal examen)  
 
3. Wat is uw huidige beroep of zijn uw werkzaamheden?  
 
4. a. Hebt u kinderen?  1. Ja   0. Nee  (ga door met vraag 5)  
b. Hoeveel kinderen heeft u?     (aantal) 
c. Hebt u een keizersnede gehad?    1. Ja (......keer)  0. Nee 
d. Hebt u een tang verlossing gehad?    1. Ja (......keer)  0. Nee 
e. Hebt u een vacuüm cup verlossing gehad?   1. Ja (......keer)  0. Nee 
f. Bent u tijdens de bevalling “ingeknipt”   1. Ja (......keer)  0. Nee 
g. Bent u tijdens de bevalling “ingescheurd”   1. Ja (......keer)  0. Nee  
h. Wanneer was uw laatste bevalling?    ....................... (dag/maand/jaar)  
e. Hoe oud was u tijdens de eerste bevalling   ........................(leeftijd in jaren)  
 
Bij de volgende vraag loopt de antwoordcategorie op van 1 (erg slecht) tot 6 (uitstekend). Wilt 
u het getal omcirkelen dat het meest op u van toepassing is?  
 
5. Hoe zou u uw algehele kwaliteit van leven gedurende de afgelopen week beoordelen?  
 
      1     2       3       4       5        6  
Erg slecht     uitstekend  
 
 
 
 
155
QUESTIONNAIRES
501420-L-bw-Detollenaere
 
U D I - 1 2  ( U R O G E N I T A L  D I S T R E S S  I N V E N T O R Y )  
 
Vrouwen met ongewenst urineverlies en / of een verzakking hebben aangegeven dat ze de 
volgende klachten hadden. Kunt u aangeven welke klachten u op dit moment ook heeft en 
hoeveel last u daar van heeft. Beantwoord svp alle vragen, ook als u geen klachten heeft.  
 
7. a. Vindt u dat u vaak moet plassen? 
1. Ja   2. Nee (ga naar 7c.)  
 
     b. Zo ja, hoeveel last heeft u hier van? 
1. Helemaal niet  2. Een beetje 3. Nogal   4. Heel erg 
       
c. Hoe veel keer plast u gemiddeld per dag?: ..........keer  
 
8.  a. Als u moet plassen voelt u dan altijd een sterke aandrang?  
1. Ja   2. Nee (ga naar 9.)  
      
b. Zo ja, hoeveel last heeft u hier van? 
1. Helemaal niet  2. Een beetje  3. Nogal   4. Heel erg  
 
9.  a. Hebt u ongewenst urineverlies als u aandrang voelt om te plassen?  
1. Ja   2. Nee (ga naar 10.)  
      
b. Zo ja, hoeveel last heeft u hier van?  
1. Helemaal niet 2. Een beetje  3. Nogal   4. Heel erg  
 
     c. Zo ja, hoe vaak verliest u ongewild urine?  
1. dagelijks 
2. paar keer per week 
3. 1 keer per week  
4. 1 keer per maand  
5. 1 keer per jaar  
 
10.  a. Hebt u ongewenst urineverlies bij lichamelijke inspanning, hoesten of niezen?  
1. Ja   2. Nee (ga naar 11.)  
        
b. Zo ja, hoeveel last heeft u hier van? 
1. Helemaal niet  2. Een beetje  3. Nogal  4. Heel erg  
         
c. Zo ja, hoe vaak verliest u ongewild urine?  
1. dagelijks 
2. paar keer per week 
3. 1 keer per week  
4. 1 keer per maand  
5. 1 keer per jaar  
 
 
 
 
E Q - 5 D  ( E U R O  Q O L - 5 D )  
 
De volgende 5 vragen hebben betrekking op uw huidige gezondheidstoestand. Omcirkel bij 
elke vraag de zin die het best past bij uw eigen gezondheidstoestand vandaag.  
 
6a.  Mobiliteit  
1. Ik heb geen problemen met lopen  
2. Ik heb enige problemen met lopen  
3. Ik ben bedlegerig  
 
6b.  Zelfzorg  
1. Ik heb geen problemen om mijzelf te wassen of aan te kleden  
2. Ik heb enige problemen om mijzelf te wassen of aan te kleden  
3. Ik ben niet in staat mijzelf te wassen of aan te kleden  
 
6c.  Dagelijkse activiteiten( bv werk, studie, huishouden, gezin- en vrijetijdsactiviteiten)  
1. Ik heb geen problemen met mijn dagelijkse activiteiten  
2. Ik heb enige problemen met mijn dagelijkse activiteiten  
3. Ik ben niet in staat mijn dagelijkse activiteiten uit te voeren  
 
6d.  Pijn/klachten  
1. Ik heb geen pijn of andere klachten  
2. Ik heb matige pijn of andere klachten  
3. Ik heb zeer ernstige pijn of andere klachten  
 
6e. Stemming  
1. Ik ben niet angstig of somber  
2. Ik ben matig angstig of somber  
3. Ik ben erg angstig of somber  
 
6f. Om mensen te helpen bij het aangeven hoe goed of hoe slecht een gezondheidstoestand 
is, hebben we een meetschaal gemaakt. Op de meetschaal betekent “100” de beste 
gezondheidstoestand die u zich kunt voorstellen, en “0” de slechtste gezondheidstoestand 
die u zich kunt voorstellen.  
We willen u vragen op deze meetschaal aan te geven hoe goed of hoe slecht volgens u uw 
eigen gezondheidstoestand vandaag is.  
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D D I  ( D E F E C A T O R Y  D I S T R E S S  I N V E N T O R Y )  
 
De navolgende verschijnselen zijn beschreven door vrouwen met klachten van de stoelgang. 
Geeft u aan welke verschijnselen u tegenwoordig herkent en hoeveel last u daarvan heeft.  
 
19.  a. Hebt u minder dan driemaal per week ontlasting?  
1. Ja   2. Nee (ga naar 20.)  
 
b. Zo ja, hoeveel last heeft u hier van? 
1. Helemaal niet  2. Een beetje  3. Nogal   4. Heel erg  
 
20. a. Moet u om ontlasting te krijgen in meer dan een kwart van de keren persen?  
1. Ja   2. Nee (ga naar 21.)  
 
b. Zo ja, hoeveel last heeft u hier van? 
1. Helemaal niet  2. Een beetje  3. Nogal   4. Heel erg  
 
21. a. Hebt u wel eens aandrang tot ontlasting terwijl er dan op het toilet geen    
    ontlasting komt?  
1. Ja   2. Nee (ga naar 22.)  
 
b. Zo ja, hoeveel last heeft u hier van? 
1. Helemaal niet  2. Een beetje  3. Nogal   4. Heel erg  
 
22.  a. Hebt u wel eens het gevoel dat er iets uit de anus hangt of er iets voor zit?  
1. Ja   2. Nee (ga naar 23.)  
 
b. Zo ja, hoeveel last heeft u hier van? 
1. Helemaal niet  2. Een beetje  3. Nogal   4. Heel erg 
 
23.  a. Ervaart u pijn tijdens de aandrang tot ontlasting?  
1. Ja   2. Nee (ga naar 24.)  
 
b. Zo ja, hoeveel last heeft u hier van? 
1. Helemaal niet  2. Een beetje  3. Nogal  4. Heel erg  
 
24. a. Ervaart u pijn tijdens of vlak na de ontlasting?  
1. Ja   2. Nee (ga naar 25.)  
 
b. Zo ja, hoeveel last heeft u hier van? 
1. Helemaal niet  2. Een beetje  3. Nogal   4. Heel erg  
 
25.  a. Verliest u wel eens dunne ontlasting zonder dat u daar controle over heeft?  
1. Ja   2. Nee (ga naar 26.)  
 
b. Zo ja, hoeveel last heeft u hier van? 
1. Helemaal niet  2. Een beetje  3. Nogal   4. Heel erg  
 
 
11.  a. Hebt u moeite uw blaas leeg te plassen?  
1. Ja   2. Nee (ga naar 12.)  
         
b. Zo ja, hoeveel last heeft u hier van? 
1. Helemaal niet  2. Een beetje  3. Nogal   4. Heel erg  
 
12.  a. Hebt u wel eens het gevoel dat de blaas na het plassen niet helemaal leeg is?  
1. Ja   2.  Nee (ga naar 13.)  
        
b. Zo ja, hoeveel last heeft u hier van? 
1. Helemaal niet  2. Een beetje  3. Nogal   4. Heel erg 
 
13.  a. Hebt u wel eens een drukkend gevoel onder in de buik?  
1. Ja   2. Nee (ga naar 14.)  
         
b. Zo ja, hoeveel last heeft u hier van? 
1. Helemaal niet  2. Een beetje  3. Nogal   4. Heel erg 
 
14.  a. Hebt u wel eens pijn onder in de buik of in de schaamstreek?  
1. Ja   2. Nee (ga naar 15.)  
         
b. Zo ja, hoeveel last heeft u hier van? 
1. Helemaal niet  2. Een beetje 3. Nogal   4. Heel erg 
 
15.  a. Hebt u wel eens het gevoel dat er iets uit de vagina stulpt?  
1. Ja   2. Nee (ga naar 16.)  
        
b. Zo ja, hoeveel last heeft u hier van? 
1. Helemaal niet  2. Een beetje  3. Nogal   4. Heel erg 
 
16.  a. Hebt u wel eens gezien dat er iets uit de vagina stulpt?  
1. Ja   2. Nee (ga naar 17.)  
        
b. Zo ja, hoeveel last heeft u hier van? 
1. Helemaal niet  2. Een beetje  3. Nogal   4. Heel erg 
 
17.  Hoe vaak hebt u het afgelopen jaar een blaasontsteking gehad?  
1. Nooit  
2. 1 keer  
3. tussen de 2 en 4 keer  
4. meer dan 4 keer  
 
18.  a. Moet u ‘s nachts meer dan 1 keer plassen?  
1. Ja   2. Nee (ga naar 19.)  
 
b. Zo ja, hoeveel last heeft u hier van? 
          1. Helemaal niet  2. Een beetje  3. Nogal   4. Heel erg  
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D D I  ( D E F E C A T O R Y  D I S T R E S S  I N V E N T O R Y )  
 
De navolgende verschijnselen zijn beschreven door vrouwen met klachten van de stoelgang. 
Geeft u aan welke verschijnselen u tegenwoordig herkent en hoeveel last u daarvan heeft.  
 
19.  a. Hebt u minder dan driemaal per week ontlasting?  
1. Ja   2. Nee (ga naar 20.)  
 
b. Zo ja, hoeveel last heeft u hier van? 
1. Helemaal niet  2. Een beetje  3. Nogal   4. Heel erg  
 
20. a. Moet u om ontlasting te krijgen in meer dan een kwart van de keren persen?  
1. Ja   2. Nee (ga naar 21.)  
 
b. Zo ja, hoeveel last heeft u hier van? 
1. Helemaal niet  2. Een beetje  3. Nogal   4. Heel erg  
 
21. a. Hebt u wel eens aandrang tot ontlasting terwijl er dan op het toilet geen    
    ontlasting komt?  
1. Ja   2. Nee (ga naar 22.)  
 
b. Zo ja, hoeveel last heeft u hier van? 
1. Helemaal niet  2. Een beetje  3. Nogal   4. Heel erg  
 
22.  a. Hebt u wel eens het gevoel dat er iets uit de anus hangt of er iets voor zit?  
1. Ja   2. Nee (ga naar 23.)  
 
b. Zo ja, hoeveel last heeft u hier van? 
1. Helemaal niet  2. Een beetje  3. Nogal   4. Heel erg 
 
23.  a. Ervaart u pijn tijdens de aandrang tot ontlasting?  
1. Ja   2. Nee (ga naar 24.)  
 
b. Zo ja, hoeveel last heeft u hier van? 
1. Helemaal niet  2. Een beetje  3. Nogal  4. Heel erg  
 
24. a. Ervaart u pijn tijdens of vlak na de ontlasting?  
1. Ja   2. Nee (ga naar 25.)  
 
b. Zo ja, hoeveel last heeft u hier van? 
1. Helemaal niet  2. Een beetje  3. Nogal   4. Heel erg  
 
25.  a. Verliest u wel eens dunne ontlasting zonder dat u daar controle over heeft?  
1. Ja   2. Nee (ga naar 26.)  
 
b. Zo ja, hoeveel last heeft u hier van? 
1. Helemaal niet  2. Een beetje  3. Nogal   4. Heel erg  
 
 
11.  a. Hebt u moeite uw blaas leeg te plassen?  
1. Ja   2. Nee (ga naar 12.)  
         
b. Zo ja, hoeveel last heeft u hier van? 
1. Helemaal niet  2. Een beetje  3. Nogal   4. Heel erg  
 
12.  a. Hebt u wel eens het gevoel dat de blaas na het plassen niet helemaal leeg is?  
1. Ja   2.  Nee (ga naar 13.)  
        
b. Zo ja, hoeveel last heeft u hier van? 
1. Helemaal niet  2. Een beetje  3. Nogal   4. Heel erg 
 
13.  a. Hebt u wel eens een drukkend gevoel onder in de buik?  
1. Ja   2. Nee (ga naar 14.)  
         
b. Zo ja, hoeveel last heeft u hier van? 
1. Helemaal niet  2. Een beetje  3. Nogal   4. Heel erg 
 
14.  a. Hebt u wel eens pijn onder in de buik of in de schaamstreek?  
1. Ja   2. Nee (ga naar 15.)  
         
b. Zo ja, hoeveel last heeft u hier van? 
1. Helemaal niet  2. Een beetje 3. Nogal   4. Heel erg 
 
15.  a. Hebt u wel eens het gevoel dat er iets uit de vagina stulpt?  
1. Ja   2. Nee (ga naar 16.)  
        
b. Zo ja, hoeveel last heeft u hier van? 
1. Helemaal niet  2. Een beetje  3. Nogal   4. Heel erg 
 
16.  a. Hebt u wel eens gezien dat er iets uit de vagina stulpt?  
1. Ja   2. Nee (ga naar 17.)  
        
b. Zo ja, hoeveel last heeft u hier van? 
1. Helemaal niet  2. Een beetje  3. Nogal   4. Heel erg 
 
17.  Hoe vaak hebt u het afgelopen jaar een blaasontsteking gehad?  
1. Nooit  
2. 1 keer  
3. tussen de 2 en 4 keer  
4. meer dan 4 keer  
 
18.  a. Moet u ‘s nachts meer dan 1 keer plassen?  
1. Ja   2. Nee (ga naar 19.)  
 
b. Zo ja, hoeveel last heeft u hier van? 
          1. Helemaal niet  2. Een beetje  3. Nogal   4. Heel erg  
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I I Q  ( I N C O N T I N E N C E  I M P A C T  Q U E S T I O N N A I R E )  
 
Sommige vrouwen vinden dat ongewenst urineverlies en/of een verzakking en/of problemen 
met de ontlasting hun activiteiten, relaties en gevoelens kunnen beïnvloeden. De vragen in 
onderstaande lijst gaan over aspecten van uw leven die door uw probleem beïnvloed of 
veranderd kunnen zijn. Geef voor iedere vraag het antwoord aan dat het beste beschrijft hoe 
zeer uw activiteiten, relaties en gevoelens beïnvloed worden door uw urineverlies en/of 
verzakking en/of problemen met de ontlasting.  
 
Hoeveel invloed heeft ongewenst urineverlies en/of verzakking en/of problemen met de 
ontlasting gehad op:  
 
30. Uw vermogen om huishoudelijk werk te doen (koken, schoonmaken, wassen)  
1. Helemaal niet  2. Een beetje  3. Nogal  4. Heel erg  
 
31. Uw vermogen om klein onderhoud of reparaties te verrichten in en om het huis 
1. Helemaal niet  2. Een beetje  3. Nogal   4. Heel erg  
 
32. Boodschappen doen en winkelen 
1. Helemaal niet  2. Een beetje  3. Nogal   4. Heel erg  
 
33.  Reizen met auto of openbaar vervoer over een afstand van minder dan 20 minuten  
1. Helemaal niet  2. Een beetje  3. Nogal   4. Heel erg  
 
34.  Ergens naar toe gaan als u niet helemaal zeker weet of er daar toiletten zijn 
1. Helemaal niet  2. Een beetje  3. Nogal   4. Heel erg  
 
35.  Bezoek krijgen van vrienden en kennissen  
1. Helemaal niet  2. Een beetje  3. Nogal   4. Heel erg  
 
36.  Relaties met vrienden en kennissen 
1. Helemaal niet  2. Een beetje  3. Nogal   4. Heel erg  
 
37.  Vermogen om een seksuele relatie te hebben 1 Helemaal niet 2 Een beetje  
1. Helemaal niet  2. Een beetje  3. Nogal   4. Heel erg  
 
38.  Geestelijke / emotionele gezondheid 
1. Helemaal niet  2. Een beetje  3. Nogal   4. Heel erg  
 
39.  Wordt u in uw activiteiten beperkt door angst dat anderen u ruiken?  
1. Helemaal niet  2. Een beetje  3. Nogal   4. Heel erg  
 
Hebt u als gevolg van uw probleem de volgende gevoelens?  
 
40.  Nervositeit of ongerustheid 
1. Helemaal niet  2. Een beetje  3. Nogal   4. Heel erg  
 
41.  Frustratie 
1. Helemaal niet  2. Een beetje  3. Nogal   4. Heel erg  
 
42.  Zich gegeneerd voelen 
1. Helemaal niet  2. Een beetje  3. Nogal   4. Heel erg  
 
c. Hoe vaak komt het voor?  
1. dagelijks 
2. paar keer per week 
3. 1 keer per week  
4. 1 keer per maand  
5. 1 keer per jaar  
 
26.  a. Verliest u wel eens vaste ontlasting zonder dat u daar controle over heeft?  
1. Ja   2. Nee (ga naar 27.)  
 
b. Zo ja, hoeveel last heeft u hier van? 
1. Helemaal niet  2. Een beetje  3. Nogal   4. Heel erg  
 
c. Hoe vaak komt het voor?  
1. dagelijks  
2. paar keer per week  
3. 1 keer per week  
4. 1 keer per maand  
5. 1 keer per jaar  
 
27. a. Verliest u wel eens windjes zonder dat u daar controle over heeft?  
1. Ja   2. Nee (ga naar 28.)  
 
b. Zo ja, hoeveel last heeft u hier van? 
1. Helemaal niet  2. Een beetje  3. Nogal   4. Heel erg  
 
c. Hoe vaak komt het voor?  
1. dagelijks  
2. paar keer per week  
3. 1 keer per week  
4. 1 keer per maand  
5. 1 keer per jaar  
 
28. a. Moet u wel eens via de schede mee drukken om ontlasting te krijgen?  
1. Ja   2. Nee (ga naar 29.)  
 
b. Zo ja, hoeveel last heeft u hier van? 
1. Helemaal niet  2. Een beetje  3. Nogal   4. Heel erg  
 
29.  a. Moet u de ontlasting wel eens met de vingers via de anus verwijderen?  
1. Ja  2. Nee (ga naar 30.)  
 
b. Zo ja, hoeveel last heeft u hier van? 
1. Helemaal niet  2. Een beetje  3. Nogal   4. Heel erg  
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I I Q  ( I N C O N T I N E N C E  I M P A C T  Q U E S T I O N N A I R E )  
 
Sommige vrouwen vinden dat ongewenst urineverlies en/of een verzakking en/of problemen 
met de ontlasting hun activiteiten, relaties en gevoelens kunnen beïnvloeden. De vragen in 
onderstaande lijst gaan over aspecten van uw leven die door uw probleem beïnvloed of 
veranderd kunnen zijn. Geef voor iedere vraag het antwoord aan dat het beste beschrijft hoe 
zeer uw activiteiten, relaties en gevoelens beïnvloed worden door uw urineverlies en/of 
verzakking en/of problemen met de ontlasting.  
 
Hoeveel invloed heeft ongewenst urineverlies en/of verzakking en/of problemen met de 
ontlasting gehad op:  
 
30. Uw vermogen om huishoudelijk werk te doen (koken, schoonmaken, wassen)  
1. Helemaal niet  2. Een beetje  3. Nogal  4. Heel erg  
 
31. Uw vermogen om klein onderhoud of reparaties te verrichten in en om het huis 
1. Helemaal niet  2. Een beetje  3. Nogal   4. Heel erg  
 
32. Boodschappen doen en winkelen 
1. Helemaal niet  2. Een beetje  3. Nogal   4. Heel erg  
 
33.  Reizen met auto of openbaar vervoer over een afstand van minder dan 20 minuten  
1. Helemaal niet  2. Een beetje  3. Nogal   4. Heel erg  
 
34.  Ergens naar toe gaan als u niet helemaal zeker weet of er daar toiletten zijn 
1. Helemaal niet  2. Een beetje  3. Nogal   4. Heel erg  
 
35.  Bezoek krijgen van vrienden en kennissen  
1. Helemaal niet  2. Een beetje  3. Nogal   4. Heel erg  
 
36.  Relaties met vrienden en kennissen 
1. Helemaal niet  2. Een beetje  3. Nogal   4. Heel erg  
 
37.  Vermogen om een seksuele relatie te hebben 1 Helemaal niet 2 Een beetje  
1. Helemaal niet  2. Een beetje  3. Nogal   4. Heel erg  
 
38.  Geestelijke / emotionele gezondheid 
1. Helemaal niet  2. Een beetje  3. Nogal   4. Heel erg  
 
39.  Wordt u in uw activiteiten beperkt door angst dat anderen u ruiken?  
1. Helemaal niet  2. Een beetje  3. Nogal   4. Heel erg  
 
Hebt u als gevolg van uw probleem de volgende gevoelens?  
 
40.  Nervositeit of ongerustheid 
1. Helemaal niet  2. Een beetje  3. Nogal   4. Heel erg  
 
41.  Frustratie 
1. Helemaal niet  2. Een beetje  3. Nogal   4. Heel erg  
 
42.  Zich gegeneerd voelen 
1. Helemaal niet  2. Een beetje  3. Nogal   4. Heel erg  
 
c. Hoe vaak komt het voor?  
1. dagelijks 
2. paar keer per week 
3. 1 keer per week  
4. 1 keer per maand  
5. 1 keer per jaar  
 
26.  a. Verliest u wel eens vaste ontlasting zonder dat u daar controle over heeft?  
1. Ja   2. Nee (ga naar 27.)  
 
b. Zo ja, hoeveel last heeft u hier van? 
1. Helemaal niet  2. Een beetje  3. Nogal   4. Heel erg  
 
c. Hoe vaak komt het voor?  
1. dagelijks  
2. paar keer per week  
3. 1 keer per week  
4. 1 keer per maand  
5. 1 keer per jaar  
 
27. a. Verliest u wel eens windjes zonder dat u daar controle over heeft?  
1. Ja   2. Nee (ga naar 28.)  
 
b. Zo ja, hoeveel last heeft u hier van? 
1. Helemaal niet  2. Een beetje  3. Nogal   4. Heel erg  
 
c. Hoe vaak komt het voor?  
1. dagelijks  
2. paar keer per week  
3. 1 keer per week  
4. 1 keer per maand  
5. 1 keer per jaar  
 
28. a. Moet u wel eens via de schede mee drukken om ontlasting te krijgen?  
1. Ja   2. Nee (ga naar 29.)  
 
b. Zo ja, hoeveel last heeft u hier van? 
1. Helemaal niet  2. Een beetje  3. Nogal   4. Heel erg  
 
29.  a. Moet u de ontlasting wel eens met de vingers via de anus verwijderen?  
1. Ja  2. Nee (ga naar 30.)  
 
b. Zo ja, hoeveel last heeft u hier van? 
1. Helemaal niet  2. Een beetje  3. Nogal   4. Heel erg  
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V r a g e n l i j s t  s e k s u e e l  f u n c t i o n e r e n  b i j  
v e r z a k k i n g  e n  o n g ew en s t  u r i n e v e r l i e s  ( k o r t e  
v e r s i e :  P I S Q - 1 2 )  
 
Voor u ligt een lijst met vragen over het seksueel leven van u en uw partner. Alle informatie is 
strikt vertrouwelijk. Bij het beantwoorden van de vragen gaat u uit van uw seksueel leven van 
de afgelopen 6 maanden..  
 
1. Hoe vaak verlangt u naar seks? Dit verlangen kan bestaan uit het willen hebben van 
seks, het plannen van seks, gevoelens van frustratie door een gebrek aan seks, 
enzovoorts.  
1. Dagelijks 
2. Wekelijks     
3. Maandelijks   
4. < 1 keer per maand   
5. Nooit  
 
2.  Heeft u een orgasme tijdens geslachtsgemeenschap met uw partner?  
1. Altijd   
2. Meestal   
3. Soms   
4. Zelden  
5. Nooit  
 
3.  Voelt u zich seksueel opgewonden tijdens seksuele activiteiten met uw partner?  
1. Altijd   
2. Meestal   
3. Soms   
4. Zelden    
5. Nooit  
 
4.  Hoe tevreden bent u over de afwisseling in seksuele activiteiten in uw huidige 
seksleven?  
1. Zeer tevreden  
2. Redelijk tevreden 
3. Noch tevreden, noch ontevreden  
4. Redelijk ontevreden 
5. Zeer ontevreden  
 
5.  Heeft u pijn tijdens geslachtsgemeenschap?  
1. Altijd    
2. Meestal  
3. Soms   
4. Zelden   
5. Nooit  
 
6.  Heeft u ongewenst urineverlies tijdens seksuele activiteiten? 
1. Altijd    
 
V r a g e n l i j s t  s e k s u e l e  d i s f u n c t i e s  
 
De volgende vragen gaan over de seksualiteit. Het is de bedoeling dat u bij het 
beantwoorden denkt aan de situatie van de afgelopen maand. Wilt U het voor u meest 
passende antwoord omcirkelen.  
 
43.  a. Hebt u wel eens seksueel contact met uw partner? (Denk hierbij aan alle vormen 
van seksueel  contact en niet alleen aan geslachtsgemeenschap)  
1. Ja (beantwoord ook vraag b)  
 
b. Zo ja, hoe tevreden bent u daarover?  
1. Helemaal niet  2. Een beetje  3. Nogal   4. Heel erg  
 
c. Zo nee, hoe vervelend vindt u dat? 
1. Helemaal niet  2. Een beetje  3. Nogal   4. Heel erg  
 
44.  Hoe vaak hebt u geslachtsgemeenschap?  
1. Nooit  
2. minder dan 1 keer per maand  
3. 1 tot 2 keer per maand  
4. 1 keer per week  
5. meerdere keren per week  
 
45.  a. Verliest u wel eens urine tijdens de geslachtsgemeenschap? 
1. Ja  2. Nee (ga naar 46.)  99.  Niet van toepassing (geen seks)  
 
b. Zo ja, hoeveel last heeft u hier van? 
1. Helemaal niet  2. Een beetje  3. Nogal   4. Heel erg  
 
46. a. Ervaart u pijn tijdens de geslachtsgemeenschap? 
1. Ja  2. Nee (ga naar 47.)  99. niet van toepassing (geen seks)  
 
b. Zo ja, hoeveel last heeft u hier van? 
1. Helemaal niet  2. Een beetje  3. Nogal   4. Heel erg  
 
47. a. Is de vagina zo nauw dat geslachtsgemeenschap daardoor niet mogelijk is?  
1. Ja 2. Nee   99 niet van toepassing (geen seks)  
 
b. Zo ja, hoeveel last heeft u hier van?  
1. Helemaal niet  2. Een beetje  3. Nogal   4. Heel erg  
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V r a g e n l i j s t  s e k s u e e l  f u n c t i o n e r e n  b i j  
v e r z a k k i n g  e n  o n g ew en s t  u r i n e v e r l i e s  ( k o r t e  
v e r s i e :  P I S Q - 1 2 )  
 
Voor u ligt een lijst met vragen over het seksueel leven van u en uw partner. Alle informatie is 
strikt vertrouwelijk. Bij het beantwoorden van de vragen gaat u uit van uw seksueel leven van 
de afgelopen 6 maanden..  
 
1. Hoe vaak verlangt u naar seks? Dit verlangen kan bestaan uit het willen hebben van 
seks, het plannen van seks, gevoelens van frustratie door een gebrek aan seks, 
enzovoorts.  
1. Dagelijks 
2. Wekelijks     
3. Maandelijks   
4. < 1 keer per maand   
5. Nooit  
 
2.  Heeft u een orgasme tijdens geslachtsgemeenschap met uw partner?  
1. Altijd   
2. Meestal   
3. Soms   
4. Zelden  
5. Nooit  
 
3.  Voelt u zich seksueel opgewonden tijdens seksuele activiteiten met uw partner?  
1. Altijd   
2. Meestal   
3. Soms   
4. Zelden    
5. Nooit  
 
4.  Hoe tevreden bent u over de afwisseling in seksuele activiteiten in uw huidige 
seksleven?  
1. Zeer tevreden  
2. Redelijk tevreden 
3. Noch tevreden, noch ontevreden  
4. Redelijk ontevreden 
5. Zeer ontevreden  
 
5.  Heeft u pijn tijdens geslachtsgemeenschap?  
1. Altijd    
2. Meestal  
3. Soms   
4. Zelden   
5. Nooit  
 
6.  Heeft u ongewenst urineverlies tijdens seksuele activiteiten? 
1. Altijd    
 
V r a g e n l i j s t  s e k s u e l e  d i s f u n c t i e s  
 
De volgende vragen gaan over de seksualiteit. Het is de bedoeling dat u bij het 
beantwoorden denkt aan de situatie van de afgelopen maand. Wilt U het voor u meest 
passende antwoord omcirkelen.  
 
43.  a. Hebt u wel eens seksueel contact met uw partner? (Denk hierbij aan alle vormen 
van seksueel  contact en niet alleen aan geslachtsgemeenschap)  
1. Ja (beantwoord ook vraag b)  
 
b. Zo ja, hoe tevreden bent u daarover?  
1. Helemaal niet  2. Een beetje  3. Nogal   4. Heel erg  
 
c. Zo nee, hoe vervelend vindt u dat? 
1. Helemaal niet  2. Een beetje  3. Nogal   4. Heel erg  
 
44.  Hoe vaak hebt u geslachtsgemeenschap?  
1. Nooit  
2. minder dan 1 keer per maand  
3. 1 tot 2 keer per maand  
4. 1 keer per week  
5. meerdere keren per week  
 
45.  a. Verliest u wel eens urine tijdens de geslachtsgemeenschap? 
1. Ja  2. Nee (ga naar 46.)  99.  Niet van toepassing (geen seks)  
 
b. Zo ja, hoeveel last heeft u hier van? 
1. Helemaal niet  2. Een beetje  3. Nogal   4. Heel erg  
 
46. a. Ervaart u pijn tijdens de geslachtsgemeenschap? 
1. Ja  2. Nee (ga naar 47.)  99. niet van toepassing (geen seks)  
 
b. Zo ja, hoeveel last heeft u hier van? 
1. Helemaal niet  2. Een beetje  3. Nogal   4. Heel erg  
 
47. a. Is de vagina zo nauw dat geslachtsgemeenschap daardoor niet mogelijk is?  
1. Ja 2. Nee   99 niet van toepassing (geen seks)  
 
b. Zo ja, hoeveel last heeft u hier van?  
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2. Meestal 
3. Soms  
4. Zelden  
 5. Nooit  
 
7.  Wordt u in uw seksuele activiteiten beperkt door angst voor ongewenst verlies van 
ontlasting of urine?  
1. Altijd 
2. Meestal 
3. Soms 
4. Zelden 
5. Nooit  
 
8.  Vermijdt u geslachtsgemeenschap vanwege een uitstulping in de vagina 
(verzakking van blaas, endeldarm of vagina)?  
1. Altijd 
2. Meestal 
3. Soms   
4. Zelden    
5. Nooit  
 
9.  Wanneer u seks heeft met uw partner, heeft u dan negatieve emotionele reacties, 
zoals angst, afkeer, schaamte of schuldgevoel?  
1. Altijd  
2. Meestal   
3. Soms   
4. Zelden    
5. Nooit  
 
10.  Heeft uw partner een erectieprobleem dat uw seksuele activiteiten beïnvloedt?  
1. Altijd   
2. Meestal   
3. Soms   
4. Zelden   
5. Nooit  
 
11.  Heeft uw partner een probleem met voortijdige zaadlozing dat uw seksuele 
activiteiten beïnvloedt?  
1. Altijd  
 2. Meestal  
 3. Soms   
4. Zelden   
 5. Nooit  
 
12.  Hoe intens zijn de orgasmen die u in de afgelopen 6 maanden heeft gehad in 
vergelijking met orgasmen in het verleden?  
1. Veel minder intens  
2. Minder intens 
3. Dezelfde intensiteit 
4. Meer intens  
5. Veel meer intens  
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Het is af! Eindelijk! Een aantal mensen wil ik bedanken omdat het ontstaan van dit 
proefschrift mede door hen is mogelijk gemaakt.  
 
Allereerst wil ik graag alle vrouwen bedanken die aan de verschillende studies hebben 
meegedaan. Zonder hun deelname was dit onderzoek niet mogelijk geweest.  
 
Veel dank ben ik verschuldigd aan mijn promotor prof. dr. M. E. Vierhout en mijn co-
promotoren dr. H.W.F. van Eijndhoven en dr. K.B. Kluivers.   
 
Mark, ik ben dankbaar dat ik gebruik heb mogen maken van jouw enorme expertise en 
ervaring op het gebied van de urogynaecologie. Ik kan me nog goed herinneren dat je 
tijdens onze eerste kennismaking in 2010 waarschuwde voor de combinatie opleiding en 
promotie. Iets dat niet geheel onterecht bleek! Gelukkig ben je altijd geduldig gebleven en 
heb ik onder jouw hoede dit proefschrift kunnen voltooien. Bedankt voor je begeleiding!   
 
Hugo, hoewel je op sommige momenten getwijfeld moet hebben of dit proefschrift de 
eindstreep zou halen, ben ik dankbaar voor je vertrouwen en de mogelijkheid om me 
wetenschappelijk te verdiepen. Ik ben trots dat we dit project samen tot een goed einde 
hebben weten te brengen en ook op onze successen (hoewel we wat jou betreft daar niet al 
te lang bij stilstaan, er moet vooral doorgewerkt worden...). Van jou (en Jan) heb ik geleerd 
dat je soms de lat hoog moet durven leggen. Heel erg bedankt! 
 
Kirsten, jouw kritische wetenschappelijk blik en commentaar op de manuscripten zorgden 
(naast vaak extra werk..) er zeker voor dat de stukken naar een higher level werden getild. 
Dank voor je enthousiasme maar ook opbeurende en aanmoedigende woorden als het 
nodig was. Het was heel fijn om met je samen te werken de afgelopen jaren! 
 
Jan den Boon, hoewel je geen co-promotor bent, verdien je wat mij betreft met jouw inzet en 
betrokkenheid bij de SAVE U trial en dit proefschrift wel de eerste plek na de co-promotoren 
in mijn dankwoord. Met plezier denk ik terug aan onze samenwerking en ik heb veel respect 
voor de keuze die je hebt gemaakt om de (uro)gynaecologie te verlaten. Dank voor je 
ideeën, hulp en enthousiasme!  
 
Leden van de leescommissie, prof. dr. Lagro-Janssen, dr. Heesakkers en prof. dr. van der 
Vaart wil ik bedanken voor het beoordelen van dit proefschrift.   
 
Alle medewerkers en onderzoekers van het consortium wil ik bedanken voor de 
ondersteuning, faciliteiten en onderwijsmomenten.  
 
Alle gynaecologen in de deelnemende centra en met name Jelle Stekelenburg, Robert 
Hakvoort, Astrid Vollebregt en Akeel Alhafidh wil ik bedanken voor hun inzet om patiënten te 
includeren in de SAVE U trial en terug te zien voor follow-up.   
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Lieve familie, vriendinnen en vrienden. Hoewel ik niet iedereen persoonlijk kan noemen, wil 
ik jullie allemaal bedanken voor de interesse in mijn onderzoek maar vooral ook voor alle 
leuke en fijne momenten daarnaast!  
 
Lieve (Ilse) Kreuwel, ik heb erg genoten van de etentjes, glazen wijn en gesprekken samen. 
Je enthousiasme als er weer een stuk werd geaccepteerd maakte de laatste loodjes minder 
zwaar. Dank voor je hulp en bereidheid om mee te denken met veel zaken. Nu is het echt tijd 
voor champagne! 
  
Mijn paranimfen Ellen Lammerink en Dianne Heijink wil ik ook in het bijzonder noemen.  
Lieve Ellen, jouw nuchtere Twentse houding en eerlijkheid kan ik erg waarderen. Het was fijn 
om met je te kunnen sparren over vanalles de afgelopen periode. Na 5000 km samen op de 
fiets in 9 maanden tijd kan ik met recht zeggen dat je naast een zeer gewaardeerde collega 
ook echt een maatje-for-life bent geworden!  
Lieve Dianne, ik ken maar weinig mensen die met zoveel gedrevenheid en plezier hun vak als 
arts uitoefenen en ik bewonder enorm je toewijding en kritische blik. Van samen in de 
collegebanken, naar paranimf bij jouw promotie, naar straks samen in Amsterdam, wat 
hebben we al veel meegemaakt! Onze vriendschap is mij heel dierbaar. 
 
Mijn lieve zussen, Anique, Denise en Michelle.   
Anique, hoewel we vroeger niet de meest harmonieuze zussen waren..;-), zijn we in de loop 
der jaren steeds meer naar elkaar toegegroeid. Ik geniet van onze ritjes op de racefiets 
samen en hoop dat ik nog vaak bij Jorne en jou mag aanschuiven voor een gezellig etentje. 
Ik ben trots op mijn grote zus! 
Denise, jij bent denk ik wel de hardst werkende van ons allemaal met soms drie bijbaantjes, 
een studie en een druk sociaal leven. Het is dan ook bijna logisch dat je niet aanwezig bent 
bij mijn promotie omdat je aan de andere kant van de wereld woont (wat ik natuurlijk wel 
heel jammer vind!). Maar ik heb heel veel bewondering voor je! 
Mies, mijn jongste zus met wie ik nu zelfs even samenwoon! Met heel veel plezier denk ik 
terug aan onze fijne reizen (you and me nyc) en culturele uitstapjes. Ik hoop dat we dit nog 
heel lang blijven doen! Ik ben zo blij met jou als zusje. Love you! 
Mijn lieve broertje Max. Als ‘Benjamin’ van de familie heb je een speciaal plekje in mijn hart. 
Ik hoop dat je altijd zo knap, grappig en sociaal blijft als je bent!  
 
Lieve pap en mam, het is fijn en dankbaar om te weten dat jullie er altijd zijn om op terug te 
vallen en dat jullie onvoorwaardelijk achter me staan. Dank voor alles wat jullie voor mij 
hebben gedaan. Ik houd heel veel van jullie!  
 
 
R e n é e  
 
 
Alle logistiek rondom de SAVE U trial had ik niet kunnen doen zonder de hulp van Nitolanda 
van Rijn. Wat een geluk had ik met jouw aanstelling als research-nurse! Ik kon met een gerust 
hart de coördinatie van de follow-up aan jou over laten toen ik naar Groningen vertrok. Heel 
veel dank voor alles!  
Jody van Walraven, bedankt voor je hulp en inzet bij het invoeren van de SAVE U data.  
 
Alle mede-auteurs en onderzoekers die meegewerkt hebben aan één of meer projecten wil 
ik bedanken voor hun inbreng.  
 
Mijn onderzoeksmaatje Mèlanie van IJsselmuiden. Promoveren naast een fulltime 
baan/opleiding is best een uitdaging en ik heb het als heel prettig ervaren dat we regelmatig 
contact hadden en ideeën bespraken. Je enthousiasme werkte aanstekelijk en motiverend. Ik 
ben onder de indruk van je voortvarendheid en heb er alle vertrouwen in dat jouw 
proefschrift vlot af is! 
 
De ‘Brisbane girls’ Karin Lammers en Nevine te West. Lieve meiden, met heel veel plezier 
denk ik terug aan mijn eerste IUGA congres in 2012 in Australië waar we elkaar hebben 
ontmoet. Naast de congressen hebben we inmiddels al de nodige etentjes en feestjes achter 
de rug en het is altijd fijn om jullie te treffen. Ik hoop dan ook dat we elkaar nog vaak blijven 
zien! 
 
Mijn opleider prof. dr. M.J. E. Mourits. Marian, bedankt dat je mij het vertrouwen en de  
mogelijkheid hebt gegeven om naast mijn opleiding dit proefschrift te kunnen schrijven.  
 
Lieve collega AIOS in Zwolle, Groningen en Leeuwarden. Dank voor de fijne samenwerking, 
alle borrels, cappuccino’s én gezelligheid op de werkvloer!   
 
Ik wil al mijn collega’s in het Medisch Centrum Leeuwarden en opleider Leonard Morssink 
hartelijk bedanken voor de interesse tijdens de afrondende fase van dit proefschrift. Ik heb 
de samenwerking en sfeer in de maanden dat ik bij jullie in opleiding was altijd als erg 
prettig ervaren. Jullie mogen trots zijn op het veilige leerklimaat dat jullie weten te creëren 
waarbij vertrouwen, gezelligheid en humor niet ontbreken. 
 
Alle (oud-)collega’s in de Isala te Zwolle. Mijn eerste jaren als A(N)IOS heb ik in de Isala 
gewerkt. Deze periode zal ik altijd blijven herinneren als een heel bijzondere en fijne tijd. 
Dank aan iedereen die me destijds heeft geholpen bij het opstarten van de SAVE U trial. Het 
is fijn om weer op het oude nest terug te komen! Harm de Haan en Ben Cohlen wil ik nog in 
het bijzonder noemen. Naast dat ik veel aan jullie heb gehad als opleiders wil ik jullie 
bedanken voor jullie steun op het moment dat het nodig was.   
 
Het wielrennen was de afgelopen jaren een heerlijke vorm van (soms teveel) afleiding. 
Iedereen van Gyn-For-Life, de Gyn-Tonics en andere fietsmaatjes wil ik bedanken voor de 
gezellige uren samen op de fiets!  
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Alle mede-auteurs en onderzoekers die meegewerkt hebben aan één of meer projecten wil 
ik bedanken voor hun inbreng.  
 
Mijn onderzoeksmaatje Mèlanie van IJsselmuiden. Promoveren naast een fulltime 
baan/opleiding is best een uitdaging en ik heb het als heel prettig ervaren dat we regelmatig 
contact hadden en ideeën bespraken. Je enthousiasme werkte aanstekelijk en motiverend. Ik 
ben onder de indruk van je voortvarendheid en heb er alle vertrouwen in dat jouw 
proefschrift vlot af is! 
 
De ‘Brisbane girls’ Karin Lammers en Nevine te West. Lieve meiden, met heel veel plezier 
denk ik terug aan mijn eerste IUGA congres in 2012 in Australië waar we elkaar hebben 
ontmoet. Naast de congressen hebben we inmiddels al de nodige etentjes en feestjes achter 
de rug en het is altijd fijn om jullie te treffen. Ik hoop dan ook dat we elkaar nog vaak blijven 
zien! 
 
Mijn opleider prof. dr. M.J. E. Mourits. Marian, bedankt dat je mij het vertrouwen en de  
mogelijkheid hebt gegeven om naast mijn opleiding dit proefschrift te kunnen schrijven.  
 
Lieve collega AIOS in Zwolle, Groningen en Leeuwarden. Dank voor de fijne samenwerking, 
alle borrels, cappuccino’s én gezelligheid op de werkvloer!   
 
Ik wil al mijn collega’s in het Medisch Centrum Leeuwarden en opleider Leonard Morssink 
hartelijk bedanken voor de interesse tijdens de afrondende fase van dit proefschrift. Ik heb 
de samenwerking en sfeer in de maanden dat ik bij jullie in opleiding was altijd als erg 
prettig ervaren. Jullie mogen trots zijn op het veilige leerklimaat dat jullie weten te creëren 
waarbij vertrouwen, gezelligheid en humor niet ontbreken. 
 
Alle (oud-)collega’s in de Isala te Zwolle. Mijn eerste jaren als A(N)IOS heb ik in de Isala 
gewerkt. Deze periode zal ik altijd blijven herinneren als een heel bijzondere en fijne tijd. 
Dank aan iedereen die me destijds heeft geholpen bij het opstarten van de SAVE U trial. Het 
is fijn om weer op het oude nest terug te komen! Harm de Haan en Ben Cohlen wil ik nog in 
het bijzonder noemen. Naast dat ik veel aan jullie heb gehad als opleiders wil ik jullie 
bedanken voor jullie steun op het moment dat het nodig was.   
 
Het wielrennen was de afgelopen jaren een heerlijke vorm van (soms teveel) afleiding. 
Iedereen van Gyn-For-Life, de Gyn-Tonics en andere fietsmaatjes wil ik bedanken voor de 
gezellige uren samen op de fiets!  
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Renée Jeanine Detollenaere werd op 9 mei 1984 geboren in Elburg, als tweede dochter van 
Camille Detollenaere en Roeli Eling. Op het Lambert Franckens College te Elburg haalde zij 
in 2002 haar VWO diploma. Hierna begon zij aan de studie Geneeskunde aan de 
Rijksuniversiteit Groningen. In 2003 haalde zij haar propedeuse. Na een wetenschappelijke 
stage op de afdeling Neonatologie in het Universitair Medisch Centrum Groningen 
(begeleider Prof. dr. A.F. Bos)  volgde zij haar co-schappen in de Isala klinieken Zwolle. Na 
een keuze co-schap Gynaecologie in Zwolle behaalde zij in mei 2008 cum laude haar 
artsexamen en aansluitend is zij als arts-assistent gaan werken in de Isala klinieken te Zwolle. 
Onder leiding van Hugo van Eijndhoven en Jan den Boon werd in het voorjaar van 2009 
gestart met het opzetten van de SAVE U trial en dit leidde tot een promotieonderzoek in 
samenwerking met de Radboud Universiteit Nijmegen (begeleiders Prof. dr. M.E. Vierhout, 
dr. K.B. Kluivers en dr. H.W.F. van Eijndhoven). In september 2011 startte zij met de opleiding 
tot gynaecoloog in de Isala klinieken (opleider dr. H.H. de Haan) en van oktober 2012 tot 
april 2015 was zij werkzaam in het Universitair Medisch Centrum Groningen (opleider Prof. 
dr. M.J.E Mourits). Tot januari 2016 werkt zij in het Medisch Centrum Leeuwarden (opleider 
dr. L.M. Morssink) en vanaf januari 2016 zal zij weer werkzaam zijn in de Isala (opleider dr. B.J. 
Cohlen).  Het laatste jaar van haar opleiding gaat ze een differentiatiestage  
Voortplantingsgeneeskunde volgen. 
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